Search Results

Cancer LncRNAID LncRNAName SubpathwayID PathwayName GeneNumber t Pvalue pAdj Cytoscape
CESC ENSG00000228151 AC004941.3 path:00250_31 Alanine, aspartate and glutamate metabolism 10 -4.00305602273776 8.98468021200511e-05 0.0345910188162197
CESC ENSG00000203335 AC006019.3 path:00250_31 Alanine, aspartate and glutamate metabolism 10 -3.99686568024612 9.2461190772425e-05 0.0355975584473836
CESC ENSG00000241409 AC064852.4 path:00010_108 Glycolysis / Gluconeogenesis 3 3.51329802104095 0.000562791938726669 0.0171867999749606
CESC ENSG00000241409 AC064852.4 path:00510_40 N-Glycan biosynthesis 16 -3.21897217651883 0.00153142365006481 0.0357632464162194
CESC ENSG00000241409 AC064852.4 path:00512_18 Mucin type O-Glycan biosynthesis 9 -4.0118004152032 9.13442846081003e-05 0.00725273619788317
CESC ENSG00000241409 AC064852.4 path:00532_1 Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate 5 -4.49638211431987 1.39142722169379e-05 0.00138099151753109
CESC ENSG00000241409 AC064852.4 path:04152_47 AMPK signaling pathway 30 -4.77319571316324 4.44729609116668e-06 0.00111543557269143
CESC ENSG00000241409 AC064852.4 path:04710_1 Circadian rhythm 27 -3.67597318290248 0.000308794380609024 0.0122026978294373
CESC ENSG00000241409 AC064852.4 path:04713_21 Circadian entrainment 64 -3.33364606698491 0.0010316754424713 0.0255984469163192
CESC ENSG00000241409 AC064852.4 path:04724_15 Glutamatergic synapse 75 -3.91536691507604 0.000131710868218703 0.00746988781183213
CESC ENSG00000241409 AC064852.4 path:04730_2 Long-term depression 52 -3.58182135156347 0.000447861135295769 0.014816739226035
CESC ENSG00000241409 AC064852.4 path:04911_2 Insulin secretion 52 -4.69486549483665 5.61932278433969e-06 0.00111543557269143
CESC ENSG00000241409 AC064852.4 path:04918_12 Thyroid hormone synthesis 39 -4.55812316372109 1.01651560232419e-05 0.00134518898040902
CESC ENSG00000241409 AC064852.4 path:04961_1 Endocrine and other factor-regulated calcium reabsorption 33 -3.39142660245134 0.000847520780089249 0.0224310499796955
CESC ENSG00000241409 AC064852.4 path:04962_1 Vasopressin-regulated water reabsorption 19 -3.6696225918165 0.000323778004137094 0.0122026978294373
CESC ENSG00000241409 AC064852.4 path:04970_1 Salivary secretion 32 -3.93238680874304 0.000123972024284854 0.00746988781183213
CESC ENSG00000241409 AC064852.4 path:05030_37 Cocaine addiction 11 -3.43163660920162 0.000756457731304323 0.0214509799519869
CESC ENSG00000241409 AC064852.4 path:05032_1 Morphine addiction 63 -3.67700642294971 0.000314562143376863 0.0122026978294373
CESC ENSG00000241409 AC064852.4 path:05034_52 Alcoholism 26 -3.65639047748657 0.000338110015425214 0.0122026978294373
CESC ENSG00000237087 AC068134.6 path:00010_108 Glycolysis / Gluconeogenesis 3 3.51329802104095 0.000562791938726669 0.0171867999749606
CESC ENSG00000237087 AC068134.6 path:00510_40 N-Glycan biosynthesis 16 -3.21897217651883 0.00153142365006481 0.0357632464162194
CESC ENSG00000237087 AC068134.6 path:00512_18 Mucin type O-Glycan biosynthesis 9 -4.0118004152032 9.13442846081003e-05 0.00725273619788317
CESC ENSG00000237087 AC068134.6 path:00532_1 Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate 5 -4.49638211431987 1.39142722169379e-05 0.00138099151753109
CESC ENSG00000237087 AC068134.6 path:04152_47 AMPK signaling pathway 30 -4.77319571316324 4.44729609116668e-06 0.00111543557269143
CESC ENSG00000237087 AC068134.6 path:04710_1 Circadian rhythm 27 -3.67597318290248 0.000308794380609024 0.0122026978294373
CESC ENSG00000237087 AC068134.6 path:04713_21 Circadian entrainment 64 -3.33364606698491 0.0010316754424713 0.0255984469163192
CESC ENSG00000237087 AC068134.6 path:04724_15 Glutamatergic synapse 75 -3.91536691507604 0.000131710868218703 0.00746988781183213
CESC ENSG00000237087 AC068134.6 path:04730_2 Long-term depression 52 -3.58182135156347 0.000447861135295769 0.014816739226035
CESC ENSG00000237087 AC068134.6 path:04911_2 Insulin secretion 52 -4.69486549483665 5.61932278433969e-06 0.00111543557269143
CESC ENSG00000237087 AC068134.6 path:04918_12 Thyroid hormone synthesis 39 -4.55812316372109 1.01651560232419e-05 0.00134518898040902
CESC ENSG00000237087 AC068134.6 path:04961_1 Endocrine and other factor-regulated calcium reabsorption 33 -3.39142660245134 0.000847520780089249 0.0224310499796955
CESC ENSG00000237087 AC068134.6 path:04962_1 Vasopressin-regulated water reabsorption 19 -3.6696225918165 0.000323778004137094 0.0122026978294373
CESC ENSG00000237087 AC068134.6 path:04970_1 Salivary secretion 32 -3.93238680874304 0.000123972024284854 0.00746988781183213
CESC ENSG00000237087 AC068134.6 path:05030_37 Cocaine addiction 11 -3.43163660920162 0.000756457731304323 0.0214509799519869
CESC ENSG00000237087 AC068134.6 path:05032_1 Morphine addiction 63 -3.67700642294971 0.000314562143376863 0.0122026978294373
CESC ENSG00000237087 AC068134.6 path:05034_52 Alcoholism 26 -3.65639047748657 0.000338110015425214 0.0122026978294373
CESC ENSG00000224516 AC068134.8 path:00010_108 Glycolysis / Gluconeogenesis 3 3.51329802104095 0.000562791938726669 0.0171867999749606
CESC ENSG00000224516 AC068134.8 path:00510_40 N-Glycan biosynthesis 16 -3.21897217651883 0.00153142365006481 0.0357632464162194
CESC ENSG00000224516 AC068134.8 path:00512_18 Mucin type O-Glycan biosynthesis 9 -4.0118004152032 9.13442846081003e-05 0.00725273619788317
CESC ENSG00000224516 AC068134.8 path:00532_1 Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate 5 -4.49638211431987 1.39142722169379e-05 0.00138099151753109
CESC ENSG00000224516 AC068134.8 path:04152_47 AMPK signaling pathway 30 -4.77319571316324 4.44729609116668e-06 0.00111543557269143
CESC ENSG00000224516 AC068134.8 path:04710_1 Circadian rhythm 27 -3.67597318290248 0.000308794380609024 0.0122026978294373
CESC ENSG00000224516 AC068134.8 path:04713_21 Circadian entrainment 64 -3.33364606698491 0.0010316754424713 0.0255984469163192
CESC ENSG00000224516 AC068134.8 path:04724_15 Glutamatergic synapse 75 -3.91536691507604 0.000131710868218703 0.00746988781183213
CESC ENSG00000224516 AC068134.8 path:04730_2 Long-term depression 52 -3.58182135156347 0.000447861135295769 0.014816739226035
CESC ENSG00000224516 AC068134.8 path:04911_2 Insulin secretion 52 -4.69486549483665 5.61932278433969e-06 0.00111543557269143
CESC ENSG00000224516 AC068134.8 path:04918_12 Thyroid hormone synthesis 39 -4.55812316372109 1.01651560232419e-05 0.00134518898040902
CESC ENSG00000224516 AC068134.8 path:04961_1 Endocrine and other factor-regulated calcium reabsorption 33 -3.39142660245134 0.000847520780089249 0.0224310499796955
CESC ENSG00000224516 AC068134.8 path:04962_1 Vasopressin-regulated water reabsorption 19 -3.6696225918165 0.000323778004137094 0.0122026978294373
CESC ENSG00000224516 AC068134.8 path:04970_1 Salivary secretion 32 -3.93238680874304 0.000123972024284854 0.00746988781183213
CESC ENSG00000224516 AC068134.8 path:05030_37 Cocaine addiction 11 -3.43163660920162 0.000756457731304323 0.0214509799519869
CESC ENSG00000224516 AC068134.8 path:05032_1 Morphine addiction 63 -3.67700642294971 0.000314562143376863 0.0122026978294373
CESC ENSG00000224516 AC068134.8 path:05034_52 Alcoholism 26 -3.65639047748657 0.000338110015425214 0.0122026978294373
CESC ENSG00000237126 AC073254.1 path:00010_108 Glycolysis / Gluconeogenesis 3 3.51329802104095 0.000562791938726669 0.0171867999749606
CESC ENSG00000237126 AC073254.1 path:00510_40 N-Glycan biosynthesis 16 -3.21897217651883 0.00153142365006481 0.0357632464162194
CESC ENSG00000237126 AC073254.1 path:00512_18 Mucin type O-Glycan biosynthesis 9 -4.0118004152032 9.13442846081003e-05 0.00725273619788317
CESC ENSG00000237126 AC073254.1 path:00532_1 Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate 5 -4.49638211431987 1.39142722169379e-05 0.00138099151753109
CESC ENSG00000237126 AC073254.1 path:04152_47 AMPK signaling pathway 30 -4.77319571316324 4.44729609116668e-06 0.00111543557269143
CESC ENSG00000237126 AC073254.1 path:04710_1 Circadian rhythm 27 -3.67597318290248 0.000308794380609024 0.0122026978294373
CESC ENSG00000237126 AC073254.1 path:04713_21 Circadian entrainment 64 -3.33364606698491 0.0010316754424713 0.0255984469163192
CESC ENSG00000237126 AC073254.1 path:04724_15 Glutamatergic synapse 75 -3.91536691507604 0.000131710868218703 0.00746988781183213
CESC ENSG00000237126 AC073254.1 path:04730_2 Long-term depression 52 -3.58182135156347 0.000447861135295769 0.014816739226035
CESC ENSG00000237126 AC073254.1 path:04911_2 Insulin secretion 52 -4.69486549483665 5.61932278433969e-06 0.00111543557269143
CESC ENSG00000237126 AC073254.1 path:04918_12 Thyroid hormone synthesis 39 -4.55812316372109 1.01651560232419e-05 0.00134518898040902
CESC ENSG00000237126 AC073254.1 path:04961_1 Endocrine and other factor-regulated calcium reabsorption 33 -3.39142660245134 0.000847520780089249 0.0224310499796955
CESC ENSG00000237126 AC073254.1 path:04962_1 Vasopressin-regulated water reabsorption 19 -3.6696225918165 0.000323778004137094 0.0122026978294373
CESC ENSG00000237126 AC073254.1 path:04970_1 Salivary secretion 32 -3.93238680874304 0.000123972024284854 0.00746988781183213
CESC ENSG00000237126 AC073254.1 path:05030_37 Cocaine addiction 11 -3.43163660920162 0.000756457731304323 0.0214509799519869
CESC ENSG00000237126 AC073254.1 path:05032_1 Morphine addiction 63 -3.67700642294971 0.000314562143376863 0.0122026978294373
CESC ENSG00000237126 AC073254.1 path:05034_52 Alcoholism 26 -3.65639047748657 0.000338110015425214 0.0122026978294373
CESC ENSG00000235785 AL109767.1 path:04014_136 Ras signaling pathway 15 -3.35932987525971 0.00156098361951259 0.0493010659829392
CESC ENSG00000235785 AL109767.1 path:04144_32 Endocytosis 8 -3.79250588125354 0.000283332788560431 0.0199835684716393
CESC ENSG00000235785 AL109767.1 path:04151_285 PI3K-Akt signaling pathway 16 -3.51867875809173 0.000687822118579373 0.0325855728676978
CESC ENSG00000235785 AL109767.1 path:04360_117 Axon guidance 15 -3.77222385734019 0.000440916737315015 0.0238724919203415
CESC ENSG00000235785 AL109767.1 path:04512_73 ECM-receptor interaction 11 -3.33143827611793 0.00132539754573172 0.0456659699847565
CESC ENSG00000235785 AL109767.1 path:04662_72 B cell receptor signaling pathway 8 -4.02041495091434 0.000187310299886989 0.0177476509142922
CESC ENSG00000235785 AL109767.1 path:04810_134 Regulation of actin cytoskeleton 31 -4.00229285571665 0.000165924471229925 0.0177476509142922
CESC ENSG00000235785 AL109767.1 path:04915_139 Estrogen signaling pathway 4 -8.41406486530196 5.72672287895484e-12 2.17042797112388e-09
CESC ENSG00000235785 AL109767.1 path:05214_1 Glioma 51 -3.8161134249716 0.000316362561556295 0.0199835684716393
CESC ENSG00000235785 AL109767.1 path:05218_1 Melanoma 63 -3.4792121008745 0.00105921735600022 0.0401443377924084
CESC ENSG00000235785 AL109767.1 path:05222_63 Small cell lung cancer 6 -6.32875822818816 3.11627491995206e-08 5.90534097330916e-06
CESC ENSG00000235785 AL109767.1 path:05231_46 Choline metabolism in cancer 24 -3.44725834743534 0.00104044835502111 0.0401443377924084
CESC ENSG00000230805 AL132709.1 path:04014_136 Ras signaling pathway 15 -3.35932987525971 0.00156098361951259 0.0493010659829392
CESC ENSG00000230805 AL132709.1 path:04144_32 Endocytosis 8 -3.79250588125354 0.000283332788560431 0.0199835684716393
CESC ENSG00000230805 AL132709.1 path:04151_285 PI3K-Akt signaling pathway 16 -3.51867875809173 0.000687822118579373 0.0325855728676978
CESC ENSG00000230805 AL132709.1 path:04360_117 Axon guidance 15 -3.77222385734019 0.000440916737315015 0.0238724919203415
CESC ENSG00000230805 AL132709.1 path:04512_73 ECM-receptor interaction 11 -3.33143827611793 0.00132539754573172 0.0456659699847565
CESC ENSG00000230805 AL132709.1 path:04662_72 B cell receptor signaling pathway 8 -4.02041495091434 0.000187310299886989 0.0177476509142922
CESC ENSG00000230805 AL132709.1 path:04810_134 Regulation of actin cytoskeleton 31 -4.00229285571665 0.000165924471229925 0.0177476509142922
CESC ENSG00000230805 AL132709.1 path:04915_139 Estrogen signaling pathway 4 -8.41406486530196 5.72672287895484e-12 2.17042797112388e-09
CESC ENSG00000230805 AL132709.1 path:05214_1 Glioma 51 -3.8161134249716 0.000316362561556295 0.0199835684716393
CESC ENSG00000230805 AL132709.1 path:05218_1 Melanoma 63 -3.4792121008745 0.00105921735600022 0.0401443377924084
CESC ENSG00000230805 AL132709.1 path:05222_63 Small cell lung cancer 6 -6.32875822818816 3.11627491995206e-08 5.90534097330916e-06
CESC ENSG00000230805 AL132709.1 path:05231_46 Choline metabolism in cancer 24 -3.44725834743534 0.00104044835502111 0.0401443377924084
CESC ENSG00000232018 AL132709.8 path:04014_136 Ras signaling pathway 15 -3.35932987525971 0.00156098361951259 0.0493010659829392
CESC ENSG00000232018 AL132709.8 path:04144_32 Endocytosis 8 -3.79250588125354 0.000283332788560431 0.0199835684716393
CESC ENSG00000232018 AL132709.8 path:04151_285 PI3K-Akt signaling pathway 16 -3.51867875809173 0.000687822118579373 0.0325855728676978
CESC ENSG00000232018 AL132709.8 path:04360_117 Axon guidance 15 -3.77222385734019 0.000440916737315015 0.0238724919203415
CESC ENSG00000232018 AL132709.8 path:04512_73 ECM-receptor interaction 11 -3.33143827611793 0.00132539754573172 0.0456659699847565
CESC ENSG00000232018 AL132709.8 path:04662_72 B cell receptor signaling pathway 8 -4.02041495091434 0.000187310299886989 0.0177476509142922
CESC ENSG00000232018 AL132709.8 path:04810_134 Regulation of actin cytoskeleton 31 -4.00229285571665 0.000165924471229925 0.0177476509142922
CESC ENSG00000232018 AL132709.8 path:04915_139 Estrogen signaling pathway 4 -8.41406486530196 5.72672287895484e-12 2.17042797112388e-09
CESC ENSG00000232018 AL132709.8 path:05214_1 Glioma 51 -3.8161134249716 0.000316362561556295 0.0199835684716393
CESC ENSG00000232018 AL132709.8 path:05218_1 Melanoma 63 -3.4792121008745 0.00105921735600022 0.0401443377924084
CESC ENSG00000232018 AL132709.8 path:05222_63 Small cell lung cancer 6 -6.32875822818816 3.11627491995206e-08 5.90534097330916e-06
CESC ENSG00000232018 AL132709.8 path:05231_46 Choline metabolism in cancer 24 -3.44725834743534 0.00104044835502111 0.0401443377924084
CESC ENSG00000237342 AL132796.1 path:04144_32 Endocytosis 8 -3.79250588125354 0.000283332788560431 0.0309244403921278
CESC ENSG00000237342 AL132796.1 path:04510_307 Focal adhesion 7 -3.72085022763615 0.000539668430464556 0.0422020712623283
CESC ENSG00000237342 AL132796.1 path:04728_178 Dopaminergic synapse 17 -4.66979916342185 2.46718733855351e-05 0.00482335124687211
CESC ENSG00000237342 AL132796.1 path:05214_1 Glioma 51 -3.8161134249716 0.000316362561556295 0.0309244403921278
CESC ENSG00000237342 AL132796.1 path:05222_73 Small cell lung cancer 3 -8.41871878753588 2.07940060962636e-12 8.13045638363907e-10
CESC ENSG00000258825 AL133168.3 path:04144_32 Endocytosis 8 -3.9416060644509 0.00016747324200157 0.0158680896796488
CESC ENSG00000258825 AL133168.3 path:04151_285 PI3K-Akt signaling pathway 16 -3.68988847823218 0.000384569068678518 0.0291503354058317
CESC ENSG00000258825 AL133168.3 path:04810_134 Regulation of actin cytoskeleton 31 -4.10940181072005 0.000114497782985166 0.0144648865837927
CESC ENSG00000258825 AL133168.3 path:04915_139 Estrogen signaling pathway 4 -7.78794033048715 9.63396136733793e-11 3.65127135822107e-08
CESC ENSG00000258825 AL133168.3 path:05222_63 Small cell lung cancer 6 -5.17171115844146 3.3015761474502e-06 0.000625648679941813
CESC ENSG00000259052 AL157871.2 path:04014_136 Ras signaling pathway 15 -3.35932987525971 0.00156098361951259 0.0493010659829392
CESC ENSG00000259052 AL157871.2 path:04144_32 Endocytosis 8 -3.79250588125354 0.000283332788560431 0.0199835684716393
CESC ENSG00000259052 AL157871.2 path:04151_285 PI3K-Akt signaling pathway 16 -3.51867875809173 0.000687822118579373 0.0325855728676978
CESC ENSG00000259052 AL157871.2 path:04360_117 Axon guidance 15 -3.77222385734019 0.000440916737315015 0.0238724919203415
CESC ENSG00000259052 AL157871.2 path:04512_73 ECM-receptor interaction 11 -3.33143827611793 0.00132539754573172 0.0456659699847565
CESC ENSG00000259052 AL157871.2 path:04662_72 B cell receptor signaling pathway 8 -4.02041495091434 0.000187310299886989 0.0177476509142922
CESC ENSG00000259052 AL157871.2 path:04810_134 Regulation of actin cytoskeleton 31 -4.00229285571665 0.000165924471229925 0.0177476509142922
CESC ENSG00000259052 AL157871.2 path:04915_139 Estrogen signaling pathway 4 -8.41406486530196 5.72672287895484e-12 2.17042797112388e-09
CESC ENSG00000259052 AL157871.2 path:05214_1 Glioma 51 -3.8161134249716 0.000316362561556295 0.0199835684716393
CESC ENSG00000259052 AL157871.2 path:05218_1 Melanoma 63 -3.4792121008745 0.00105921735600022 0.0401443377924084
CESC ENSG00000259052 AL157871.2 path:05222_63 Small cell lung cancer 6 -6.32875822818816 3.11627491995206e-08 5.90534097330916e-06
CESC ENSG00000259052 AL157871.2 path:05231_46 Choline metabolism in cancer 24 -3.44725834743534 0.00104044835502111 0.0401443377924084
CESC ENSG00000229402 AL162151.4 path:04014_136 Ras signaling pathway 15 -3.35932987525971 0.00156098361951259 0.0493010659829392
CESC ENSG00000229402 AL162151.4 path:04144_32 Endocytosis 8 -3.79250588125354 0.000283332788560431 0.0199835684716393
CESC ENSG00000229402 AL162151.4 path:04151_285 PI3K-Akt signaling pathway 16 -3.51867875809173 0.000687822118579373 0.0325855728676978
CESC ENSG00000229402 AL162151.4 path:04360_117 Axon guidance 15 -3.77222385734019 0.000440916737315015 0.0238724919203415
CESC ENSG00000229402 AL162151.4 path:04512_73 ECM-receptor interaction 11 -3.33143827611793 0.00132539754573172 0.0456659699847565
CESC ENSG00000229402 AL162151.4 path:04662_72 B cell receptor signaling pathway 8 -4.02041495091434 0.000187310299886989 0.0177476509142922
CESC ENSG00000229402 AL162151.4 path:04810_134 Regulation of actin cytoskeleton 31 -4.00229285571665 0.000165924471229925 0.0177476509142922
CESC ENSG00000229402 AL162151.4 path:04915_139 Estrogen signaling pathway 4 -8.41406486530196 5.72672287895484e-12 2.17042797112388e-09
CESC ENSG00000229402 AL162151.4 path:05214_1 Glioma 51 -3.8161134249716 0.000316362561556295 0.0199835684716393
CESC ENSG00000229402 AL162151.4 path:05218_1 Melanoma 63 -3.4792121008745 0.00105921735600022 0.0401443377924084
CESC ENSG00000229402 AL162151.4 path:05222_63 Small cell lung cancer 6 -6.32875822818816 3.11627491995206e-08 5.90534097330916e-06
CESC ENSG00000229402 AL162151.4 path:05231_46 Choline metabolism in cancer 24 -3.44725834743534 0.00104044835502111 0.0401443377924084
CESC ENSG00000254902 ANO1-AS1 path:00250_1 Alanine, aspartate and glutamate metabolism 27 -5.24332559656715 2.12327254848793e-06 0.000429962691068805
CESC ENSG00000254902 ANO1-AS1 path:00330_2 Arginine and proline metabolism 49 -4.86460130322601 9.98024781664144e-06 0.00134733345524659
CESC ENSG00000254902 ANO1-AS1 path:00910_1 Nitrogen metabolism 4 -5.81283470693019 5.90529514003344e-08 2.39164453171354e-05
CESC ENSG00000254902 ANO1-AS1 path:04015_204 Rap1 signaling pathway 6 -3.77032186114971 0.000275505321869178 0.0185966092261695
CESC ENSG00000254902 ANO1-AS1 path:04152_66 AMPK signaling pathway 9 -4.32385012170038 7.22670823416972e-05 0.00731704208709684
CESC ENSG00000254902 ANO1-AS1 path:04530_89 Tight junction 39 -3.61133325804688 0.000767392474427052 0.0345326613492173
CESC ENSG00000254902 ANO1-AS1 path:04662_68 B cell receptor signaling pathway 9 -3.75198858769731 0.000591851191230892 0.0299624665560639
CESC ENSG00000254902 ANO1-AS1 path:04920_78 Adipocytokine signaling pathway 4 -3.78767242757758 0.000461015790334286 0.0266730564407694
CESC ENSG00000254902 ANO1-AS1 path:04973_1 Carbohydrate digestion and absorption 12 -4.27956312704729 9.58718248016551e-05 0.00776561780893406
CESC ENSG00000254417 ANO1-AS2 path:00250_1 Alanine, aspartate and glutamate metabolism 27 -5.24332559656715 2.12327254848793e-06 0.000434209236165781
CESC ENSG00000254417 ANO1-AS2 path:00330_2 Arginine and proline metabolism 49 -4.86460130322601 9.98024781664144e-06 0.00136064045233545
CESC ENSG00000254417 ANO1-AS2 path:00910_1 Nitrogen metabolism 4 -5.81283470693019 5.90529514003344e-08 2.41526571227368e-05
CESC ENSG00000231324 AP000696.2 path:00603_9 Glycosphingolipid biosynthesis - globo series 3 -4.92228114270879 4.58932118398926e-06 0.00191374693372352
CESC ENSG00000231324 AP000696.2 path:03460_36 Fanconi anemia pathway 23 4.16835771508427 0.000136894876442126 0.0285425817381832
CESC ENSG00000224269 AP000697.6 path:00603_9 Glycosphingolipid biosynthesis - globo series 3 -4.92228114270879 4.58932118398926e-06 0.00191374693372352
CESC ENSG00000224269 AP000697.6 path:03460_36 Fanconi anemia pathway 23 4.16835771508427 0.000136894876442126 0.0285425817381832
CESC ENSG00000224790 AP000704.5 path:00603_9 Glycosphingolipid biosynthesis - globo series 3 -4.92228114270879 4.58932118398926e-06 0.00191374693372352
CESC ENSG00000224790 AP000704.5 path:03460_36 Fanconi anemia pathway 23 4.16835771508427 0.000136894876442126 0.0285425817381832
CESC ENSG00000272948 AP001412.1 path:00603_9 Glycosphingolipid biosynthesis - globo series 3 -4.92228114270879 4.58932118398926e-06 0.00191374693372352
CESC ENSG00000272948 AP001412.1 path:03460_36 Fanconi anemia pathway 23 4.16835771508427 0.000136894876442126 0.0285425817381832
CESC ENSG00000270116 AP001429.1 path:00603_9 Glycosphingolipid biosynthesis - globo series 3 -4.92228114270879 4.58932118398926e-06 0.00191374693372352
CESC ENSG00000270116 AP001429.1 path:03460_36 Fanconi anemia pathway 23 4.16835771508427 0.000136894876442126 0.0285425817381832
CESC ENSG00000242553 AP001432.14 path:00603_9 Glycosphingolipid biosynthesis - globo series 3 -4.92228114270879 4.58932118398926e-06 0.00191374693372352
CESC ENSG00000242553 AP001432.14 path:03460_36 Fanconi anemia pathway 23 4.16835771508427 0.000136894876442126 0.0285425817381832
CESC ENSG00000273210 AP001437.1 path:00603_9 Glycosphingolipid biosynthesis - globo series 3 -4.68094981280812 1.2438535559188e-05 0.00519930786374057
CESC ENSG00000273210 AP001437.1 path:03460_36 Fanconi anemia pathway 23 4.13199745676238 0.000164741155087629 0.0344309014133144
CESC ENSG00000237612 AP002856.7 path:04723_23 Retrograde endocannabinoid signaling 25 4.2769580281484 3.1260495620895e-05 0.011910248831561
CESC ENSG00000204934 ATP6V0E2-AS1 path:00250_31 Alanine, aspartate and glutamate metabolism 10 -4.00305602273776 8.98468021200511e-05 0.0345910188162197
CESC ENSG00000235903 CPB2-AS1 path:00071_3 Fatty acid degradation 24 -3.56076633349354 0.000467858862918507 0.0460840719987837
CESC ENSG00000235903 CPB2-AS1 path:00120_4 Primary bile acid biosynthesis 5 -3.59149380944528 0.000419764391357462 0.0460840719987837
CESC ENSG00000235903 CPB2-AS1 path:00640_31 Propanoate metabolism 3 -5.50992219346562 1.17678645700667e-07 4.89543166114773e-05
CESC ENSG00000235903 CPB2-AS1 path:00980_85 Metabolism of xenobiotics by cytochrome P450 10 -3.51334249393173 0.000553895096139228 0.0460840719987837
CESC ENSG00000235903 CPB2-AS1 path:05169_37 Epstein-Barr virus infection 6 -3.68948772415836 0.000293736506150681 0.0460840719987837
CESC ENSG00000254484 CTA-797E19.1 path:00250_1 Alanine, aspartate and glutamate metabolism 27 -5.24332559656715 2.12327254848793e-06 0.000429962691068805
CESC ENSG00000254484 CTA-797E19.1 path:00330_2 Arginine and proline metabolism 49 -4.86460130322601 9.98024781664144e-06 0.00134733345524659
CESC ENSG00000254484 CTA-797E19.1 path:00910_1 Nitrogen metabolism 4 -5.81283470693019 5.90529514003344e-08 2.39164453171354e-05
CESC ENSG00000254484 CTA-797E19.1 path:04015_204 Rap1 signaling pathway 6 -3.77032186114971 0.000275505321869178 0.0185966092261695
CESC ENSG00000254484 CTA-797E19.1 path:04152_66 AMPK signaling pathway 9 -4.32385012170038 7.22670823416972e-05 0.00731704208709684
CESC ENSG00000254484 CTA-797E19.1 path:04530_89 Tight junction 39 -3.61133325804688 0.000767392474427052 0.0345326613492173
CESC ENSG00000254484 CTA-797E19.1 path:04662_68 B cell receptor signaling pathway 9 -3.75198858769731 0.000591851191230892 0.0299624665560639
CESC ENSG00000254484 CTA-797E19.1 path:04920_78 Adipocytokine signaling pathway 4 -3.78767242757758 0.000461015790334286 0.0266730564407694
CESC ENSG00000254484 CTA-797E19.1 path:04973_1 Carbohydrate digestion and absorption 12 -4.27956312704729 9.58718248016551e-05 0.00776561780893406
CESC ENSG00000255539 CTA-797E19.2 path:00250_1 Alanine, aspartate and glutamate metabolism 27 -5.24332559656715 2.12327254848793e-06 0.000429962691068805
CESC ENSG00000255539 CTA-797E19.2 path:00330_2 Arginine and proline metabolism 49 -4.86460130322601 9.98024781664144e-06 0.00134733345524659
CESC ENSG00000255539 CTA-797E19.2 path:00910_1 Nitrogen metabolism 4 -5.81283470693019 5.90529514003344e-08 2.39164453171354e-05
CESC ENSG00000255539 CTA-797E19.2 path:04015_204 Rap1 signaling pathway 6 -3.77032186114971 0.000275505321869178 0.0185966092261695
CESC ENSG00000255539 CTA-797E19.2 path:04152_66 AMPK signaling pathway 9 -4.32385012170038 7.22670823416972e-05 0.00731704208709684
CESC ENSG00000255539 CTA-797E19.2 path:04530_89 Tight junction 39 -3.61133325804688 0.000767392474427052 0.0345326613492173
CESC ENSG00000255539 CTA-797E19.2 path:04662_68 B cell receptor signaling pathway 9 -3.75198858769731 0.000591851191230892 0.0299624665560639
CESC ENSG00000255539 CTA-797E19.2 path:04920_78 Adipocytokine signaling pathway 4 -3.78767242757758 0.000461015790334286 0.0266730564407694
CESC ENSG00000255539 CTA-797E19.2 path:04973_1 Carbohydrate digestion and absorption 12 -4.27956312704729 9.58718248016551e-05 0.00776561780893406
CESC ENSG00000256705 CTD-2017C7.1 path:04014_136 Ras signaling pathway 15 -3.56275251658194 0.000827209242788163 0.0348347003351904
CESC ENSG00000256705 CTD-2017C7.1 path:04151_285 PI3K-Akt signaling pathway 16 -3.67558898141013 0.000394184204421611 0.0248993022459651
CESC ENSG00000256705 CTD-2017C7.1 path:04360_117 Axon guidance 15 -4.00931509832394 0.000200283268993397 0.0151814717896995
CESC ENSG00000256705 CTD-2017C7.1 path:04512_73 ECM-receptor interaction 11 -3.51548076622067 0.000716598834260619 0.0339488697730968
CESC ENSG00000256705 CTD-2017C7.1 path:04662_72 B cell receptor signaling pathway 8 -4.32651156209582 6.96500888680659e-05 0.00745004463869429
CESC ENSG00000256705 CTD-2017C7.1 path:04810_134 Regulation of actin cytoskeleton 31 -4.2043558540194 7.86284394585149e-05 0.00745004463869429
CESC ENSG00000256705 CTD-2017C7.1 path:04915_139 Estrogen signaling pathway 4 -8.7302243647037 1.43439292186618e-12 5.43634917387284e-10
CESC ENSG00000256705 CTD-2017C7.1 path:05214_1 Glioma 51 -3.61327842189849 0.000594190697243503 0.0321711820364697
CESC ENSG00000256705 CTD-2017C7.1 path:05222_63 Small cell lung cancer 6 -6.47987205940697 1.35326603474504e-08 2.56443913584185e-06
CESC ENSG00000256705 CTD-2017C7.1 path:05231_46 Choline metabolism in cancer 24 -3.43054481651577 0.00106049036922131 0.0401925849934876
CESC ENSG00000259088 CTD-2017C7.2 path:04014_136 Ras signaling pathway 15 -3.56275251658194 0.000827209242788163 0.0348347003351904
CESC ENSG00000259088 CTD-2017C7.2 path:04151_285 PI3K-Akt signaling pathway 16 -3.67558898141013 0.000394184204421611 0.0248993022459651
CESC ENSG00000259088 CTD-2017C7.2 path:04360_117 Axon guidance 15 -4.00931509832394 0.000200283268993397 0.0151814717896995
CESC ENSG00000259088 CTD-2017C7.2 path:04512_73 ECM-receptor interaction 11 -3.51548076622067 0.000716598834260619 0.0339488697730968
CESC ENSG00000259088 CTD-2017C7.2 path:04662_72 B cell receptor signaling pathway 8 -4.32651156209582 6.96500888680659e-05 0.00745004463869429
CESC ENSG00000259088 CTD-2017C7.2 path:04810_134 Regulation of actin cytoskeleton 31 -4.2043558540194 7.86284394585149e-05 0.00745004463869429
CESC ENSG00000259088 CTD-2017C7.2 path:04915_139 Estrogen signaling pathway 4 -8.7302243647037 1.43439292186618e-12 5.43634917387284e-10
CESC ENSG00000259088 CTD-2017C7.2 path:05214_1 Glioma 51 -3.61327842189849 0.000594190697243503 0.0321711820364697
CESC ENSG00000259088 CTD-2017C7.2 path:05222_63 Small cell lung cancer 6 -6.47987205940697 1.35326603474504e-08 2.56443913584185e-06
CESC ENSG00000259088 CTD-2017C7.2 path:05231_46 Choline metabolism in cancer 24 -3.43054481651577 0.00106049036922131 0.0401925849934876
CESC ENSG00000246283 CTD-2036P10.3 path:00230_18 Purine metabolism 117 -3.91217653277665 0.000189476725011798 0.0347846624038195
CESC ENSG00000246283 CTD-2036P10.3 path:04024_100 cAMP signaling pathway 37 -3.95086249589602 0.00013721027096423 0.0347846624038195
CESC ENSG00000246283 CTD-2036P10.3 path:04070_29 Phosphatidylinositol signaling system 25 -3.34041572101225 0.00117744424287895 0.0472155141394458
CESC ENSG00000246283 CTD-2036P10.3 path:04370_2 VEGF signaling pathway 53 -3.64774827251458 0.00047713674541307 0.0347846624038195
CESC ENSG00000246283 CTD-2036P10.3 path:04662_78 B cell receptor signaling pathway 6 -3.55907535413072 0.000693958352195899 0.0347846624038195
CESC ENSG00000246283 CTD-2036P10.3 path:04713_90 Circadian entrainment 21 -3.54654308125873 0.000539102744287524 0.0347846624038195
CESC ENSG00000246283 CTD-2036P10.3 path:04720_56 Long-term potentiation 17 -3.50828702096056 0.000636133724720179 0.0347846624038195
CESC ENSG00000246283 CTD-2036P10.3 path:04740_2 Olfactory transduction 22 -3.59168013276418 0.000458967539760309 0.0347846624038195
CESC ENSG00000246283 CTD-2036P10.3 path:04744_5 Phototransduction 5 -3.35449738226488 0.00103232007436437 0.045995594424457
CESC ENSG00000246283 CTD-2036P10.3 path:05169_35 Epstein-Barr virus infection 7 -3.56360355246189 0.000666892290434796 0.0347846624038195
CESC ENSG00000259031 CTD-2062F14.3 path:04014_136 Ras signaling pathway 15 -3.35932987525971 0.00156098361951259 0.0493010659829392
CESC ENSG00000259031 CTD-2062F14.3 path:04144_32 Endocytosis 8 -3.79250588125354 0.000283332788560431 0.0199835684716393
CESC ENSG00000259031 CTD-2062F14.3 path:04151_285 PI3K-Akt signaling pathway 16 -3.51867875809173 0.000687822118579373 0.0325855728676978
CESC ENSG00000259031 CTD-2062F14.3 path:04360_117 Axon guidance 15 -3.77222385734019 0.000440916737315015 0.0238724919203415
CESC ENSG00000259031 CTD-2062F14.3 path:04512_73 ECM-receptor interaction 11 -3.33143827611793 0.00132539754573172 0.0456659699847565
CESC ENSG00000259031 CTD-2062F14.3 path:04662_72 B cell receptor signaling pathway 8 -4.02041495091434 0.000187310299886989 0.0177476509142922
CESC ENSG00000259031 CTD-2062F14.3 path:04810_134 Regulation of actin cytoskeleton 31 -4.00229285571665 0.000165924471229925 0.0177476509142922
CESC ENSG00000259031 CTD-2062F14.3 path:04915_139 Estrogen signaling pathway 4 -8.41406486530196 5.72672287895484e-12 2.17042797112388e-09
CESC ENSG00000259031 CTD-2062F14.3 path:05214_1 Glioma 51 -3.8161134249716 0.000316362561556295 0.0199835684716393
CESC ENSG00000259031 CTD-2062F14.3 path:05218_1 Melanoma 63 -3.4792121008745 0.00105921735600022 0.0401443377924084
CESC ENSG00000259031 CTD-2062F14.3 path:05222_63 Small cell lung cancer 6 -6.32875822818816 3.11627491995206e-08 5.90534097330916e-06
CESC ENSG00000259031 CTD-2062F14.3 path:05231_46 Choline metabolism in cancer 24 -3.44725834743534 0.00104044835502111 0.0401443377924084
CESC ENSG00000258914 CTD-2134A5.3 path:04062_169 Chemokine signaling pathway 27 -3.74561305149265 0.000495875610085168 0.0453726183227929
CESC ENSG00000258914 CTD-2134A5.3 path:04660_129 T cell receptor signaling pathway 9 -4.90396950750985 9.12818145798239e-06 0.00167045720681078
CESC ENSG00000258914 CTD-2134A5.3 path:04670_142 Leukocyte transendothelial migration 6 -4.05512953712353 0.000153688356290849 0.0187499794674836
CESC ENSG00000258914 CTD-2134A5.3 path:04915_139 Estrogen signaling pathway 4 -8.44510106866434 7.09316234329053e-12 2.59609741764434e-09
CESC ENSG00000258534 CTD-2134A5.4 path:04062_169 Chemokine signaling pathway 27 -3.74561305149265 0.000495875610085168 0.0453726183227929
CESC ENSG00000258534 CTD-2134A5.4 path:04660_129 T cell receptor signaling pathway 9 -4.90396950750985 9.12818145798239e-06 0.00167045720681078
CESC ENSG00000258534 CTD-2134A5.4 path:04670_142 Leukocyte transendothelial migration 6 -4.05512953712353 0.000153688356290849 0.0187499794674836
CESC ENSG00000258534 CTD-2134A5.4 path:04915_139 Estrogen signaling pathway 4 -8.44510106866434 7.09316234329053e-12 2.59609741764434e-09
CESC ENSG00000243295 CTD-2185K10.1 path:00051_33 Fructose and mannose metabolism 5 -3.4602925970913 0.000669360297186074 0.0116410486467143
CESC ENSG00000243295 CTD-2185K10.1 path:00071_14 Fatty acid degradation 15 -4.16255952390921 4.78856288481799e-05 0.00179347888617035
CESC ENSG00000243295 CTD-2185K10.1 path:00140_36 Steroid hormone biosynthesis 6 2.74357627599978 0.00690738510540293 0.0493384650385924
CESC ENSG00000243295 CTD-2185K10.1 path:00270_57 Cysteine and methionine metabolism 7 -3.29998968685271 0.00115990733421158 0.0171838123586901
CESC ENSG00000243295 CTD-2185K10.1 path:00330_29 Arginine and proline metabolism 26 -3.57795238586914 0.000450562353729396 0.00858214007103611
CESC ENSG00000243295 CTD-2185K10.1 path:00340_11 Histidine metabolism 10 -4.28165785306819 2.95350867112365e-05 0.00147675433556182
CESC ENSG00000243295 CTD-2185K10.1 path:00524_1 Butirosin and neomycin biosynthesis 4 2.96360628406625 0.00358216747075846 0.0358216747075846
CESC ENSG00000243295 CTD-2185K10.1 path:00531_2 Glycosaminoglycan degradation 4 -3.33590514814314 0.00104310785464516 0.0160478131483871
CESC ENSG00000243295 CTD-2185K10.1 path:00561_56 Glycerolipid metabolism 6 -2.71582991009166 0.00722408515164519 0.0494715799633842
CESC ENSG00000243295 CTD-2185K10.1 path:00604_1 Glycosphingolipid biosynthesis - ganglio series 9 -3.6757363391747 0.000308894911506596 0.00754271215018023
CESC ENSG00000243295 CTD-2185K10.1 path:00620_33 Pyruvate metabolism 16 -2.74196571207832 0.00669470752651882 0.048688782011046
CESC ENSG00000243295 CTD-2185K10.1 path:00640_31 Propanoate metabolism 3 -3.37035969232366 0.000911156268699381 0.0145785002991901
CESC ENSG00000243295 CTD-2185K10.1 path:04010_72 MAPK signaling pathway 34 3.10820084909273 0.00234800131921699 0.0276235449319646
CESC ENSG00000243295 CTD-2185K10.1 path:04015_221 Rap1 signaling pathway 4 -3.66075044476277 0.00033942204675811 0.00754271215018023
CESC ENSG00000243295 CTD-2185K10.1 path:04022_67 cGMP-PKG signaling pathway 27 -2.78414202243604 0.00602693559099054 0.0477530561695038
CESC ENSG00000243295 CTD-2185K10.1 path:04062_146 Chemokine signaling pathway 34 -4.9285917064379 2.04529417702494e-06 0.000204529417702494
CESC ENSG00000243295 CTD-2185K10.1 path:04066_1 HIF-1 signaling pathway 96 -2.78354223077143 0.00593598116124543 0.0477530561695038
CESC ENSG00000243295 CTD-2185K10.1 path:04068_70 FoxO signaling pathway 3 2.85916012838525 0.00540718123255444 0.0470189672396039
CESC ENSG00000243295 CTD-2185K10.1 path:04071_34 Sphingolipid signaling pathway 48 -3.66330159464154 0.000332967994104952 0.00754271215018023
CESC ENSG00000243295 CTD-2185K10.1 path:04110_43 Cell cycle 77 2.88982629865903 0.00436760293411391 0.0426107603328187
CESC ENSG00000243295 CTD-2185K10.1 path:04150_25 mTOR signaling pathway 35 -2.78908798419898 0.00582926676177531 0.0477530561695038
CESC ENSG00000243295 CTD-2185K10.1 path:04152_66 AMPK signaling pathway 9 -2.7728668755804 0.0061636390685945 0.0477530561695038
CESC ENSG00000243295 CTD-2185K10.1 path:04310_2 Wnt signaling pathway 115 -2.96702721360547 0.00341878552522323 0.0358216747075846
CESC ENSG00000243295 CTD-2185K10.1 path:04330_22 Notch signaling pathway 24 4.38848550683947 2.2726961338488e-05 0.00130061949560794
CESC ENSG00000243295 CTD-2185K10.1 path:04350_30 TGF-beta signaling pathway 24 -3.14190557644935 0.00197423004549607 0.0246778755687009
CESC ENSG00000243295 CTD-2185K10.1 path:04360_168 Axon guidance 3 -4.18023458971711 4.88766678277284e-05 0.00179347888617035
CESC ENSG00000243295 CTD-2185K10.1 path:04520_33 Adherens junction 38 -3.72466163058428 0.000261686037891977 0.00733665038276598
CESC ENSG00000243295 CTD-2185K10.1 path:04520_61 Adherens junction 15 3.0575335027244 0.00270950684990346 0.030105631665594
CESC ENSG00000243295 CTD-2185K10.1 path:04520_77 Adherens junction 5 4.44348058657213 1.75446024160183e-05 0.00130061949560794
CESC ENSG00000243295 CTD-2185K10.1 path:04610_16 Complement and coagulation cascades 58 -3.0557359470428 0.00257162800819435 0.029390034379364
CESC ENSG00000243295 CTD-2185K10.1 path:04611_105 Platelet activation 27 -3.55408986603925 0.000496770470186989 0.00903219036703617
CESC ENSG00000243295 CTD-2185K10.1 path:04620_88 Toll-like receptor signaling pathway 12 -2.80623251354755 0.00559322468216496 0.0476019121886379
CESC ENSG00000243295 CTD-2185K10.1 path:04660_50 T cell receptor signaling pathway 35 -3.19623406319623 0.00167193035751636 0.0222924047668848
CESC ENSG00000243295 CTD-2185K10.1 path:04662_67 B cell receptor signaling pathway 10 -2.84461481211269 0.00498598718380218 0.0461592988966304
CESC ENSG00000243295 CTD-2185K10.1 path:04722_146 Neurotrophin signaling pathway 6 2.7573762569468 0.00660110305854639 0.048688782011046
CESC ENSG00000243295 CTD-2185K10.1 path:04723_13 Retrograde endocannabinoid signaling 31 3.72906493183134 0.000269045847498087 0.00733665038276598
CESC ENSG00000243295 CTD-2185K10.1 path:04723_35 Retrograde endocannabinoid signaling 16 -3.12973556408891 0.00205672071610135 0.0249299480739557
CESC ENSG00000243295 CTD-2185K10.1 path:04725_106 Cholinergic synapse 12 -3.59083929833944 0.000420417012171994 0.00840834024343987
CESC ENSG00000243295 CTD-2185K10.1 path:04725_51 Cholinergic synapse 41 -3.29251392710253 0.00120741550315519 0.017248792902217
CESC ENSG00000243295 CTD-2185K10.1 path:04810_179 Regulation of actin cytoskeleton 23 -2.84206703755991 0.00507752287862934 0.0461592988966304
CESC ENSG00000243295 CTD-2185K10.1 path:04921_137 Oxytocin signaling pathway 16 -3.22955613316475 0.00149744023808247 0.0206543481114823
CESC ENSG00000243295 CTD-2185K10.1 path:04921_44 Oxytocin signaling pathway 82 -2.95710935329771 0.00350885159230205 0.0358216747075846
CESC ENSG00000243295 CTD-2185K10.1 path:04960_1 Aldosterone-regulated sodium reabsorption 29 2.74695093046334 0.00667198766981431 0.048688782011046
CESC ENSG00000243295 CTD-2185K10.1 path:05030_43 Cocaine addiction 8 -5.80397549861488 2.69357625220166e-08 3.59143500293554e-06
CESC ENSG00000243295 CTD-2185K10.1 path:05100_8 Bacterial invasion of epithelial cells 48 -2.87554225182397 0.00457441030825505 0.0435658124595719
CESC ENSG00000243295 CTD-2185K10.1 path:05110_3 Vibrio cholerae infection 7 -3.6071288512545 0.000409876458612839 0.00840834024343987
CESC ENSG00000243295 CTD-2185K10.1 path:05132_1 Salmonella infection 42 -3.37988325214859 0.000898266894725888 0.0145785002991901
CESC ENSG00000243295 CTD-2185K10.1 path:05133_4 Pertussis 24 -2.71496182823893 0.00729705804459918 0.0494715799633842
CESC ENSG00000243295 CTD-2185K10.1 path:05160_47 Hepatitis C 3 2.85916012838525 0.00540718123255444 0.0470189672396039
CESC ENSG00000243295 CTD-2185K10.1 path:05161_51 Hepatitis B 31 -2.72533556772707 0.00703470638711182 0.049366360611311
CESC ENSG00000243295 CTD-2185K10.1 path:05210_4 Colorectal cancer 34 -4.35182327992658 2.27608411731389e-05 0.00130061949560794
CESC ENSG00000243295 CTD-2185K10.1 path:05210_46 Colorectal cancer 4 -4.1672849191542 4.93206693696845e-05 0.00179347888617035
CESC ENSG00000243295 CTD-2185K10.1 path:05216_11 Thyroid cancer 5 -2.96863425521112 0.00338551865709216 0.0358216747075846
CESC ENSG00000243295 CTD-2185K10.1 path:05221_1 Acute myeloid leukemia 54 3.88398930861748 0.000149357883443967 0.00497859611479889
CESC ENSG00000243295 CTD-2185K10.1 path:05410_10 Hypertrophic cardiomyopathy (HCM) 3 -6.13952125333161 5.50838793168987e-09 1.10167758633797e-06
CESC ENSG00000243295 CTD-2185K10.1 path:05410_9 Hypertrophic cardiomyopathy (HCM) 8 -3.176988907218 0.00178033309302991 0.0229720399100633
CESC ENSG00000243295 CTD-2185K10.1 path:05414_12 Dilated cardiomyopathy 21 -2.77258698921082 0.00620789730203549 0.0477530561695038
CESC ENSG00000243295 CTD-2185K10.1 path:05414_27 Dilated cardiomyopathy 3 -6.13952125333161 5.50838793168987e-09 1.10167758633797e-06
CESC ENSG00000243295 CTD-2185K10.1 path:05416_1 Viral myocarditis 5 -3.71758989641219 0.000275124389353724 0.00733665038276598
CESC ENSG00000258383 CTD-2200A16.1 path:04014_136 Ras signaling pathway 15 -3.35932987525971 0.00156098361951259 0.0493010659829392
CESC ENSG00000258383 CTD-2200A16.1 path:04144_32 Endocytosis 8 -3.79250588125354 0.000283332788560431 0.0199835684716393
CESC ENSG00000258383 CTD-2200A16.1 path:04151_285 PI3K-Akt signaling pathway 16 -3.51867875809173 0.000687822118579373 0.0325855728676978
CESC ENSG00000258383 CTD-2200A16.1 path:04360_117 Axon guidance 15 -3.77222385734019 0.000440916737315015 0.0238724919203415
CESC ENSG00000258383 CTD-2200A16.1 path:04512_73 ECM-receptor interaction 11 -3.33143827611793 0.00132539754573172 0.0456659699847565
CESC ENSG00000258383 CTD-2200A16.1 path:04662_72 B cell receptor signaling pathway 8 -4.02041495091434 0.000187310299886989 0.0177476509142922
CESC ENSG00000258383 CTD-2200A16.1 path:04810_134 Regulation of actin cytoskeleton 31 -4.00229285571665 0.000165924471229925 0.0177476509142922
CESC ENSG00000258383 CTD-2200A16.1 path:04915_139 Estrogen signaling pathway 4 -8.41406486530196 5.72672287895484e-12 2.17042797112388e-09
CESC ENSG00000258383 CTD-2200A16.1 path:05214_1 Glioma 51 -3.8161134249716 0.000316362561556295 0.0199835684716393
CESC ENSG00000258383 CTD-2200A16.1 path:05218_1 Melanoma 63 -3.4792121008745 0.00105921735600022 0.0401443377924084
CESC ENSG00000258383 CTD-2200A16.1 path:05222_63 Small cell lung cancer 6 -6.32875822818816 3.11627491995206e-08 5.90534097330916e-06
CESC ENSG00000258383 CTD-2200A16.1 path:05231_46 Choline metabolism in cancer 24 -3.44725834743534 0.00104044835502111 0.0401443377924084
CESC ENSG00000258748 CTD-2223O18.1 path:04062_169 Chemokine signaling pathway 27 -3.74561305149265 0.000495875610085168 0.0453726183227929
CESC ENSG00000258748 CTD-2223O18.1 path:04660_129 T cell receptor signaling pathway 9 -4.90396950750985 9.12818145798239e-06 0.00167045720681078
CESC ENSG00000258748 CTD-2223O18.1 path:04670_142 Leukocyte transendothelial migration 6 -4.05512953712353 0.000153688356290849 0.0187499794674836
CESC ENSG00000258748 CTD-2223O18.1 path:04915_139 Estrogen signaling pathway 4 -8.44510106866434 7.09316234329053e-12 2.59609741764434e-09
CESC ENSG00000259143 CTD-2240H23.2 path:04144_32 Endocytosis 8 -3.8120411613074 0.00027465296025793 0.0140416325931867
CESC ENSG00000259143 CTD-2240H23.2 path:04666_232 Fc gamma R-mediated phagocytosis 8 -5.93206723888842 3.90772055029302e-07 5.32752568356615e-05
CESC ENSG00000259143 CTD-2240H23.2 path:04750_88 Inflammatory mediator regulation of TRP channels 5 -4.37576741008785 3.98693083245436e-05 0.00326130942094767
CESC ENSG00000259143 CTD-2240H23.2 path:04810_134 Regulation of actin cytoskeleton 31 -3.92225757003324 0.000226955894199594 0.0132607086753763
CESC ENSG00000259143 CTD-2240H23.2 path:04932_103 Non-alcoholic fatty liver disease (NAFLD) 4 -7.63219113822838 2.61083960396887e-10 5.33916699011635e-08
CESC ENSG00000259143 CTD-2240H23.2 path:05206_136 MicroRNAs in cancer 2 -7.6192948454595 7.64545406442571e-11 3.12699071235011e-08
CESC ENSG00000259143 CTD-2240H23.2 path:05206_97 MicroRNAs in cancer 26 -4.17580752031433 8.56420162379312e-05 0.00583793077355231
CESC ENSG00000259143 CTD-2240H23.2 path:05222_63 Small cell lung cancer 6 -5.02599323818842 6.28076073558987e-06 0.000642207785214064
CESC ENSG00000259563 CTD-2329K10.1 path:00230_18 Purine metabolism 117 -3.91217653277665 0.000189476725011798 0.0347846624038195
CESC ENSG00000259563 CTD-2329K10.1 path:04024_100 cAMP signaling pathway 37 -3.95086249589602 0.00013721027096423 0.0347846624038195
CESC ENSG00000259563 CTD-2329K10.1 path:04070_29 Phosphatidylinositol signaling system 25 -3.34041572101225 0.00117744424287895 0.0472155141394458
CESC ENSG00000259563 CTD-2329K10.1 path:04370_2 VEGF signaling pathway 53 -3.64774827251458 0.00047713674541307 0.0347846624038195
CESC ENSG00000259563 CTD-2329K10.1 path:04662_78 B cell receptor signaling pathway 6 -3.55907535413072 0.000693958352195899 0.0347846624038195
CESC ENSG00000259563 CTD-2329K10.1 path:04713_90 Circadian entrainment 21 -3.54654308125873 0.000539102744287524 0.0347846624038195
CESC ENSG00000259563 CTD-2329K10.1 path:04720_56 Long-term potentiation 17 -3.50828702096056 0.000636133724720179 0.0347846624038195
CESC ENSG00000259563 CTD-2329K10.1 path:04740_2 Olfactory transduction 22 -3.59168013276418 0.000458967539760309 0.0347846624038195
CESC ENSG00000259563 CTD-2329K10.1 path:04744_5 Phototransduction 5 -3.35449738226488 0.00103232007436437 0.045995594424457
CESC ENSG00000259563 CTD-2329K10.1 path:05169_35 Epstein-Barr virus infection 7 -3.56360355246189 0.000666892290434796 0.0347846624038195
CESC ENSG00000258560 CTD-2376I20.1 path:04014_136 Ras signaling pathway 15 -3.35932987525971 0.00156098361951259 0.0493010659829392
CESC ENSG00000258560 CTD-2376I20.1 path:04144_32 Endocytosis 8 -3.79250588125354 0.000283332788560431 0.0199835684716393
CESC ENSG00000258560 CTD-2376I20.1 path:04151_285 PI3K-Akt signaling pathway 16 -3.51867875809173 0.000687822118579373 0.0325855728676978
CESC ENSG00000258560 CTD-2376I20.1 path:04360_117 Axon guidance 15 -3.77222385734019 0.000440916737315015 0.0238724919203415
CESC ENSG00000258560 CTD-2376I20.1 path:04512_73 ECM-receptor interaction 11 -3.33143827611793 0.00132539754573172 0.0456659699847565
CESC ENSG00000258560 CTD-2376I20.1 path:04662_72 B cell receptor signaling pathway 8 -4.02041495091434 0.000187310299886989 0.0177476509142922
CESC ENSG00000258560 CTD-2376I20.1 path:04810_134 Regulation of actin cytoskeleton 31 -4.00229285571665 0.000165924471229925 0.0177476509142922
CESC ENSG00000258560 CTD-2376I20.1 path:04915_139 Estrogen signaling pathway 4 -8.41406486530196 5.72672287895484e-12 2.17042797112388e-09
CESC ENSG00000258560 CTD-2376I20.1 path:05214_1 Glioma 51 -3.8161134249716 0.000316362561556295 0.0199835684716393
CESC ENSG00000258560 CTD-2376I20.1 path:05218_1 Melanoma 63 -3.4792121008745 0.00105921735600022 0.0401443377924084
CESC ENSG00000258560 CTD-2376I20.1 path:05222_63 Small cell lung cancer 6 -6.32875822818816 3.11627491995206e-08 5.90534097330916e-06
CESC ENSG00000258560 CTD-2376I20.1 path:05231_46 Choline metabolism in cancer 24 -3.44725834743534 0.00104044835502111 0.0401443377924084
CESC ENSG00000246084 CTD-2506J14.1 path:04144_32 Endocytosis 8 -3.9416060644509 0.00016747324200157 0.0158680896796488
CESC ENSG00000246084 CTD-2506J14.1 path:04151_285 PI3K-Akt signaling pathway 16 -3.68988847823218 0.000384569068678518 0.0291503354058317
CESC ENSG00000246084 CTD-2506J14.1 path:04810_134 Regulation of actin cytoskeleton 31 -4.10940181072005 0.000114497782985166 0.0144648865837927
CESC ENSG00000246084 CTD-2506J14.1 path:04915_139 Estrogen signaling pathway 4 -7.78794033048715 9.63396136733793e-11 3.65127135822107e-08
CESC ENSG00000246084 CTD-2506J14.1 path:05222_63 Small cell lung cancer 6 -5.17171115844146 3.3015761474502e-06 0.000625648679941813
CESC ENSG00000260810 CTD-2547L24.4 path:04810_134 Regulation of actin cytoskeleton 31 -3.92225757003324 0.000226955894199594 0.0415329286385257
CESC ENSG00000260810 CTD-2547L24.4 path:05222_63 Small cell lung cancer 6 -5.02599323818842 6.28076073558987e-06 0.00229875842922589
CESC ENSG00000258497 CTD-2561F5.1 path:04014_136 Ras signaling pathway 15 -3.35932987525971 0.00156098361951259 0.0493010659829392
CESC ENSG00000258497 CTD-2561F5.1 path:04144_32 Endocytosis 8 -3.79250588125354 0.000283332788560431 0.0199835684716393
CESC ENSG00000258497 CTD-2561F5.1 path:04151_285 PI3K-Akt signaling pathway 16 -3.51867875809173 0.000687822118579373 0.0325855728676978
CESC ENSG00000258497 CTD-2561F5.1 path:04360_117 Axon guidance 15 -3.77222385734019 0.000440916737315015 0.0238724919203415
CESC ENSG00000258497 CTD-2561F5.1 path:04512_73 ECM-receptor interaction 11 -3.33143827611793 0.00132539754573172 0.0456659699847565
CESC ENSG00000258497 CTD-2561F5.1 path:04662_72 B cell receptor signaling pathway 8 -4.02041495091434 0.000187310299886989 0.0177476509142922
CESC ENSG00000258497 CTD-2561F5.1 path:04810_134 Regulation of actin cytoskeleton 31 -4.00229285571665 0.000165924471229925 0.0177476509142922
CESC ENSG00000258497 CTD-2561F5.1 path:04915_139 Estrogen signaling pathway 4 -8.41406486530196 5.72672287895484e-12 2.17042797112388e-09
CESC ENSG00000258497 CTD-2561F5.1 path:05214_1 Glioma 51 -3.8161134249716 0.000316362561556295 0.0199835684716393
CESC ENSG00000258497 CTD-2561F5.1 path:05218_1 Melanoma 63 -3.4792121008745 0.00105921735600022 0.0401443377924084
CESC ENSG00000258497 CTD-2561F5.1 path:05222_63 Small cell lung cancer 6 -6.32875822818816 3.11627491995206e-08 5.90534097330916e-06
CESC ENSG00000258497 CTD-2561F5.1 path:05231_46 Choline metabolism in cancer 24 -3.44725834743534 0.00104044835502111 0.0401443377924084
CESC ENSG00000258576 CTD-2644I21.1 path:04014_136 Ras signaling pathway 15 -3.35932987525971 0.00156098361951259 0.0493010659829392
CESC ENSG00000258576 CTD-2644I21.1 path:04144_32 Endocytosis 8 -3.79250588125354 0.000283332788560431 0.0199835684716393
CESC ENSG00000258576 CTD-2644I21.1 path:04151_285 PI3K-Akt signaling pathway 16 -3.51867875809173 0.000687822118579373 0.0325855728676978
CESC ENSG00000258576 CTD-2644I21.1 path:04360_117 Axon guidance 15 -3.77222385734019 0.000440916737315015 0.0238724919203415
CESC ENSG00000258576 CTD-2644I21.1 path:04512_73 ECM-receptor interaction 11 -3.33143827611793 0.00132539754573172 0.0456659699847565
CESC ENSG00000258576 CTD-2644I21.1 path:04662_72 B cell receptor signaling pathway 8 -4.02041495091434 0.000187310299886989 0.0177476509142922
CESC ENSG00000258576 CTD-2644I21.1 path:04810_134 Regulation of actin cytoskeleton 31 -4.00229285571665 0.000165924471229925 0.0177476509142922
CESC ENSG00000258576 CTD-2644I21.1 path:04915_139 Estrogen signaling pathway 4 -8.41406486530196 5.72672287895484e-12 2.17042797112388e-09
CESC ENSG00000258576 CTD-2644I21.1 path:05214_1 Glioma 51 -3.8161134249716 0.000316362561556295 0.0199835684716393
CESC ENSG00000258576 CTD-2644I21.1 path:05218_1 Melanoma 63 -3.4792121008745 0.00105921735600022 0.0401443377924084
CESC ENSG00000258576 CTD-2644I21.1 path:05222_63 Small cell lung cancer 6 -6.32875822818816 3.11627491995206e-08 5.90534097330916e-06
CESC ENSG00000258576 CTD-2644I21.1 path:05231_46 Choline metabolism in cancer 24 -3.44725834743534 0.00104044835502111 0.0401443377924084
CESC ENSG00000258884 CTD-3035D6.2 path:05222_63 Small cell lung cancer 6 -4.74599771384656 1.78761708221618e-05 0.00654267852091122
CESC ENSG00000258811 CTD-3051D23.1 path:04062_169 Chemokine signaling pathway 27 -3.74561305149265 0.000495875610085168 0.0453726183227929
CESC ENSG00000258811 CTD-3051D23.1 path:04660_129 T cell receptor signaling pathway 9 -4.90396950750985 9.12818145798239e-06 0.00167045720681078
CESC ENSG00000258811 CTD-3051D23.1 path:04670_142 Leukocyte transendothelial migration 6 -4.05512953712353 0.000153688356290849 0.0187499794674836
CESC ENSG00000258811 CTD-3051D23.1 path:04915_139 Estrogen signaling pathway 4 -8.44510106866434 7.09316234329053e-12 2.59609741764434e-09
CESC ENSG00000259067 CTD-3051D23.3 path:04062_169 Chemokine signaling pathway 27 -3.74561305149265 0.000495875610085168 0.0453726183227929
CESC ENSG00000259067 CTD-3051D23.3 path:04660_129 T cell receptor signaling pathway 9 -4.90396950750985 9.12818145798239e-06 0.00167045720681078
CESC ENSG00000259067 CTD-3051D23.3 path:04670_142 Leukocyte transendothelial migration 6 -4.05512953712353 0.000153688356290849 0.0187499794674836
CESC ENSG00000259067 CTD-3051D23.3 path:04915_139 Estrogen signaling pathway 4 -8.44510106866434 7.09316234329053e-12 2.59609741764434e-09
CESC ENSG00000258593 CTD-3051D23.4 path:04062_169 Chemokine signaling pathway 27 -3.74561305149265 0.000495875610085168 0.0453726183227929
CESC ENSG00000258593 CTD-3051D23.4 path:04660_129 T cell receptor signaling pathway 9 -4.90396950750985 9.12818145798239e-06 0.00167045720681078
CESC ENSG00000258593 CTD-3051D23.4 path:04670_142 Leukocyte transendothelial migration 6 -4.05512953712353 0.000153688356290849 0.0187499794674836
CESC ENSG00000258593 CTD-3051D23.4 path:04915_139 Estrogen signaling pathway 4 -8.44510106866434 7.09316234329053e-12 2.59609741764434e-09
CESC ENSG00000235706 DICER1-AS1 path:04144_32 Endocytosis 8 -3.8120411613074 0.00027465296025793 0.0140416325931867
CESC ENSG00000235706 DICER1-AS1 path:04666_232 Fc gamma R-mediated phagocytosis 8 -5.93206723888842 3.90772055029302e-07 5.32752568356615e-05
CESC ENSG00000235706 DICER1-AS1 path:04750_88 Inflammatory mediator regulation of TRP channels 5 -4.37576741008785 3.98693083245436e-05 0.00326130942094767
CESC ENSG00000235706 DICER1-AS1 path:04810_134 Regulation of actin cytoskeleton 31 -3.92225757003324 0.000226955894199594 0.0132607086753763
CESC ENSG00000235706 DICER1-AS1 path:04932_103 Non-alcoholic fatty liver disease (NAFLD) 4 -7.63219113822838 2.61083960396887e-10 5.33916699011635e-08
CESC ENSG00000235706 DICER1-AS1 path:05206_136 MicroRNAs in cancer 2 -7.6192948454595 7.64545406442571e-11 3.12699071235011e-08
CESC ENSG00000235706 DICER1-AS1 path:05206_97 MicroRNAs in cancer 26 -4.17580752031433 8.56420162379312e-05 0.00583793077355231
CESC ENSG00000235706 DICER1-AS1 path:05222_63 Small cell lung cancer 6 -5.02599323818842 6.28076073558987e-06 0.000642207785214064
CESC ENSG00000258498 DIO3OS path:04144_32 Endocytosis 8 -3.85078756461405 0.000222032136197222 0.0189211539181846
CESC ENSG00000258498 DIO3OS path:04151_285 PI3K-Akt signaling pathway 16 -3.63272584635927 0.0004549736468741 0.0280069675218179
CESC ENSG00000258498 DIO3OS path:04360_117 Axon guidance 15 -3.70747106537217 0.000517279083516426 0.0280069675218179
CESC ENSG00000258498 DIO3OS path:04512_73 ECM-receptor interaction 11 -3.32688941172977 0.0013093687485597 0.0496250755704127
CESC ENSG00000258498 DIO3OS path:04662_72 B cell receptor signaling pathway 8 -3.9175440658236 0.000249619444830932 0.0189211539181846
CESC ENSG00000258498 DIO3OS path:04810_134 Regulation of actin cytoskeleton 31 -4.01794025517307 0.000149035748931194 0.0188281829483076
CESC ENSG00000258498 DIO3OS path:04915_139 Estrogen signaling pathway 4 -8.01627724742971 2.6365925721093e-11 9.99268584829423e-09
CESC ENSG00000258498 DIO3OS path:05218_1 Melanoma 63 -3.63652113189466 0.000632121671649378 0.0299467641943893
CESC ENSG00000258498 DIO3OS path:05222_63 Small cell lung cancer 6 -6.25928748534202 3.43347207162087e-08 6.50642957572156e-06
CESC ENSG00000258498 DIO3OS path:05231_46 Choline metabolism in cancer 24 -3.45715608729631 0.000975238352315897 0.0410683706141917
CESC ENSG00000230366 DSCR9 path:00603_9 Glycosphingolipid biosynthesis - globo series 3 -4.92228114270879 4.58932118398926e-06 0.00191374693372352
CESC ENSG00000230366 DSCR9 path:03460_36 Fanconi anemia pathway 23 4.16835771508427 0.000136894876442126 0.0285425817381832
CESC ENSG00000179523 EIF3J-AS1 path:00230_18 Purine metabolism 117 -3.91217653277665 0.000189476725011798 0.0347846624038195
CESC ENSG00000179523 EIF3J-AS1 path:04024_100 cAMP signaling pathway 37 -3.95086249589602 0.00013721027096423 0.0347846624038195
CESC ENSG00000179523 EIF3J-AS1 path:04070_29 Phosphatidylinositol signaling system 25 -3.34041572101225 0.00117744424287895 0.0472155141394458
CESC ENSG00000179523 EIF3J-AS1 path:04370_2 VEGF signaling pathway 53 -3.64774827251458 0.00047713674541307 0.0347846624038195
CESC ENSG00000179523 EIF3J-AS1 path:04662_78 B cell receptor signaling pathway 6 -3.55907535413072 0.000693958352195899 0.0347846624038195
CESC ENSG00000179523 EIF3J-AS1 path:04713_90 Circadian entrainment 21 -3.54654308125873 0.000539102744287524 0.0347846624038195
CESC ENSG00000179523 EIF3J-AS1 path:04720_56 Long-term potentiation 17 -3.50828702096056 0.000636133724720179 0.0347846624038195
CESC ENSG00000179523 EIF3J-AS1 path:04740_2 Olfactory transduction 22 -3.59168013276418 0.000458967539760309 0.0347846624038195
CESC ENSG00000179523 EIF3J-AS1 path:04744_5 Phototransduction 5 -3.35449738226488 0.00103232007436437 0.045995594424457
CESC ENSG00000179523 EIF3J-AS1 path:05169_35 Epstein-Barr virus infection 7 -3.56360355246189 0.000666892290434796 0.0347846624038195
CESC ENSG00000197558 ENSG00000197558 path:00250_31 Alanine, aspartate and glutamate metabolism 10 -4.00305602273776 8.98468021200511e-05 0.0345910188162197
CESC ENSG00000229645 ENSG00000229645 path:04144_32 Endocytosis 8 -3.8120411613074 0.00027465296025793 0.0140416325931867
CESC ENSG00000229645 ENSG00000229645 path:04666_232 Fc gamma R-mediated phagocytosis 8 -5.93206723888842 3.90772055029302e-07 5.32752568356615e-05
CESC ENSG00000229645 ENSG00000229645 path:04750_88 Inflammatory mediator regulation of TRP channels 5 -4.37576741008785 3.98693083245436e-05 0.00326130942094767
CESC ENSG00000229645 ENSG00000229645 path:04810_134 Regulation of actin cytoskeleton 31 -3.92225757003324 0.000226955894199594 0.0132607086753763
CESC ENSG00000229645 ENSG00000229645 path:04932_103 Non-alcoholic fatty liver disease (NAFLD) 4 -7.63219113822838 2.61083960396887e-10 5.33916699011635e-08
CESC ENSG00000229645 ENSG00000229645 path:05206_136 MicroRNAs in cancer 2 -7.6192948454595 7.64545406442571e-11 3.12699071235011e-08
CESC ENSG00000229645 ENSG00000229645 path:05206_97 MicroRNAs in cancer 26 -4.17580752031433 8.56420162379312e-05 0.00583793077355231
CESC ENSG00000229645 ENSG00000229645 path:05222_63 Small cell lung cancer 6 -5.02599323818842 6.28076073558987e-06 0.000642207785214064
CESC ENSG00000243637 ENSG00000243637 path:00010_108 Glycolysis / Gluconeogenesis 3 3.51329802104095 0.000562791938726669 0.0171867999749606
CESC ENSG00000243637 ENSG00000243637 path:00510_40 N-Glycan biosynthesis 16 -3.21897217651883 0.00153142365006481 0.0357632464162194
CESC ENSG00000243637 ENSG00000243637 path:00512_18 Mucin type O-Glycan biosynthesis 9 -4.0118004152032 9.13442846081003e-05 0.00725273619788317
CESC ENSG00000243637 ENSG00000243637 path:00532_1 Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate 5 -4.49638211431987 1.39142722169379e-05 0.00138099151753109
CESC ENSG00000243637 ENSG00000243637 path:04152_47 AMPK signaling pathway 30 -4.77319571316324 4.44729609116668e-06 0.00111543557269143
CESC ENSG00000243637 ENSG00000243637 path:04710_1 Circadian rhythm 27 -3.67597318290248 0.000308794380609024 0.0122026978294373
CESC ENSG00000243637 ENSG00000243637 path:04713_21 Circadian entrainment 64 -3.33364606698491 0.0010316754424713 0.0255984469163192
CESC ENSG00000243637 ENSG00000243637 path:04724_15 Glutamatergic synapse 75 -3.91536691507604 0.000131710868218703 0.00746988781183213
CESC ENSG00000243637 ENSG00000243637 path:04730_2 Long-term depression 52 -3.58182135156347 0.000447861135295769 0.014816739226035
CESC ENSG00000243637 ENSG00000243637 path:04911_2 Insulin secretion 52 -4.69486549483665 5.61932278433969e-06 0.00111543557269143
CESC ENSG00000243637 ENSG00000243637 path:04918_12 Thyroid hormone synthesis 39 -4.55812316372109 1.01651560232419e-05 0.00134518898040902
CESC ENSG00000243637 ENSG00000243637 path:04961_1 Endocrine and other factor-regulated calcium reabsorption 33 -3.39142660245134 0.000847520780089249 0.0224310499796955
CESC ENSG00000243637 ENSG00000243637 path:04962_1 Vasopressin-regulated water reabsorption 19 -3.6696225918165 0.000323778004137094 0.0122026978294373
CESC ENSG00000243637 ENSG00000243637 path:04970_1 Salivary secretion 32 -3.93238680874304 0.000123972024284854 0.00746988781183213
CESC ENSG00000243637 ENSG00000243637 path:05030_37 Cocaine addiction 11 -3.43163660920162 0.000756457731304323 0.0214509799519869
CESC ENSG00000243637 ENSG00000243637 path:05032_1 Morphine addiction 63 -3.67700642294971 0.000314562143376863 0.0122026978294373
CESC ENSG00000243637 ENSG00000243637 path:05034_52 Alcoholism 26 -3.65639047748657 0.000338110015425214 0.0122026978294373
CESC ENSG00000259634 ENSG00000259634 path:04810_134 Regulation of actin cytoskeleton 31 -3.92225757003324 0.000226955894199594 0.0415329286385257
CESC ENSG00000259634 ENSG00000259634 path:05222_63 Small cell lung cancer 6 -5.02599323818842 6.28076073558987e-06 0.00229875842922589
CESC ENSG00000261372 ENSG00000261372 path:04810_134 Regulation of actin cytoskeleton 31 -3.92225757003324 0.000226955894199594 0.0415329286385257
CESC ENSG00000261372 ENSG00000261372 path:05222_63 Small cell lung cancer 6 -5.02599323818842 6.28076073558987e-06 0.00229875842922589
CESC ENSG00000269963 ENSG00000269963 path:04062_169 Chemokine signaling pathway 27 -3.74561305149265 0.000495875610085168 0.0453726183227929
CESC ENSG00000269963 ENSG00000269963 path:04660_129 T cell receptor signaling pathway 9 -4.90396950750985 9.12818145798239e-06 0.00167045720681078
CESC ENSG00000269963 ENSG00000269963 path:04670_142 Leukocyte transendothelial migration 6 -4.05512953712353 0.000153688356290849 0.0187499794674836
CESC ENSG00000269963 ENSG00000269963 path:04915_139 Estrogen signaling pathway 4 -8.44510106866434 7.09316234329053e-12 2.59609741764434e-09
CESC ENSG00000273087 ENSG00000273087 path:04014_136 Ras signaling pathway 15 -3.35932987525971 0.00156098361951259 0.0493010659829392
CESC ENSG00000273087 ENSG00000273087 path:04144_32 Endocytosis 8 -3.79250588125354 0.000283332788560431 0.0199835684716393
CESC ENSG00000273087 ENSG00000273087 path:04151_285 PI3K-Akt signaling pathway 16 -3.51867875809173 0.000687822118579373 0.0325855728676978
CESC ENSG00000273087 ENSG00000273087 path:04360_117 Axon guidance 15 -3.77222385734019 0.000440916737315015 0.0238724919203415
CESC ENSG00000273087 ENSG00000273087 path:04512_73 ECM-receptor interaction 11 -3.33143827611793 0.00132539754573172 0.0456659699847565
CESC ENSG00000273087 ENSG00000273087 path:04662_72 B cell receptor signaling pathway 8 -4.02041495091434 0.000187310299886989 0.0177476509142922
CESC ENSG00000273087 ENSG00000273087 path:04810_134 Regulation of actin cytoskeleton 31 -4.00229285571665 0.000165924471229925 0.0177476509142922
CESC ENSG00000273087 ENSG00000273087 path:04915_139 Estrogen signaling pathway 4 -8.41406486530196 5.72672287895484e-12 2.17042797112388e-09
CESC ENSG00000273087 ENSG00000273087 path:05214_1 Glioma 51 -3.8161134249716 0.000316362561556295 0.0199835684716393
CESC ENSG00000273087 ENSG00000273087 path:05218_1 Melanoma 63 -3.4792121008745 0.00105921735600022 0.0401443377924084
CESC ENSG00000273087 ENSG00000273087 path:05222_63 Small cell lung cancer 6 -6.32875822818816 3.11627491995206e-08 5.90534097330916e-06
CESC ENSG00000273087 ENSG00000273087 path:05231_46 Choline metabolism in cancer 24 -3.44725834743534 0.00104044835502111 0.0401443377924084
CESC ENSG00000251165 F11-AS1 path:00071_3 Fatty acid degradation 24 -4.20832484528428 4.0764957961561e-05 0.00841796381906235
CESC ENSG00000251165 F11-AS1 path:00120_4 Primary bile acid biosynthesis 5 -4.02703693101367 8.23092734627747e-05 0.0113312433133753
CESC ENSG00000251165 F11-AS1 path:00280_36 Valine, leucine and isoleucine degradation 21 -3.57777583912029 0.000440271928745071 0.0303053844286191
CESC ENSG00000251165 F11-AS1 path:00340_11 Histidine metabolism 10 -3.3219908488513 0.00107294680162495 0.0492363365634563
CESC ENSG00000251165 F11-AS1 path:00650_11 Butanoate metabolism 6 -3.87830100204728 0.000145542502725232 0.0130684714401475
CESC ENSG00000251165 F11-AS1 path:00830_44 Retinol metabolism 8 -4.78454457672744 3.45063893083125e-06 0.0014251138784333
CESC ENSG00000251165 F11-AS1 path:00980_127 Metabolism of xenobiotics by cytochrome P450 3 -3.86046775854922 0.00015821393995336 0.0130684714401475
CESC ENSG00000251165 F11-AS1 path:04150_50 mTOR signaling pathway 7 -3.35000957988712 0.000978993932425476 0.0492363365634563
CESC ENSG00000251165 F11-AS1 path:04151_194 PI3K-Akt signaling pathway 41 -3.46029608570749 0.000667178941676075 0.0393635575588884
CESC ENSG00000258584 FAM181A-AS1 path:04144_32 Endocytosis 8 -3.8120411613074 0.00027465296025793 0.0140416325931867
CESC ENSG00000258584 FAM181A-AS1 path:04666_232 Fc gamma R-mediated phagocytosis 8 -5.93206723888842 3.90772055029302e-07 5.32752568356615e-05
CESC ENSG00000258584 FAM181A-AS1 path:04750_88 Inflammatory mediator regulation of TRP channels 5 -4.37576741008785 3.98693083245436e-05 0.00326130942094767
CESC ENSG00000258584 FAM181A-AS1 path:04810_134 Regulation of actin cytoskeleton 31 -3.92225757003324 0.000226955894199594 0.0132607086753763
CESC ENSG00000258584 FAM181A-AS1 path:04932_103 Non-alcoholic fatty liver disease (NAFLD) 4 -7.63219113822838 2.61083960396887e-10 5.33916699011635e-08
CESC ENSG00000258584 FAM181A-AS1 path:05206_136 MicroRNAs in cancer 2 -7.6192948454595 7.64545406442571e-11 3.12699071235011e-08
CESC ENSG00000258584 FAM181A-AS1 path:05206_97 MicroRNAs in cancer 26 -4.17580752031433 8.56420162379312e-05 0.00583793077355231
CESC ENSG00000258584 FAM181A-AS1 path:05222_63 Small cell lung cancer 6 -5.02599323818842 6.28076073558987e-06 0.000642207785214064
CESC ENSG00000237646 HLCS-IT1 path:00603_9 Glycosphingolipid biosynthesis - globo series 3 -4.92228114270879 4.58932118398926e-06 0.00191374693372352
CESC ENSG00000237646 HLCS-IT1 path:03460_36 Fanconi anemia pathway 23 4.16835771508427 0.000136894876442126 0.0285425817381832
CESC ENSG00000224517 HTR2A-AS1 path:00640_31 Propanoate metabolism 3 -5.55189744255061 9.57912557969566e-08 3.82207110629857e-05
CESC ENSG00000258730 ITPK1-AS1 path:04144_32 Endocytosis 8 -3.8120411613074 0.00027465296025793 0.0140416325931867
CESC ENSG00000258730 ITPK1-AS1 path:04666_232 Fc gamma R-mediated phagocytosis 8 -5.93206723888842 3.90772055029302e-07 5.32752568356615e-05
CESC ENSG00000258730 ITPK1-AS1 path:04750_88 Inflammatory mediator regulation of TRP channels 5 -4.37576741008785 3.98693083245436e-05 0.00326130942094767
CESC ENSG00000258730 ITPK1-AS1 path:04810_134 Regulation of actin cytoskeleton 31 -3.92225757003324 0.000226955894199594 0.0132607086753763
CESC ENSG00000258730 ITPK1-AS1 path:04932_103 Non-alcoholic fatty liver disease (NAFLD) 4 -7.63219113822838 2.61083960396887e-10 5.33916699011635e-08
CESC ENSG00000258730 ITPK1-AS1 path:05206_136 MicroRNAs in cancer 2 -7.6192948454595 7.64545406442571e-11 3.12699071235011e-08
CESC ENSG00000258730 ITPK1-AS1 path:05206_97 MicroRNAs in cancer 26 -4.17580752031433 8.56420162379312e-05 0.00583793077355231
CESC ENSG00000258730 ITPK1-AS1 path:05222_63 Small cell lung cancer 6 -5.02599323818842 6.28076073558987e-06 0.000642207785214064
CESC ENSG00000233213 KCNJ6-AS1 path:00603_9 Glycosphingolipid biosynthesis - globo series 3 -4.92228114270879 4.58932118398926e-06 0.00191374693372352
CESC ENSG00000233213 KCNJ6-AS1 path:03460_36 Fanconi anemia pathway 23 4.16835771508427 0.000136894876442126 0.0285425817381832
CESC ENSG00000233725 LINC00284 path:00640_31 Propanoate metabolism 3 -5.20298328672517 5.09726642875375e-07 0.000203380930507274
CESC ENSG00000235097 LINC00330 path:00640_31 Propanoate metabolism 3 -5.48914366022956 1.29521174104563e-07 5.16789484677207e-05
CESC ENSG00000225077 LINC00337 path:04151_222 PI3K-Akt signaling pathway 29 -4.13213972757443 0.000233121682616893 0.0332459871314831
CESC ENSG00000225077 LINC00337 path:04530_214 Tight junction 2 -5.25314438100398 5.46950218487821e-06 0.00213857535428738
CESC ENSG00000225077 LINC00337 path:04666_128 Fc gamma R-mediated phagocytosis 28 -4.13232942376634 0.000255084300241558 0.0332459871314831
CESC ENSG00000226519 LINC00390 path:00640_31 Propanoate metabolism 3 -5.20298328672517 5.09726642875375e-07 0.000203380930507274
CESC ENSG00000237585 LINC00407 path:00640_31 Propanoate metabolism 3 -5.48914366022956 1.29521174104563e-07 5.16789484677207e-05
CESC ENSG00000226722 LINC00424 path:00240_203 Pyrimidine metabolism 2 -6.37022580078121 1.47303504916088e-09 5.99525265008478e-07
CESC ENSG00000226722 LINC00424 path:00603_7 Glycosphingolipid biosynthesis - globo series 4 -3.64334863925656 0.000347617613917447 0.0471601229548003
CESC ENSG00000226722 LINC00424 path:00640_31 Propanoate metabolism 3 -4.60176237748396 7.66759237907097e-06 0.00156035504914094
CESC ENSG00000231473 LINC00441 path:00640_31 Propanoate metabolism 3 -5.55189744255061 9.57912557969566e-08 3.82207110629857e-05
CESC ENSG00000234689 LINC00444 path:00640_31 Propanoate metabolism 3 -5.55189744255061 9.57912557969566e-08 3.82207110629857e-05
CESC ENSG00000233610 LINC00462 path:00640_31 Propanoate metabolism 3 -5.18636789219499 5.52054946654238e-07 0.000220269923715041
CESC ENSG00000175699 LINC00521 path:04144_32 Endocytosis 8 -3.8120411613074 0.00027465296025793 0.0140416325931867
CESC ENSG00000175699 LINC00521 path:04666_232 Fc gamma R-mediated phagocytosis 8 -5.93206723888842 3.90772055029302e-07 5.32752568356615e-05
CESC ENSG00000175699 LINC00521 path:04750_88 Inflammatory mediator regulation of TRP channels 5 -4.37576741008785 3.98693083245436e-05 0.00326130942094767
CESC ENSG00000175699 LINC00521 path:04810_134 Regulation of actin cytoskeleton 31 -3.92225757003324 0.000226955894199594 0.0132607086753763
CESC ENSG00000175699 LINC00521 path:04932_103 Non-alcoholic fatty liver disease (NAFLD) 4 -7.63219113822838 2.61083960396887e-10 5.33916699011635e-08
CESC ENSG00000175699 LINC00521 path:05206_136 MicroRNAs in cancer 2 -7.6192948454595 7.64545406442571e-11 3.12699071235011e-08
CESC ENSG00000175699 LINC00521 path:05206_97 MicroRNAs in cancer 26 -4.17580752031433 8.56420162379312e-05 0.00583793077355231
CESC ENSG00000175699 LINC00521 path:05222_63 Small cell lung cancer 6 -5.02599323818842 6.28076073558987e-06 0.000642207785214064
CESC ENSG00000196273 LINC00523 path:04014_136 Ras signaling pathway 15 -3.35932987525971 0.00156098361951259 0.0493010659829392
CESC ENSG00000196273 LINC00523 path:04144_32 Endocytosis 8 -3.79250588125354 0.000283332788560431 0.0199835684716393
CESC ENSG00000196273 LINC00523 path:04151_285 PI3K-Akt signaling pathway 16 -3.51867875809173 0.000687822118579373 0.0325855728676978
CESC ENSG00000196273 LINC00523 path:04360_117 Axon guidance 15 -3.77222385734019 0.000440916737315015 0.0238724919203415
CESC ENSG00000196273 LINC00523 path:04512_73 ECM-receptor interaction 11 -3.33143827611793 0.00132539754573172 0.0456659699847565
CESC ENSG00000196273 LINC00523 path:04662_72 B cell receptor signaling pathway 8 -4.02041495091434 0.000187310299886989 0.0177476509142922
CESC ENSG00000196273 LINC00523 path:04810_134 Regulation of actin cytoskeleton 31 -4.00229285571665 0.000165924471229925 0.0177476509142922
CESC ENSG00000196273 LINC00523 path:04915_139 Estrogen signaling pathway 4 -8.41406486530196 5.72672287895484e-12 2.17042797112388e-09
CESC ENSG00000196273 LINC00523 path:05214_1 Glioma 51 -3.8161134249716 0.000316362561556295 0.0199835684716393
CESC ENSG00000196273 LINC00523 path:05218_1 Melanoma 63 -3.4792121008745 0.00105921735600022 0.0401443377924084
CESC ENSG00000196273 LINC00523 path:05222_63 Small cell lung cancer 6 -6.32875822818816 3.11627491995206e-08 5.90534097330916e-06
CESC ENSG00000196273 LINC00523 path:05231_46 Choline metabolism in cancer 24 -3.44725834743534 0.00104044835502111 0.0401443377924084
CESC ENSG00000259023 LINC00524 path:04014_136 Ras signaling pathway 15 -3.35932987525971 0.00156098361951259 0.0493010659829392
CESC ENSG00000259023 LINC00524 path:04144_32 Endocytosis 8 -3.79250588125354 0.000283332788560431 0.0199835684716393
CESC ENSG00000259023 LINC00524 path:04151_285 PI3K-Akt signaling pathway 16 -3.51867875809173 0.000687822118579373 0.0325855728676978
CESC ENSG00000259023 LINC00524 path:04360_117 Axon guidance 15 -3.77222385734019 0.000440916737315015 0.0238724919203415
CESC ENSG00000259023 LINC00524 path:04512_73 ECM-receptor interaction 11 -3.33143827611793 0.00132539754573172 0.0456659699847565
CESC ENSG00000259023 LINC00524 path:04662_72 B cell receptor signaling pathway 8 -4.02041495091434 0.000187310299886989 0.0177476509142922
CESC ENSG00000259023 LINC00524 path:04810_134 Regulation of actin cytoskeleton 31 -4.00229285571665 0.000165924471229925 0.0177476509142922
CESC ENSG00000259023 LINC00524 path:04915_139 Estrogen signaling pathway 4 -8.41406486530196 5.72672287895484e-12 2.17042797112388e-09
CESC ENSG00000259023 LINC00524 path:05214_1 Glioma 51 -3.8161134249716 0.000316362561556295 0.0199835684716393
CESC ENSG00000259023 LINC00524 path:05218_1 Melanoma 63 -3.4792121008745 0.00105921735600022 0.0401443377924084
CESC ENSG00000259023 LINC00524 path:05222_63 Small cell lung cancer 6 -6.32875822818816 3.11627491995206e-08 5.90534097330916e-06
CESC ENSG00000259023 LINC00524 path:05231_46 Choline metabolism in cancer 24 -3.44725834743534 0.00104044835502111 0.0401443377924084
CESC ENSG00000260388 LINC00562 path:00640_31 Propanoate metabolism 3 -5.55189744255061 9.57912557969566e-08 3.82207110629857e-05
CESC ENSG00000261097 LINC00563 path:00640_31 Propanoate metabolism 3 -5.48914366022956 1.29521174104563e-07 5.16789484677207e-05
CESC ENSG00000251533 LINC00605 path:00240_204 Pyrimidine metabolism 2 -3.85118877777033 0.000234909217550938 0.0183229189689731
CESC ENSG00000251533 LINC00605 path:04261_79 Adrenergic signaling in cardiomyocytes 38 -3.52529099625749 0.000785276267876378 0.0437511063531125
CESC ENSG00000251533 LINC00605 path:04662_72 B cell receptor signaling pathway 8 -4.41157726496846 4.87456458086943e-05 0.00633693395513026
CESC ENSG00000251533 LINC00605 path:04670_142 Leukocyte transendothelial migration 6 -4.13705349646663 0.000106226364862271 0.0103570705740714
CESC ENSG00000251533 LINC00605 path:05206_78 MicroRNAs in cancer 48 -4.47485823510021 3.13116287151947e-05 0.00610576759946296
CESC ENSG00000251533 LINC00605 path:05214_1 Glioma 51 -3.57831652883344 0.00064217781280233 0.0417415578321515
CESC ENSG00000251533 LINC00605 path:05222_73 Small cell lung cancer 3 -8.424666082184 1.3911714147316e-12 5.42556851745323e-10
CESC ENSG00000225163 LINC00618 path:04144_32 Endocytosis 8 -3.9416060644509 0.00016747324200157 0.0158680896796488
CESC ENSG00000225163 LINC00618 path:04151_285 PI3K-Akt signaling pathway 16 -3.68988847823218 0.000384569068678518 0.0291503354058317
CESC ENSG00000225163 LINC00618 path:04810_134 Regulation of actin cytoskeleton 31 -4.10940181072005 0.000114497782985166 0.0144648865837927
CESC ENSG00000225163 LINC00618 path:04915_139 Estrogen signaling pathway 4 -7.78794033048715 9.63396136733793e-11 3.65127135822107e-08
CESC ENSG00000225163 LINC00618 path:05222_63 Small cell lung cancer 6 -5.17171115844146 3.3015761474502e-06 0.000625648679941813
CESC ENSG00000258735 LINC00637 path:04062_169 Chemokine signaling pathway 27 -3.74561305149265 0.000495875610085168 0.0453726183227929
CESC ENSG00000258735 LINC00637 path:04660_129 T cell receptor signaling pathway 9 -4.90396950750985 9.12818145798239e-06 0.00167045720681078
CESC ENSG00000258735 LINC00637 path:04670_142 Leukocyte transendothelial migration 6 -4.05512953712353 0.000153688356290849 0.0187499794674836
CESC ENSG00000258735 LINC00637 path:04915_139 Estrogen signaling pathway 4 -8.44510106866434 7.09316234329053e-12 2.59609741764434e-09
CESC ENSG00000258701 LINC00638 path:04062_169 Chemokine signaling pathway 27 -3.74561305149265 0.000495875610085168 0.0453726183227929
CESC ENSG00000258701 LINC00638 path:04660_129 T cell receptor signaling pathway 9 -4.90396950750985 9.12818145798239e-06 0.00167045720681078
CESC ENSG00000258701 LINC00638 path:04670_142 Leukocyte transendothelial migration 6 -4.05512953712353 0.000153688356290849 0.0187499794674836
CESC ENSG00000258701 LINC00638 path:04915_139 Estrogen signaling pathway 4 -8.44510106866434 7.09316234329053e-12 2.59609741764434e-09
CESC ENSG00000259717 LINC00677 path:04662_72 B cell receptor signaling pathway 8 -4.32651156209582 6.96500888680659e-05 0.00870626110850824
CESC ENSG00000259717 LINC00677 path:04670_142 Leukocyte transendothelial migration 6 -4.27838227993545 6.85288789765611e-05 0.00870626110850824
CESC ENSG00000259717 LINC00677 path:05222_73 Small cell lung cancer 3 -8.73301570813389 4.08856386456954e-13 1.53321144921358e-10
CESC ENSG00000235366 LINC01055 path:00640_31 Propanoate metabolism 3 -5.42254258714793 1.78380054193679e-07 7.11736416232781e-05
CESC ENSG00000233456 LINC01077 path:00640_31 Propanoate metabolism 3 -5.18636789219499 5.52054946654238e-07 0.000220269923715041
CESC ENSG00000231817 LINC01198 path:00640_31 Propanoate metabolism 3 -5.48914366022956 1.29521174104563e-07 5.16789484677207e-05
CESC ENSG00000234722 LINC01287 path:00250_31 Alanine, aspartate and glutamate metabolism 10 -3.99686568024612 9.2461190772425e-05 0.0355975584473836
CESC ENSG00000229111 MED4-AS1 path:00640_31 Propanoate metabolism 3 -5.55189744255061 9.57912557969566e-08 3.82207110629857e-05
CESC ENSG00000214548 MEG3 path:04014_136 Ras signaling pathway 15 -3.35932987525971 0.00156098361951259 0.0493010659829392
CESC ENSG00000214548 MEG3 path:04144_32 Endocytosis 8 -3.79250588125354 0.000283332788560431 0.0199835684716393
CESC ENSG00000214548 MEG3 path:04151_285 PI3K-Akt signaling pathway 16 -3.51867875809173 0.000687822118579373 0.0325855728676978
CESC ENSG00000214548 MEG3 path:04360_117 Axon guidance 15 -3.77222385734019 0.000440916737315015 0.0238724919203415
CESC ENSG00000214548 MEG3 path:04512_73 ECM-receptor interaction 11 -3.33143827611793 0.00132539754573172 0.0456659699847565
CESC ENSG00000214548 MEG3 path:04662_72 B cell receptor signaling pathway 8 -4.02041495091434 0.000187310299886989 0.0177476509142922
CESC ENSG00000214548 MEG3 path:04810_134 Regulation of actin cytoskeleton 31 -4.00229285571665 0.000165924471229925 0.0177476509142922
CESC ENSG00000214548 MEG3 path:04915_139 Estrogen signaling pathway 4 -8.41406486530196 5.72672287895484e-12 2.17042797112388e-09
CESC ENSG00000214548 MEG3 path:05214_1 Glioma 51 -3.8161134249716 0.000316362561556295 0.0199835684716393
CESC ENSG00000214548 MEG3 path:05218_1 Melanoma 63 -3.4792121008745 0.00105921735600022 0.0401443377924084
CESC ENSG00000214548 MEG3 path:05222_63 Small cell lung cancer 6 -6.32875822818816 3.11627491995206e-08 5.90534097330916e-06
CESC ENSG00000214548 MEG3 path:05231_46 Choline metabolism in cancer 24 -3.44725834743534 0.00104044835502111 0.0401443377924084
CESC ENSG00000258399 MEG8 path:04014_136 Ras signaling pathway 15 -3.35932987525971 0.00156098361951259 0.0493010659829392
CESC ENSG00000258399 MEG8 path:04144_32 Endocytosis 8 -3.79250588125354 0.000283332788560431 0.0199835684716393
CESC ENSG00000258399 MEG8 path:04151_285 PI3K-Akt signaling pathway 16 -3.51867875809173 0.000687822118579373 0.0325855728676978
CESC ENSG00000258399 MEG8 path:04360_117 Axon guidance 15 -3.77222385734019 0.000440916737315015 0.0238724919203415
CESC ENSG00000258399 MEG8 path:04512_73 ECM-receptor interaction 11 -3.33143827611793 0.00132539754573172 0.0456659699847565
CESC ENSG00000258399 MEG8 path:04662_72 B cell receptor signaling pathway 8 -4.02041495091434 0.000187310299886989 0.0177476509142922
CESC ENSG00000258399 MEG8 path:04810_134 Regulation of actin cytoskeleton 31 -4.00229285571665 0.000165924471229925 0.0177476509142922
CESC ENSG00000258399 MEG8 path:04915_139 Estrogen signaling pathway 4 -8.41406486530196 5.72672287895484e-12 2.17042797112388e-09
CESC ENSG00000258399 MEG8 path:05214_1 Glioma 51 -3.8161134249716 0.000316362561556295 0.0199835684716393
CESC ENSG00000258399 MEG8 path:05218_1 Melanoma 63 -3.4792121008745 0.00105921735600022 0.0401443377924084
CESC ENSG00000258399 MEG8 path:05222_63 Small cell lung cancer 6 -6.32875822818816 3.11627491995206e-08 5.90534097330916e-06
CESC ENSG00000258399 MEG8 path:05231_46 Choline metabolism in cancer 24 -3.44725834743534 0.00104044835502111 0.0401443377924084
CESC ENSG00000223403 MEG9 path:04014_136 Ras signaling pathway 15 -3.35932987525971 0.00156098361951259 0.0493010659829392
CESC ENSG00000223403 MEG9 path:04144_32 Endocytosis 8 -3.79250588125354 0.000283332788560431 0.0199835684716393
CESC ENSG00000223403 MEG9 path:04151_285 PI3K-Akt signaling pathway 16 -3.51867875809173 0.000687822118579373 0.0325855728676978
CESC ENSG00000223403 MEG9 path:04360_117 Axon guidance 15 -3.77222385734019 0.000440916737315015 0.0238724919203415
CESC ENSG00000223403 MEG9 path:04512_73 ECM-receptor interaction 11 -3.33143827611793 0.00132539754573172 0.0456659699847565
CESC ENSG00000223403 MEG9 path:04662_72 B cell receptor signaling pathway 8 -4.02041495091434 0.000187310299886989 0.0177476509142922
CESC ENSG00000223403 MEG9 path:04810_134 Regulation of actin cytoskeleton 31 -4.00229285571665 0.000165924471229925 0.0177476509142922
CESC ENSG00000223403 MEG9 path:04915_139 Estrogen signaling pathway 4 -8.41406486530196 5.72672287895484e-12 2.17042797112388e-09
CESC ENSG00000223403 MEG9 path:05214_1 Glioma 51 -3.8161134249716 0.000316362561556295 0.0199835684716393
CESC ENSG00000223403 MEG9 path:05218_1 Melanoma 63 -3.4792121008745 0.00105921735600022 0.0401443377924084
CESC ENSG00000223403 MEG9 path:05222_63 Small cell lung cancer 6 -6.32875822818816 3.11627491995206e-08 5.90534097330916e-06
CESC ENSG00000223403 MEG9 path:05231_46 Choline metabolism in cancer 24 -3.44725834743534 0.00104044835502111 0.0401443377924084
CESC ENSG00000228526 MIR34AHG path:00330_108 Arginine and proline metabolism 2 -4.39819184364159 2.98806795895875e-05 0.00966316373428374
CESC ENSG00000228526 MIR34AHG path:04725_51 Cholinergic synapse 41 -4.29869663796693 4.69085618169114e-05 0.00966316373428374
CESC ENSG00000258861 MIR381HG path:04014_136 Ras signaling pathway 15 -3.35932987525971 0.00156098361951259 0.0493010659829392
CESC ENSG00000258861 MIR381HG path:04144_32 Endocytosis 8 -3.79250588125354 0.000283332788560431 0.0199835684716393
CESC ENSG00000258861 MIR381HG path:04151_285 PI3K-Akt signaling pathway 16 -3.51867875809173 0.000687822118579373 0.0325855728676978
CESC ENSG00000258861 MIR381HG path:04360_117 Axon guidance 15 -3.77222385734019 0.000440916737315015 0.0238724919203415
CESC ENSG00000258861 MIR381HG path:04512_73 ECM-receptor interaction 11 -3.33143827611793 0.00132539754573172 0.0456659699847565
CESC ENSG00000258861 MIR381HG path:04662_72 B cell receptor signaling pathway 8 -4.02041495091434 0.000187310299886989 0.0177476509142922
CESC ENSG00000258861 MIR381HG path:04810_134 Regulation of actin cytoskeleton 31 -4.00229285571665 0.000165924471229925 0.0177476509142922
CESC ENSG00000258861 MIR381HG path:04915_139 Estrogen signaling pathway 4 -8.41406486530196 5.72672287895484e-12 2.17042797112388e-09
CESC ENSG00000258861 MIR381HG path:05214_1 Glioma 51 -3.8161134249716 0.000316362561556295 0.0199835684716393
CESC ENSG00000258861 MIR381HG path:05218_1 Melanoma 63 -3.4792121008745 0.00105921735600022 0.0401443377924084
CESC ENSG00000258861 MIR381HG path:05222_63 Small cell lung cancer 6 -6.32875822818816 3.11627491995206e-08 5.90534097330916e-06
CESC ENSG00000258861 MIR381HG path:05231_46 Choline metabolism in cancer 24 -3.44725834743534 0.00104044835502111 0.0401443377924084
CESC ENSG00000231789 PIK3CD-AS2 path:00330_108 Arginine and proline metabolism 2 -4.29753215374342 4.80512856226761e-05 0.0197971296765426
CESC ENSG00000231789 PIK3CD-AS2 path:04725_51 Cholinergic synapse 41 -4.04110313447155 0.000119517705236951 0.024620647278812
CESC ENSG00000226944 RP1-120G22.11 path:04151_222 PI3K-Akt signaling pathway 29 -4.13213972757443 0.000233121682616893 0.0332459871314831
CESC ENSG00000226944 RP1-120G22.11 path:04530_214 Tight junction 2 -5.25314438100398 5.46950218487821e-06 0.00213857535428738
CESC ENSG00000226944 RP1-120G22.11 path:04666_128 Fc gamma R-mediated phagocytosis 28 -4.13232942376634 0.000255084300241558 0.0332459871314831
CESC ENSG00000231868 RP1-202O8.2 path:04530_214 Tight junction 2 -4.96530768734558 1.3817923348898e-05 0.00543044387611691
CESC ENSG00000270174 RP1-256G22.2 path:00260_1 Glycine, serine and threonine metabolism 29 3.82028569621953 0.000364377923206984 0.0433504081232415
CESC ENSG00000270174 RP1-256G22.2 path:04668_46 TNF signaling pathway 10 -3.72267169212394 0.000409932937335617 0.0433504081232415
CESC ENSG00000270174 RP1-256G22.2 path:05014_26 Amyotrophic lateral sclerosis (ALS) 7 -4.96502897683372 9.08684677249562e-06 0.00384373618476565
CESC ENSG00000270174 RP1-256G22.2 path:05169_46 Epstein-Barr virus infection 3 -4.21094646820305 9.80858817517291e-05 0.0207451639904907
CESC ENSG00000260972 RP1-58B11.1 path:04151_222 PI3K-Akt signaling pathway 29 -4.13213972757443 0.000233121682616893 0.0332459871314831
CESC ENSG00000260972 RP1-58B11.1 path:04530_214 Tight junction 2 -5.25314438100398 5.46950218487821e-06 0.00213857535428738
CESC ENSG00000260972 RP1-58B11.1 path:04666_128 Fc gamma R-mediated phagocytosis 28 -4.13232942376634 0.000255084300241558 0.0332459871314831
CESC ENSG00000258959 RP11-1017G21.4 path:04014_136 Ras signaling pathway 15 -3.56275251658194 0.000827209242788163 0.0348347003351904
CESC ENSG00000258959 RP11-1017G21.4 path:04151_285 PI3K-Akt signaling pathway 16 -3.67558898141013 0.000394184204421611 0.0248993022459651
CESC ENSG00000258959 RP11-1017G21.4 path:04360_117 Axon guidance 15 -4.00931509832394 0.000200283268993397 0.0151814717896995
CESC ENSG00000258959 RP11-1017G21.4 path:04512_73 ECM-receptor interaction 11 -3.51548076622067 0.000716598834260619 0.0339488697730968
CESC ENSG00000258959 RP11-1017G21.4 path:04662_72 B cell receptor signaling pathway 8 -4.32651156209582 6.96500888680659e-05 0.00745004463869429
CESC ENSG00000258959 RP11-1017G21.4 path:04810_134 Regulation of actin cytoskeleton 31 -4.2043558540194 7.86284394585149e-05 0.00745004463869429
CESC ENSG00000258959 RP11-1017G21.4 path:04915_139 Estrogen signaling pathway 4 -8.7302243647037 1.43439292186618e-12 5.43634917387284e-10
CESC ENSG00000258959 RP11-1017G21.4 path:05214_1 Glioma 51 -3.61327842189849 0.000594190697243503 0.0321711820364697
CESC ENSG00000258959 RP11-1017G21.4 path:05222_63 Small cell lung cancer 6 -6.47987205940697 1.35326603474504e-08 2.56443913584185e-06
CESC ENSG00000258959 RP11-1017G21.4 path:05231_46 Choline metabolism in cancer 24 -3.43054481651577 0.00106049036922131 0.0401925849934876
CESC ENSG00000271780 RP11-1017G21.5 path:04014_136 Ras signaling pathway 15 -3.56275251658194 0.000827209242788163 0.0348347003351904
CESC ENSG00000271780 RP11-1017G21.5 path:04151_285 PI3K-Akt signaling pathway 16 -3.67558898141013 0.000394184204421611 0.0248993022459651
CESC ENSG00000271780 RP11-1017G21.5 path:04360_117 Axon guidance 15 -4.00931509832394 0.000200283268993397 0.0151814717896995
CESC ENSG00000271780 RP11-1017G21.5 path:04512_73 ECM-receptor interaction 11 -3.51548076622067 0.000716598834260619 0.0339488697730968
CESC ENSG00000271780 RP11-1017G21.5 path:04662_72 B cell receptor signaling pathway 8 -4.32651156209582 6.96500888680659e-05 0.00745004463869429
CESC ENSG00000271780 RP11-1017G21.5 path:04810_134 Regulation of actin cytoskeleton 31 -4.2043558540194 7.86284394585149e-05 0.00745004463869429
CESC ENSG00000271780 RP11-1017G21.5 path:04915_139 Estrogen signaling pathway 4 -8.7302243647037 1.43439292186618e-12 5.43634917387284e-10
CESC ENSG00000271780 RP11-1017G21.5 path:05214_1 Glioma 51 -3.61327842189849 0.000594190697243503 0.0321711820364697
CESC ENSG00000271780 RP11-1017G21.5 path:05222_63 Small cell lung cancer 6 -6.47987205940697 1.35326603474504e-08 2.56443913584185e-06
CESC ENSG00000271780 RP11-1017G21.5 path:05231_46 Choline metabolism in cancer 24 -3.43054481651577 0.00106049036922131 0.0401925849934876
CESC ENSG00000272444 RP11-1017G21.6 path:04014_136 Ras signaling pathway 15 -3.56275251658194 0.000827209242788163 0.0348347003351904
CESC ENSG00000272444 RP11-1017G21.6 path:04151_285 PI3K-Akt signaling pathway 16 -3.67558898141013 0.000394184204421611 0.0248993022459651
CESC ENSG00000272444 RP11-1017G21.6 path:04360_117 Axon guidance 15 -4.00931509832394 0.000200283268993397 0.0151814717896995
CESC ENSG00000272444 RP11-1017G21.6 path:04512_73 ECM-receptor interaction 11 -3.51548076622067 0.000716598834260619 0.0339488697730968
CESC ENSG00000272444 RP11-1017G21.6 path:04662_72 B cell receptor signaling pathway 8 -4.32651156209582 6.96500888680659e-05 0.00745004463869429
CESC ENSG00000272444 RP11-1017G21.6 path:04810_134 Regulation of actin cytoskeleton 31 -4.2043558540194 7.86284394585149e-05 0.00745004463869429
CESC ENSG00000272444 RP11-1017G21.6 path:04915_139 Estrogen signaling pathway 4 -8.7302243647037 1.43439292186618e-12 5.43634917387284e-10
CESC ENSG00000272444 RP11-1017G21.6 path:05214_1 Glioma 51 -3.61327842189849 0.000594190697243503 0.0321711820364697
CESC ENSG00000272444 RP11-1017G21.6 path:05222_63 Small cell lung cancer 6 -6.47987205940697 1.35326603474504e-08 2.56443913584185e-06
CESC ENSG00000272444 RP11-1017G21.6 path:05231_46 Choline metabolism in cancer 24 -3.43054481651577 0.00106049036922131 0.0401925849934876
CESC ENSG00000259166 RP11-1029J19.2 path:04014_136 Ras signaling pathway 15 -3.35932987525971 0.00156098361951259 0.0493010659829392
CESC ENSG00000259166 RP11-1029J19.2 path:04144_32 Endocytosis 8 -3.79250588125354 0.000283332788560431 0.0199835684716393
CESC ENSG00000259166 RP11-1029J19.2 path:04151_285 PI3K-Akt signaling pathway 16 -3.51867875809173 0.000687822118579373 0.0325855728676978
CESC ENSG00000259166 RP11-1029J19.2 path:04360_117 Axon guidance 15 -3.77222385734019 0.000440916737315015 0.0238724919203415
CESC ENSG00000259166 RP11-1029J19.2 path:04512_73 ECM-receptor interaction 11 -3.33143827611793 0.00132539754573172 0.0456659699847565
CESC ENSG00000259166 RP11-1029J19.2 path:04662_72 B cell receptor signaling pathway 8 -4.02041495091434 0.000187310299886989 0.0177476509142922
CESC ENSG00000259166 RP11-1029J19.2 path:04810_134 Regulation of actin cytoskeleton 31 -4.00229285571665 0.000165924471229925 0.0177476509142922
CESC ENSG00000259166 RP11-1029J19.2 path:04915_139 Estrogen signaling pathway 4 -8.41406486530196 5.72672287895484e-12 2.17042797112388e-09
CESC ENSG00000259166 RP11-1029J19.2 path:05214_1 Glioma 51 -3.8161134249716 0.000316362561556295 0.0199835684716393
CESC ENSG00000259166 RP11-1029J19.2 path:05218_1 Melanoma 63 -3.4792121008745 0.00105921735600022 0.0401443377924084
CESC ENSG00000259166 RP11-1029J19.2 path:05222_63 Small cell lung cancer 6 -6.32875822818816 3.11627491995206e-08 5.90534097330916e-06
CESC ENSG00000259166 RP11-1029J19.2 path:05231_46 Choline metabolism in cancer 24 -3.44725834743534 0.00104044835502111 0.0401443377924084
CESC ENSG00000258919 RP11-1029J19.4 path:04014_136 Ras signaling pathway 15 -3.56275251658194 0.000827209242788163 0.0348347003351904
CESC ENSG00000258919 RP11-1029J19.4 path:04151_285 PI3K-Akt signaling pathway 16 -3.67558898141013 0.000394184204421611 0.0248993022459651
CESC ENSG00000258919 RP11-1029J19.4 path:04360_117 Axon guidance 15 -4.00931509832394 0.000200283268993397 0.0151814717896995
CESC ENSG00000258919 RP11-1029J19.4 path:04512_73 ECM-receptor interaction 11 -3.51548076622067 0.000716598834260619 0.0339488697730968
CESC ENSG00000258919 RP11-1029J19.4 path:04662_72 B cell receptor signaling pathway 8 -4.32651156209582 6.96500888680659e-05 0.00745004463869429
CESC ENSG00000258919 RP11-1029J19.4 path:04810_134 Regulation of actin cytoskeleton 31 -4.2043558540194 7.86284394585149e-05 0.00745004463869429
CESC ENSG00000258919 RP11-1029J19.4 path:04915_139 Estrogen signaling pathway 4 -8.7302243647037 1.43439292186618e-12 5.43634917387284e-10
CESC ENSG00000258919 RP11-1029J19.4 path:05214_1 Glioma 51 -3.61327842189849 0.000594190697243503 0.0321711820364697
CESC ENSG00000258919 RP11-1029J19.4 path:05222_63 Small cell lung cancer 6 -6.47987205940697 1.35326603474504e-08 2.56443913584185e-06
CESC ENSG00000258919 RP11-1029J19.4 path:05231_46 Choline metabolism in cancer 24 -3.43054481651577 0.00106049036922131 0.0401925849934876
CESC ENSG00000258404 RP11-1029J19.5 path:04014_136 Ras signaling pathway 15 -3.56275251658194 0.000827209242788163 0.0348347003351904
CESC ENSG00000258404 RP11-1029J19.5 path:04151_285 PI3K-Akt signaling pathway 16 -3.67558898141013 0.000394184204421611 0.0248993022459651
CESC ENSG00000258404 RP11-1029J19.5 path:04360_117 Axon guidance 15 -4.00931509832394 0.000200283268993397 0.0151814717896995
CESC ENSG00000258404 RP11-1029J19.5 path:04512_73 ECM-receptor interaction 11 -3.51548076622067 0.000716598834260619 0.0339488697730968
CESC ENSG00000258404 RP11-1029J19.5 path:04662_72 B cell receptor signaling pathway 8 -4.32651156209582 6.96500888680659e-05 0.00745004463869429
CESC ENSG00000258404 RP11-1029J19.5 path:04810_134 Regulation of actin cytoskeleton 31 -4.2043558540194 7.86284394585149e-05 0.00745004463869429
CESC ENSG00000258404 RP11-1029J19.5 path:04915_139 Estrogen signaling pathway 4 -8.7302243647037 1.43439292186618e-12 5.43634917387284e-10
CESC ENSG00000258404 RP11-1029J19.5 path:05214_1 Glioma 51 -3.61327842189849 0.000594190697243503 0.0321711820364697
CESC ENSG00000258404 RP11-1029J19.5 path:05222_63 Small cell lung cancer 6 -6.47987205940697 1.35326603474504e-08 2.56443913584185e-06
CESC ENSG00000258404 RP11-1029J19.5 path:05231_46 Choline metabolism in cancer 24 -3.43054481651577 0.00106049036922131 0.0401925849934876
CESC ENSG00000258390 RP11-1070N10.4 path:04144_32 Endocytosis 8 -3.8120411613074 0.00027465296025793 0.0140416325931867
CESC ENSG00000258390 RP11-1070N10.4 path:04666_232 Fc gamma R-mediated phagocytosis 8 -5.93206723888842 3.90772055029302e-07 5.32752568356615e-05
CESC ENSG00000258390 RP11-1070N10.4 path:04750_88 Inflammatory mediator regulation of TRP channels 5 -4.37576741008785 3.98693083245436e-05 0.00326130942094767
CESC ENSG00000258390 RP11-1070N10.4 path:04810_134 Regulation of actin cytoskeleton 31 -3.92225757003324 0.000226955894199594 0.0132607086753763
CESC ENSG00000258390 RP11-1070N10.4 path:04932_103 Non-alcoholic fatty liver disease (NAFLD) 4 -7.63219113822838 2.61083960396887e-10 5.33916699011635e-08
CESC ENSG00000258390 RP11-1070N10.4 path:05206_136 MicroRNAs in cancer 2 -7.6192948454595 7.64545406442571e-11 3.12699071235011e-08
CESC ENSG00000258390 RP11-1070N10.4 path:05206_97 MicroRNAs in cancer 26 -4.17580752031433 8.56420162379312e-05 0.00583793077355231
CESC ENSG00000258390 RP11-1070N10.4 path:05222_63 Small cell lung cancer 6 -5.02599323818842 6.28076073558987e-06 0.000642207785214064
CESC ENSG00000258927 RP11-1070N10.5 path:04144_32 Endocytosis 8 -3.8120411613074 0.00027465296025793 0.0140416325931867
CESC ENSG00000258927 RP11-1070N10.5 path:04666_232 Fc gamma R-mediated phagocytosis 8 -5.93206723888842 3.90772055029302e-07 5.32752568356615e-05
CESC ENSG00000258927 RP11-1070N10.5 path:04750_88 Inflammatory mediator regulation of TRP channels 5 -4.37576741008785 3.98693083245436e-05 0.00326130942094767
CESC ENSG00000258927 RP11-1070N10.5 path:04810_134 Regulation of actin cytoskeleton 31 -3.92225757003324 0.000226955894199594 0.0132607086753763
CESC ENSG00000258927 RP11-1070N10.5 path:04932_103 Non-alcoholic fatty liver disease (NAFLD) 4 -7.63219113822838 2.61083960396887e-10 5.33916699011635e-08
CESC ENSG00000258927 RP11-1070N10.5 path:05206_136 MicroRNAs in cancer 2 -7.6192948454595 7.64545406442571e-11 3.12699071235011e-08
CESC ENSG00000258927 RP11-1070N10.5 path:05206_97 MicroRNAs in cancer 26 -4.17580752031433 8.56420162379312e-05 0.00583793077355231
CESC ENSG00000258927 RP11-1070N10.5 path:05222_63 Small cell lung cancer 6 -5.02599323818842 6.28076073558987e-06 0.000642207785214064
CESC ENSG00000259084 RP11-1070N10.6 path:04144_32 Endocytosis 8 -3.8120411613074 0.00027465296025793 0.0140416325931867
CESC ENSG00000259084 RP11-1070N10.6 path:04666_232 Fc gamma R-mediated phagocytosis 8 -5.93206723888842 3.90772055029302e-07 5.32752568356615e-05
CESC ENSG00000259084 RP11-1070N10.6 path:04750_88 Inflammatory mediator regulation of TRP channels 5 -4.37576741008785 3.98693083245436e-05 0.00326130942094767
CESC ENSG00000259084 RP11-1070N10.6 path:04810_134 Regulation of actin cytoskeleton 31 -3.92225757003324 0.000226955894199594 0.0132607086753763
CESC ENSG00000259084 RP11-1070N10.6 path:04932_103 Non-alcoholic fatty liver disease (NAFLD) 4 -7.63219113822838 2.61083960396887e-10 5.33916699011635e-08
CESC ENSG00000259084 RP11-1070N10.6 path:05206_136 MicroRNAs in cancer 2 -7.6192948454595 7.64545406442571e-11 3.12699071235011e-08
CESC ENSG00000259084 RP11-1070N10.6 path:05206_97 MicroRNAs in cancer 26 -4.17580752031433 8.56420162379312e-05 0.00583793077355231
CESC ENSG00000259084 RP11-1070N10.6 path:05222_63 Small cell lung cancer 6 -5.02599323818842 6.28076073558987e-06 0.000642207785214064
CESC ENSG00000270038 RP11-1070N10.7 path:04144_32 Endocytosis 8 -3.8120411613074 0.00027465296025793 0.0140416325931867
CESC ENSG00000270038 RP11-1070N10.7 path:04666_232 Fc gamma R-mediated phagocytosis 8 -5.93206723888842 3.90772055029302e-07 5.32752568356615e-05
CESC ENSG00000270038 RP11-1070N10.7 path:04750_88 Inflammatory mediator regulation of TRP channels 5 -4.37576741008785 3.98693083245436e-05 0.00326130942094767
CESC ENSG00000270038 RP11-1070N10.7 path:04810_134 Regulation of actin cytoskeleton 31 -3.92225757003324 0.000226955894199594 0.0132607086753763
CESC ENSG00000270038 RP11-1070N10.7 path:04932_103 Non-alcoholic fatty liver disease (NAFLD) 4 -7.63219113822838 2.61083960396887e-10 5.33916699011635e-08
CESC ENSG00000270038 RP11-1070N10.7 path:05206_136 MicroRNAs in cancer 2 -7.6192948454595 7.64545406442571e-11 3.12699071235011e-08
CESC ENSG00000270038 RP11-1070N10.7 path:05206_97 MicroRNAs in cancer 26 -4.17580752031433 8.56420162379312e-05 0.00583793077355231
CESC ENSG00000270038 RP11-1070N10.7 path:05222_63 Small cell lung cancer 6 -5.02599323818842 6.28076073558987e-06 0.000642207785214064
CESC ENSG00000258795 RP11-1082A3.1 path:04144_32 Endocytosis 8 -3.85942891682161 0.000215403908962631 0.0204095203742093
CESC ENSG00000258795 RP11-1082A3.1 path:04151_285 PI3K-Akt signaling pathway 16 -3.60005884541621 0.00050785811220903 0.0320797040878704
CESC ENSG00000258795 RP11-1082A3.1 path:04360_117 Axon guidance 15 -3.48274180541256 0.00104262033041477 0.0475724426059716
CESC ENSG00000258795 RP11-1082A3.1 path:04512_73 ECM-receptor interaction 11 -3.33092378646045 0.00129260215481327 0.0489896216674228
CESC ENSG00000258795 RP11-1082A3.1 path:04662_72 B cell receptor signaling pathway 8 -3.5207020936867 0.00090247764965174 0.0475724426059716
CESC ENSG00000258795 RP11-1082A3.1 path:04810_134 Regulation of actin cytoskeleton 31 -4.05721041677141 0.000130019966566195 0.016425855776196
CESC ENSG00000258795 RP11-1082A3.1 path:04915_139 Estrogen signaling pathway 4 -8.03351644188768 2.42399911503361e-11 9.18695664597738e-09
CESC ENSG00000258795 RP11-1082A3.1 path:05214_1 Glioma 51 -3.73439137078991 0.000397417724151354 0.0301242634906726
CESC ENSG00000258795 RP11-1082A3.1 path:05222_63 Small cell lung cancer 6 -5.43972942772094 1.12072767134325e-06 0.000212377893719545
CESC ENSG00000258795 RP11-1082A3.1 path:05231_46 Choline metabolism in cancer 24 -3.4104330246693 0.00112968861069589 0.0475724426059716
CESC ENSG00000259119 RP11-1127D7.1 path:04144_32 Endocytosis 8 -3.79250588125354 0.000283332788560431 0.0309244403921278
CESC ENSG00000259119 RP11-1127D7.1 path:04510_307 Focal adhesion 7 -3.72085022763615 0.000539668430464556 0.0422020712623283
CESC ENSG00000259119 RP11-1127D7.1 path:04728_178 Dopaminergic synapse 17 -4.66979916342185 2.46718733855351e-05 0.00482335124687211
CESC ENSG00000259119 RP11-1127D7.1 path:05214_1 Glioma 51 -3.8161134249716 0.000316362561556295 0.0309244403921278
CESC ENSG00000259119 RP11-1127D7.1 path:05222_73 Small cell lung cancer 3 -8.41871878753588 2.07940060962636e-12 8.13045638363907e-10
CESC ENSG00000250829 RP11-11N5.1 path:00071_3 Fatty acid degradation 24 -3.9048370835803 0.000135443722801807 0.0279691287585731
CESC ENSG00000250829 RP11-11N5.1 path:00830_44 Retinol metabolism 8 -4.64912636236933 6.24505397583482e-06 0.00257920729201978
CESC ENSG00000272218 RP11-11N5.3 path:00071_3 Fatty acid degradation 24 -3.9048370835803 0.000135443722801807 0.0279691287585731
CESC ENSG00000272218 RP11-11N5.3 path:00830_44 Retinol metabolism 8 -4.64912636236933 6.24505397583482e-06 0.00257920729201978
CESC ENSG00000258663 RP11-123M6.2 path:04014_136 Ras signaling pathway 15 -3.35932987525971 0.00156098361951259 0.0493010659829392
CESC ENSG00000258663 RP11-123M6.2 path:04144_32 Endocytosis 8 -3.79250588125354 0.000283332788560431 0.0199835684716393
CESC ENSG00000258663 RP11-123M6.2 path:04151_285 PI3K-Akt signaling pathway 16 -3.51867875809173 0.000687822118579373 0.0325855728676978
CESC ENSG00000258663 RP11-123M6.2 path:04360_117 Axon guidance 15 -3.77222385734019 0.000440916737315015 0.0238724919203415
CESC ENSG00000258663 RP11-123M6.2 path:04512_73 ECM-receptor interaction 11 -3.33143827611793 0.00132539754573172 0.0456659699847565
CESC ENSG00000258663 RP11-123M6.2 path:04662_72 B cell receptor signaling pathway 8 -4.02041495091434 0.000187310299886989 0.0177476509142922
CESC ENSG00000258663 RP11-123M6.2 path:04810_134 Regulation of actin cytoskeleton 31 -4.00229285571665 0.000165924471229925 0.0177476509142922
CESC ENSG00000258663 RP11-123M6.2 path:04915_139 Estrogen signaling pathway 4 -8.41406486530196 5.72672287895484e-12 2.17042797112388e-09
CESC ENSG00000258663 RP11-123M6.2 path:05214_1 Glioma 51 -3.8161134249716 0.000316362561556295 0.0199835684716393
CESC ENSG00000258663 RP11-123M6.2 path:05218_1 Melanoma 63 -3.4792121008745 0.00105921735600022 0.0401443377924084
CESC ENSG00000258663 RP11-123M6.2 path:05222_63 Small cell lung cancer 6 -6.32875822818816 3.11627491995206e-08 5.90534097330916e-06
CESC ENSG00000258663 RP11-123M6.2 path:05231_46 Choline metabolism in cancer 24 -3.44725834743534 0.00104044835502111 0.0401443377924084
CESC ENSG00000272866 RP11-12D24.10 path:00120_5 Primary bile acid biosynthesis 4 3.0052114106492 0.00362547242800525 0.0274085715557197
CESC ENSG00000272866 RP11-12D24.10 path:00140_24 Steroid hormone biosynthesis 10 3.21407066756881 0.00187996790531209 0.0192061586002154
CESC ENSG00000272866 RP11-12D24.10 path:00310_1 Lysine degradation 25 -3.08800036101601 0.0025685995631186 0.0220666053377007
CESC ENSG00000272866 RP11-12D24.10 path:00430_1 Taurine and hypotaurine metabolism 7 2.57499432353643 0.0116398436164603 0.049273607399323
CESC ENSG00000272866 RP11-12D24.10 path:00562_57 Inositol phosphate metabolism 10 2.89908823881023 0.00495920741229509 0.0328568084700191
CESC ENSG00000272866 RP11-12D24.10 path:00562_58 Inositol phosphate metabolism 10 -3.59684934087303 0.000481176901932677 0.0117355795756413
CESC ENSG00000272866 RP11-12D24.10 path:00740_1 Riboflavin metabolism 8 3.59966458636898 0.000574341145636246 0.0117355795756413
CESC ENSG00000272866 RP11-12D24.10 path:00750_1 Vitamin B6 metabolism 3 2.68517278657439 0.00874363602143963 0.042373005334669
CESC ENSG00000272866 RP11-12D24.10 path:00983_7 Drug metabolism - other enzymes 9 2.95115437598668 0.00435700305403659 0.0310744746118081
CESC ENSG00000272866 RP11-12D24.10 path:03015_1 mRNA surveillance pathway 32 -3.00737629176074 0.00320522694990732 0.0252411622305201
CESC ENSG00000272866 RP11-12D24.10 path:04014_202 Ras signaling pathway 4 -2.57409454970705 0.0112125431940033 0.0491548627558097
CESC ENSG00000272866 RP11-12D24.10 path:04014_36 Ras signaling pathway 129 -2.59063248602447 0.0111781597538505 0.0491548627558097
CESC ENSG00000272866 RP11-12D24.10 path:04015_168 Rap1 signaling pathway 10 -3.03969578375133 0.00283613778071429 0.023305653937174
CESC ENSG00000272866 RP11-12D24.10 path:04015_7 Rap1 signaling pathway 172 -2.79477806531367 0.00624126808536547 0.0339218263548799
CESC ENSG00000272866 RP11-12D24.10 path:04022_2 cGMP-PKG signaling pathway 143 -2.81889275604702 0.00580245476968778 0.0332735775259979
CESC ENSG00000272866 RP11-12D24.10 path:04024_106 cAMP signaling pathway 31 -3.4819550889172 0.000746193720495562 0.0122635315803184
CESC ENSG00000272866 RP11-12D24.10 path:04024_130 cAMP signaling pathway 21 -2.94556615903346 0.00381740309480924 0.0282936935262332
CESC ENSG00000272866 RP11-12D24.10 path:04062_303 Chemokine signaling pathway 4 2.68796987155764 0.00845084743908237 0.0414859783373134
CESC ENSG00000272866 RP11-12D24.10 path:04070_71 Phosphatidylinositol signaling system 11 3.15415446847338 0.00235094720218723 0.0206664661029482
CESC ENSG00000272866 RP11-12D24.10 path:04071_120 Sphingolipid signaling pathway 6 -4.15501972221421 7.28903095871969e-05 0.00459208950399341
CESC ENSG00000272866 RP11-12D24.10 path:04122_1 Sulfur relay system 5 2.76801447280191 0.00658460270286113 0.0342201184405113
CESC ENSG00000272866 RP11-12D24.10 path:04152_54 AMPK signaling pathway 17 -3.33142045861702 0.00110671189918388 0.0142117952281809
CESC ENSG00000272866 RP11-12D24.10 path:04210_46 Apoptosis 29 -2.55998710267514 0.0118267426631398 0.049273607399323
CESC ENSG00000272866 RP11-12D24.10 path:04261_1 Adrenergic signaling in cardiomyocytes 130 -3.24543803409154 0.00161437596039526 0.0182851939171667
CESC ENSG00000272866 RP11-12D24.10 path:04270_1 Vascular smooth muscle contraction 96 -3.64280277060923 0.000373800320613316 0.0117355795756413
CESC ENSG00000272866 RP11-12D24.10 path:04330_7 Notch signaling pathway 39 -2.66729890169338 0.00912100596641655 0.0436422817127273
CESC ENSG00000272866 RP11-12D24.10 path:04360_109 Axon guidance 18 -4.40971716271107 2.16793374140057e-05 0.00389568867508113
CESC ENSG00000272866 RP11-12D24.10 path:04360_42 Axon guidance 75 -4.1975294738908 6.5915333069884e-05 0.00459208950399341
CESC ENSG00000272866 RP11-12D24.10 path:04380_74 Osteoclast differentiation 17 3.18847090663454 0.00203723492108013 0.0202651263202181
CESC ENSG00000272866 RP11-12D24.10 path:04390_76 Hippo signaling pathway 39 -2.58335219991843 0.0111863338510875 0.0491548627558097
CESC ENSG00000272866 RP11-12D24.10 path:04514_30 Cell adhesion molecules (CAMs) 2 2.62978191661505 0.0113134207930038 0.0491548627558097
CESC ENSG00000272866 RP11-12D24.10 path:04520_73 Adherens junction 7 -2.80816737568982 0.00580967226644408 0.0332735775259979
CESC ENSG00000272866 RP11-12D24.10 path:04540_77 Gap junction 19 -3.31176348900767 0.00116551759807833 0.0142117952281809
CESC ENSG00000272866 RP11-12D24.10 path:04550_30 Signaling pathways regulating pluripotency of stem cells 59 -3.94000786070975 0.000136602614442668 0.00521060845550323
CESC ENSG00000272866 RP11-12D24.10 path:04620_106 Toll-like receptor signaling pathway 4 3.66748187670122 0.000481570757098783 0.0117355795756413
CESC ENSG00000272866 RP11-12D24.10 path:04620_50 Toll-like receptor signaling pathway 29 2.89402349741357 0.00522026173593264 0.0328568084700191
CESC ENSG00000272866 RP11-12D24.10 path:04622_48 RIG-I-like receptor signaling pathway 10 3.5579489295572 0.000638302798760281 0.0117355795756413
CESC ENSG00000272866 RP11-12D24.10 path:04623_11 Cytosolic DNA-sensing pathway 8 3.40642050979575 0.00103143334268428 0.0139243501262378
CESC ENSG00000272866 RP11-12D24.10 path:04650_28 Natural killer cell mediated cytotoxicity 81 2.9302806091874 0.00472393232908988 0.0328568084700191
CESC ENSG00000272866 RP11-12D24.10 path:04660_65 T cell receptor signaling pathway 27 -3.41225163941438 0.000863304766078248 0.0127791448838085
CESC ENSG00000272866 RP11-12D24.10 path:04662_51 B cell receptor signaling pathway 15 -3.51968249061808 0.000598397324286138 0.0117355795756413
CESC ENSG00000272866 RP11-12D24.10 path:04664_59 Fc epsilon RI signaling pathway 13 -4.09424325886213 7.10682717193196e-05 0.00459208950399341
CESC ENSG00000272866 RP11-12D24.10 path:04666_22 Fc gamma R-mediated phagocytosis 65 -3.43972669261707 0.000883537305129908 0.0127791448838085
CESC ENSG00000272866 RP11-12D24.10 path:04666_264 Fc gamma R-mediated phagocytosis 4 2.89813719156501 0.00547581371795221 0.0328568084700191
CESC ENSG00000272866 RP11-12D24.10 path:04670_116 Leukocyte transendothelial migration 12 -2.58429268458947 0.0112248669781852 0.0491548627558097
CESC ENSG00000272866 RP11-12D24.10 path:04670_143 Leukocyte transendothelial migration 6 -4.35034582534593 3.09181640879455e-05 0.00389568867508113
CESC ENSG00000272866 RP11-12D24.10 path:04713_198 Circadian entrainment 4 2.6056618719549 0.0108216720660257 0.0491548627558097
CESC ENSG00000272866 RP11-12D24.10 path:04722_102 Neurotrophin signaling pathway 16 -3.93980511494678 0.000131526290992789 0.00521060845550323
CESC ENSG00000272866 RP11-12D24.10 path:04722_96 Neurotrophin signaling pathway 19 -3.13628852098052 0.00228157082405803 0.0206664661029482
CESC ENSG00000272866 RP11-12D24.10 path:04723_25 Retrograde endocannabinoid signaling 24 -2.82338807843459 0.00556305751873339 0.0328568084700191
CESC ENSG00000272866 RP11-12D24.10 path:04724_162 Glutamatergic synapse 7 2.81749190729977 0.00597603164394957 0.0334864233897779
CESC ENSG00000272866 RP11-12D24.10 path:04724_33 Glutamatergic synapse 62 -3.28278588019948 0.00129200475959899 0.0152618062227631
CESC ENSG00000272866 RP11-12D24.10 path:04728_193 Dopaminergic synapse 13 -2.76887564602674 0.00652478080164366 0.0342201184405113
CESC ENSG00000272866 RP11-12D24.10 path:04728_53 Dopaminergic synapse 60 -3.86739123629123 0.000167727688346739 0.00576373329046066
CESC ENSG00000272866 RP11-12D24.10 path:04730_38 Long-term depression 30 -3.32183472977552 0.00113179947672259 0.0142117952281809
CESC ENSG00000272866 RP11-12D24.10 path:04742_1 Taste transduction 14 -3.12111091337226 0.00232496072497294 0.0206664661029482
CESC ENSG00000272866 RP11-12D24.10 path:04744_1 Phototransduction 10 -2.76012603384457 0.00660864721205641 0.0342201184405113
CESC ENSG00000272866 RP11-12D24.10 path:04750_11 Inflammatory mediator regulation of TRP channels 71 -3.22155188893419 0.00169307351084877 0.0182851939171667
CESC ENSG00000272866 RP11-12D24.10 path:04810_14 Regulation of actin cytoskeleton 148 -2.85607472796529 0.0053115816936869 0.0328568084700191
CESC ENSG00000272866 RP11-12D24.10 path:04810_162 Regulation of actin cytoskeleton 26 -3.38759923078001 0.000899483847519868 0.0127791448838085
CESC ENSG00000272866 RP11-12D24.10 path:04910_144 Insulin signaling pathway 6 -2.76742721552918 0.00670091917827236 0.0342290195863102
CESC ENSG00000272866 RP11-12D24.10 path:04911_2 Insulin secretion 52 -3.09448374495592 0.00235009383671136 0.0206664661029482
CESC ENSG00000272866 RP11-12D24.10 path:04912_2 GnRH signaling pathway 75 -3.02175814227937 0.00313844356998428 0.0252410993500864
CESC ENSG00000272866 RP11-12D24.10 path:04915_2 Estrogen signaling pathway 80 -2.7010860858993 0.00828200441894848 0.0414859783373134
CESC ENSG00000272866 RP11-12D24.10 path:04916_33 Melanogenesis 46 -2.62227806454771 0.00995568764879087 0.0470406241405368
CESC ENSG00000272866 RP11-12D24.10 path:04917_41 Prolactin signaling pathway 32 -4.56556158517227 1.04756776373738e-05 0.00389568867508113
CESC ENSG00000272866 RP11-12D24.10 path:04918_1 Thyroid hormone synthesis 44 -3.20266986283168 0.00165788343604018 0.0182851939171667
CESC ENSG00000272866 RP11-12D24.10 path:04919_1 Thyroid hormone signaling pathway 107 -2.84318081909313 0.00544419399408049 0.0328568084700191
CESC ENSG00000272866 RP11-12D24.10 path:04920_53 Adipocytokine signaling pathway 15 -2.81598718919883 0.00554731517921165 0.0328568084700191
CESC ENSG00000272866 RP11-12D24.10 path:04921_44 Oxytocin signaling pathway 82 -2.56751217930212 0.0118621647442815 0.049273607399323
CESC ENSG00000272866 RP11-12D24.10 path:04930_40 Type II diabetes mellitus 11 2.57386402994839 0.0117580645792949 0.049273607399323
CESC ENSG00000272866 RP11-12D24.10 path:04932_67 Non-alcoholic fatty liver disease (NAFLD) 19 -3.52204566602185 0.000603193807718945 0.0117355795756413
CESC ENSG00000272866 RP11-12D24.10 path:04961_6 Endocrine and other factor-regulated calcium reabsorption 20 -3.38291144141177 0.00091279606312918 0.0127791448838085
CESC ENSG00000272866 RP11-12D24.10 path:04970_1 Salivary secretion 32 -3.10693967887872 0.00224585036056294 0.0206664661029482
CESC ENSG00000272866 RP11-12D24.10 path:04973_1 Carbohydrate digestion and absorption 12 -2.84409454892892 0.00527024719464472 0.0328568084700191
CESC ENSG00000272866 RP11-12D24.10 path:04976_1 Bile secretion 15 -3.16512242983653 0.00186478487051077 0.0192061586002154
CESC ENSG00000272866 RP11-12D24.10 path:05030_1 Cocaine addiction 42 -3.05277367283801 0.00273469559377906 0.0229714429877441
CESC ENSG00000272866 RP11-12D24.10 path:05031_25 Amphetamine addiction 20 -2.81735880299844 0.00550468998078156 0.0328568084700191
CESC ENSG00000272866 RP11-12D24.10 path:05032_66 Morphine addiction 21 -3.53139829080143 0.000546654242772551 0.0117355795756413
CESC ENSG00000272866 RP11-12D24.10 path:05143_3 African trypanosomiasis 6 2.90854567022728 0.00520748679268855 0.0328568084700191
CESC ENSG00000272866 RP11-12D24.10 path:05160_45 Hepatitis C 4 -4.01402275457515 0.000109587771374561 0.00521060845550323
CESC ENSG00000272866 RP11-12D24.10 path:05166_10 HTLV-I infection 75 -2.68587590942671 0.00841798699502012 0.0414859783373134
CESC ENSG00000272866 RP11-12D24.10 path:05206_124 MicroRNAs in cancer 5 -2.91841923735604 0.00420423565207731 0.0305615591631774
CESC ENSG00000272866 RP11-12D24.10 path:05213_15 Endometrial cancer 13 -3.45384064239454 0.000737994772578141 0.0122635315803184
CESC ENSG00000272866 RP11-12D24.10 path:05213_9 Endometrial cancer 16 -3.93307160127918 0.000137846784537122 0.00521060845550323
CESC ENSG00000272866 RP11-12D24.10 path:05214_1 Glioma 51 -2.78704155583998 0.00628181969534813 0.0339218263548799
CESC ENSG00000272866 RP11-12D24.10 path:05215_8 Prostate cancer 72 -2.58318623106872 0.0111927585294414 0.0491548627558097
CESC ENSG00000272866 RP11-12D24.10 path:05220_48 Chronic myeloid leukemia 7 -2.98290217712855 0.00357533507895784 0.0274085715557197
CESC ENSG00000272866 RP11-12D24.10 path:05231_108 Choline metabolism in cancer 2 -2.80227262338705 0.00602401267329339 0.0334864233897779
CESC ENSG00000272866 RP11-12D24.10 path:05323_2 Rheumatoid arthritis 4 3.61209112563248 0.000517752492500323 0.0117355795756413
CESC ENSG00000272866 RP11-12D24.10 path:05414_1 Dilated cardiomyopathy 28 -3.48546870111541 0.000651976643091182 0.0117355795756413
CESC ENSG00000261842 RP11-143I21.1 path:00250_31 Alanine, aspartate and glutamate metabolism 10 -4.00305602273776 8.98468021200511e-05 0.0345910188162197
CESC ENSG00000259659 RP11-151N17.1 path:00230_18 Purine metabolism 117 -3.91217653277665 0.000189476725011798 0.0347846624038195
CESC ENSG00000259659 RP11-151N17.1 path:04024_100 cAMP signaling pathway 37 -3.95086249589602 0.00013721027096423 0.0347846624038195
CESC ENSG00000259659 RP11-151N17.1 path:04070_29 Phosphatidylinositol signaling system 25 -3.34041572101225 0.00117744424287895 0.0472155141394458
CESC ENSG00000259659 RP11-151N17.1 path:04370_2 VEGF signaling pathway 53 -3.64774827251458 0.00047713674541307 0.0347846624038195
CESC ENSG00000259659 RP11-151N17.1 path:04662_78 B cell receptor signaling pathway 6 -3.55907535413072 0.000693958352195899 0.0347846624038195
CESC ENSG00000259659 RP11-151N17.1 path:04713_90 Circadian entrainment 21 -3.54654308125873 0.000539102744287524 0.0347846624038195
CESC ENSG00000259659 RP11-151N17.1 path:04720_56 Long-term potentiation 17 -3.50828702096056 0.000636133724720179 0.0347846624038195
CESC ENSG00000259659 RP11-151N17.1 path:04740_2 Olfactory transduction 22 -3.59168013276418 0.000458967539760309 0.0347846624038195
CESC ENSG00000259659 RP11-151N17.1 path:04744_5 Phototransduction 5 -3.35449738226488 0.00103232007436437 0.045995594424457
CESC ENSG00000259659 RP11-151N17.1 path:05169_35 Epstein-Barr virus infection 7 -3.56360355246189 0.000666892290434796 0.0347846624038195
CESC ENSG00000241383 RP11-152C17.1 path:00100_4 Steroid biosynthesis 11 4.13167758763128 7.24596097327209e-05 0.00481856404722594
CESC ENSG00000241383 RP11-152C17.1 path:00140_23 Steroid hormone biosynthesis 10 3.43080276961191 0.000762175465487852 0.0253423342274711
CESC ENSG00000241383 RP11-152C17.1 path:00563_10 Glycosylphosphatidylinositol(GPI)-anchor biosynthesis 5 4.85315055368681 6.50236040940809e-06 0.000648610450838457
CESC ENSG00000241383 RP11-152C17.1 path:00565_4 Ether lipid metabolism 24 3.51918550456677 0.0006343213280068 0.0230085645340648
CESC ENSG00000241383 RP11-152C17.1 path:00980_121 Metabolism of xenobiotics by cytochrome P450 4 3.89759327581809 0.000145402211156127 0.00725193528141183
CESC ENSG00000241383 RP11-152C17.1 path:00980_73 Metabolism of xenobiotics by cytochrome P450 11 3.66681702693277 0.000325248895592202 0.0144193677045876
CESC ENSG00000241383 RP11-152C17.1 path:03460_52 Fanconi anemia pathway 3 3.99235340243392 0.00011275232248205 0.00642688238147687
CESC ENSG00000241383 RP11-152C17.1 path:04210_83 Apoptosis 5 4.93574313631746 1.79495765812924e-06 0.000238729368531189
CESC ENSG00000241383 RP11-152C17.1 path:04370_11 VEGF signaling pathway 46 4.27967836266837 5.22053026365332e-05 0.00416598315039535
CESC ENSG00000241383 RP11-152C17.1 path:04650_17 Natural killer cell mediated cytotoxicity 89 3.38059514036687 0.000943672194722329 0.028963477361093
CESC ENSG00000241383 RP11-152C17.1 path:05162_43 Measles 5 4.93574313631746 1.79495765812924e-06 0.000238729368531189
CESC ENSG00000241383 RP11-152C17.1 path:05164_48 Influenza A 5 4.93574313631746 1.79495765812924e-06 0.000238729368531189
CESC ENSG00000241383 RP11-152C17.1 path:05220_62 Chronic myeloid leukemia 2 3.58533952410822 0.000583681111297343 0.0230085645340648
CESC ENSG00000241383 RP11-152C17.1 path:05221_7 Acute myeloid leukemia 49 3.35314358567171 0.00126720599589101 0.0361153708828937
CESC ENSG00000236948 RP11-154H17.1 path:04151_222 PI3K-Akt signaling pathway 29 -4.13213972757443 0.000233121682616893 0.0332459871314831
CESC ENSG00000236948 RP11-154H17.1 path:04530_214 Tight junction 2 -5.25314438100398 5.46950218487821e-06 0.00213857535428738
CESC ENSG00000236948 RP11-154H17.1 path:04666_128 Fc gamma R-mediated phagocytosis 28 -4.13232942376634 0.000255084300241558 0.0332459871314831
CESC ENSG00000257275 RP11-164H13.1 path:04144_32 Endocytosis 8 -3.8120411613074 0.00027465296025793 0.0140416325931867
CESC ENSG00000257275 RP11-164H13.1 path:04666_232 Fc gamma R-mediated phagocytosis 8 -5.93206723888842 3.90772055029302e-07 5.32752568356615e-05
CESC ENSG00000257275 RP11-164H13.1 path:04750_88 Inflammatory mediator regulation of TRP channels 5 -4.37576741008785 3.98693083245436e-05 0.00326130942094767
CESC ENSG00000257275 RP11-164H13.1 path:04810_134 Regulation of actin cytoskeleton 31 -3.92225757003324 0.000226955894199594 0.0132607086753763
CESC ENSG00000257275 RP11-164H13.1 path:04932_103 Non-alcoholic fatty liver disease (NAFLD) 4 -7.63219113822838 2.61083960396887e-10 5.33916699011635e-08
CESC ENSG00000257275 RP11-164H13.1 path:05206_136 MicroRNAs in cancer 2 -7.6192948454595 7.64545406442571e-11 3.12699071235011e-08
CESC ENSG00000257275 RP11-164H13.1 path:05206_97 MicroRNAs in cancer 26 -4.17580752031433 8.56420162379312e-05 0.00583793077355231
CESC ENSG00000257275 RP11-164H13.1 path:05222_63 Small cell lung cancer 6 -5.02599323818842 6.28076073558987e-06 0.000642207785214064
CESC ENSG00000258461 RP11-164J13.1 path:00230_18 Purine metabolism 117 -3.48420172607411 0.000804765228501329 0.0425342677169457
CESC ENSG00000258461 RP11-164J13.1 path:04024_100 cAMP signaling pathway 37 -3.92972571149667 0.000143927608648667 0.0367621186244692
CESC ENSG00000258461 RP11-164J13.1 path:04070_29 Phosphatidylinositol signaling system 25 -3.43392515220671 0.000848563944477721 0.0425342677169457
CESC ENSG00000258461 RP11-164J13.1 path:04370_2 VEGF signaling pathway 53 -3.78147586672354 0.000293843993422977 0.0367621186244692
CESC ENSG00000258461 RP11-164J13.1 path:04662_78 B cell receptor signaling pathway 6 -3.78290194221531 0.000325824520946503 0.0367621186244692
CESC ENSG00000258461 RP11-164J13.1 path:04713_90 Circadian entrainment 21 -3.53620244391416 0.000550056637772606 0.0367621186244692
CESC ENSG00000258461 RP11-164J13.1 path:04720_56 Long-term potentiation 17 -3.55872381864915 0.00052451576670736 0.0367621186244692
CESC ENSG00000258461 RP11-164J13.1 path:04740_2 Olfactory transduction 22 -3.57116026406189 0.000485461601666931 0.0367621186244692
CESC ENSG00000258461 RP11-164J13.1 path:04744_5 Phototransduction 5 -3.33023760263875 0.00110550496194758 0.044330748974098
CESC ENSG00000258461 RP11-164J13.1 path:05169_35 Epstein-Barr virus infection 7 -3.41185417316903 0.00105866365121999 0.044330748974098
CESC ENSG00000258460 RP11-168L7.1 path:04014_136 Ras signaling pathway 15 -3.35932987525971 0.00156098361951259 0.0493010659829392
CESC ENSG00000258460 RP11-168L7.1 path:04144_32 Endocytosis 8 -3.79250588125354 0.000283332788560431 0.0199835684716393
CESC ENSG00000258460 RP11-168L7.1 path:04151_285 PI3K-Akt signaling pathway 16 -3.51867875809173 0.000687822118579373 0.0325855728676978
CESC ENSG00000258460 RP11-168L7.1 path:04360_117 Axon guidance 15 -3.77222385734019 0.000440916737315015 0.0238724919203415
CESC ENSG00000258460 RP11-168L7.1 path:04512_73 ECM-receptor interaction 11 -3.33143827611793 0.00132539754573172 0.0456659699847565
CESC ENSG00000258460 RP11-168L7.1 path:04662_72 B cell receptor signaling pathway 8 -4.02041495091434 0.000187310299886989 0.0177476509142922
CESC ENSG00000258460 RP11-168L7.1 path:04810_134 Regulation of actin cytoskeleton 31 -4.00229285571665 0.000165924471229925 0.0177476509142922
CESC ENSG00000258460 RP11-168L7.1 path:04915_139 Estrogen signaling pathway 4 -8.41406486530196 5.72672287895484e-12 2.17042797112388e-09
CESC ENSG00000258460 RP11-168L7.1 path:05214_1 Glioma 51 -3.8161134249716 0.000316362561556295 0.0199835684716393
CESC ENSG00000258460 RP11-168L7.1 path:05218_1 Melanoma 63 -3.4792121008745 0.00105921735600022 0.0401443377924084
CESC ENSG00000258460 RP11-168L7.1 path:05222_63 Small cell lung cancer 6 -6.32875822818816 3.11627491995206e-08 5.90534097330916e-06
CESC ENSG00000258460 RP11-168L7.1 path:05231_46 Choline metabolism in cancer 24 -3.44725834743534 0.00104044835502111 0.0401443377924084
CESC ENSG00000259082 RP11-168L7.3 path:04014_136 Ras signaling pathway 15 -3.35932987525971 0.00156098361951259 0.0493010659829392
CESC ENSG00000259082 RP11-168L7.3 path:04144_32 Endocytosis 8 -3.79250588125354 0.000283332788560431 0.0199835684716393
CESC ENSG00000259082 RP11-168L7.3 path:04151_285 PI3K-Akt signaling pathway 16 -3.51867875809173 0.000687822118579373 0.0325855728676978
CESC ENSG00000259082 RP11-168L7.3 path:04360_117 Axon guidance 15 -3.77222385734019 0.000440916737315015 0.0238724919203415
CESC ENSG00000259082 RP11-168L7.3 path:04512_73 ECM-receptor interaction 11 -3.33143827611793 0.00132539754573172 0.0456659699847565
CESC ENSG00000259082 RP11-168L7.3 path:04662_72 B cell receptor signaling pathway 8 -4.02041495091434 0.000187310299886989 0.0177476509142922
CESC ENSG00000259082 RP11-168L7.3 path:04810_134 Regulation of actin cytoskeleton 31 -4.00229285571665 0.000165924471229925 0.0177476509142922
CESC ENSG00000259082 RP11-168L7.3 path:04915_139 Estrogen signaling pathway 4 -8.41406486530196 5.72672287895484e-12 2.17042797112388e-09
CESC ENSG00000259082 RP11-168L7.3 path:05214_1 Glioma 51 -3.8161134249716 0.000316362561556295 0.0199835684716393
CESC ENSG00000259082 RP11-168L7.3 path:05218_1 Melanoma 63 -3.4792121008745 0.00105921735600022 0.0401443377924084
CESC ENSG00000259082 RP11-168L7.3 path:05222_63 Small cell lung cancer 6 -6.32875822818816 3.11627491995206e-08 5.90534097330916e-06
CESC ENSG00000259082 RP11-168L7.3 path:05231_46 Choline metabolism in cancer 24 -3.44725834743534 0.00104044835502111 0.0401443377924084
CESC ENSG00000270522 RP11-168P13.1 path:00640_31 Propanoate metabolism 3 -5.20298328672517 5.09726642875375e-07 0.000203380930507274
CESC ENSG00000240497 RP11-185E8.1 path:00071_14 Fatty acid degradation 15 -3.41009789218762 0.0012885420823183 0.0370916042267339
CESC ENSG00000240497 RP11-185E8.1 path:00100_15 Steroid biosynthesis 9 4.20429704732536 5.44590945700872e-05 0.00365783585195752
CESC ENSG00000240497 RP11-185E8.1 path:00140_23 Steroid hormone biosynthesis 10 3.38508815748897 0.000888999108157138 0.0298555533822772
CESC ENSG00000240497 RP11-185E8.1 path:00980_121 Metabolism of xenobiotics by cytochrome P450 4 3.95651764919754 0.00011606920459113 0.00656032797741703
CESC ENSG00000240497 RP11-185E8.1 path:00980_73 Metabolism of xenobiotics by cytochrome P450 11 3.43051127716778 0.000751341473750407 0.0275264194474013
CESC ENSG00000240497 RP11-185E8.1 path:03460_52 Fanconi anemia pathway 3 3.96362813982066 0.000130229835779991 0.00656032797741703
CESC ENSG00000240497 RP11-185E8.1 path:04060_14 Cytokine-cytokine receptor interaction 8 4.5967318773826 7.90424909975221e-06 0.000796353096800035
CESC ENSG00000240497 RP11-185E8.1 path:04210_83 Apoptosis 5 4.76675513331163 3.77264349512409e-06 0.000506791776178336
CESC ENSG00000240497 RP11-185E8.1 path:04370_11 VEGF signaling pathway 46 4.29098436403437 5.26428372151558e-05 0.00365783585195752
CESC ENSG00000240497 RP11-185E8.1 path:04650_17 Natural killer cell mediated cytotoxicity 89 3.36567960300742 0.00100492095387095 0.0311525495699994
CESC ENSG00000240497 RP11-185E8.1 path:05162_43 Measles 5 4.76675513331163 3.77264349512409e-06 0.000506791776178336
CESC ENSG00000240497 RP11-185E8.1 path:05164_48 Influenza A 5 4.76675513331163 3.77264349512409e-06 0.000506791776178336
CESC ENSG00000240497 RP11-185E8.1 path:05220_62 Chronic myeloid leukemia 2 3.6395916917994 0.000510541787859457 0.0205915478068162
CESC ENSG00000240497 RP11-185E8.1 path:05221_7 Acute myeloid leukemia 49 3.63842077176597 0.000510956521260947 0.0205915478068162
CESC ENSG00000258516 RP11-185P18.2 path:04144_32 Endocytosis 8 -3.8120411613074 0.00027465296025793 0.0140416325931867
CESC ENSG00000258516 RP11-185P18.2 path:04666_232 Fc gamma R-mediated phagocytosis 8 -5.93206723888842 3.90772055029302e-07 5.32752568356615e-05
CESC ENSG00000258516 RP11-185P18.2 path:04750_88 Inflammatory mediator regulation of TRP channels 5 -4.37576741008785 3.98693083245436e-05 0.00326130942094767
CESC ENSG00000258516 RP11-185P18.2 path:04810_134 Regulation of actin cytoskeleton 31 -3.92225757003324 0.000226955894199594 0.0132607086753763
CESC ENSG00000258516 RP11-185P18.2 path:04932_103 Non-alcoholic fatty liver disease (NAFLD) 4 -7.63219113822838 2.61083960396887e-10 5.33916699011635e-08
CESC ENSG00000258516 RP11-185P18.2 path:05206_136 MicroRNAs in cancer 2 -7.6192948454595 7.64545406442571e-11 3.12699071235011e-08
CESC ENSG00000258516 RP11-185P18.2 path:05206_97 MicroRNAs in cancer 26 -4.17580752031433 8.56420162379312e-05 0.00583793077355231
CESC ENSG00000258516 RP11-185P18.2 path:05222_63 Small cell lung cancer 6 -5.02599323818842 6.28076073558987e-06 0.000642207785214064
CESC ENSG00000260969 RP11-190D6.2 path:03320_1 PPAR signaling pathway 48 -3.69962575180617 0.000332545869346469 0.0243987285481469
CESC ENSG00000260969 RP11-190D6.2 path:04022_82 cGMP-PKG signaling pathway 17 -4.94243125112663 4.14895884776196e-06 0.00155171060906297
CESC ENSG00000260969 RP11-190D6.2 path:04062_265 Chemokine signaling pathway 8 -4.20175095709178 8.6365059957379e-05 0.00807513310601494
CESC ENSG00000260969 RP11-190D6.2 path:04145_10 Phagosome 11 -3.62149587699583 0.000391423452644068 0.0243987285481469
CESC ENSG00000260969 RP11-190D6.2 path:04360_145 Axon guidance 8 -4.2745007718475 6.10722593290639e-05 0.00761367499635664
CESC ENSG00000260969 RP11-190D6.2 path:04660_107 T cell receptor signaling pathway 12 -4.28593708588599 5.26271692890627e-05 0.00761367499635664
CESC ENSG00000260969 RP11-190D6.2 path:05146_1 Amoebiasis 11 -3.63318573396567 0.000473435948198383 0.0252950063751707
CESC ENSG00000258379 RP11-204N11.2 path:04144_32 Endocytosis 8 -3.9416060644509 0.00016747324200157 0.0158680896796488
CESC ENSG00000258379 RP11-204N11.2 path:04151_285 PI3K-Akt signaling pathway 16 -3.68988847823218 0.000384569068678518 0.0291503354058317
CESC ENSG00000258379 RP11-204N11.2 path:04810_134 Regulation of actin cytoskeleton 31 -4.10940181072005 0.000114497782985166 0.0144648865837927
CESC ENSG00000258379 RP11-204N11.2 path:04915_139 Estrogen signaling pathway 4 -7.78794033048715 9.63396136733793e-11 3.65127135822107e-08
CESC ENSG00000258379 RP11-204N11.2 path:05222_63 Small cell lung cancer 6 -5.17171115844146 3.3015761474502e-06 0.000625648679941813
CESC ENSG00000249742 RP11-217E13.1 path:00071_3 Fatty acid degradation 24 -4.12129769728783 5.84091226161406e-05 0.012061483820233
CESC ENSG00000249742 RP11-217E13.1 path:00120_4 Primary bile acid biosynthesis 5 -3.76604017997487 0.000223533340970016 0.0307730899402056
CESC ENSG00000249742 RP11-217E13.1 path:00650_11 Butanoate metabolism 6 -3.6036925668946 0.000403237847467118 0.0363511602050627
CESC ENSG00000249742 RP11-217E13.1 path:00830_44 Retinol metabolism 8 -4.83042570407045 2.80773972600884e-06 0.00115959650684165
CESC ENSG00000249742 RP11-217E13.1 path:00980_127 Metabolism of xenobiotics by cytochrome P450 3 -3.58375998955675 0.000440086685291316 0.0363511602050627
CESC ENSG00000249742 RP11-217E13.1 path:04151_194 PI3K-Akt signaling pathway 41 -3.50121166686976 0.000577823032660323 0.0397734854147855
CESC ENSG00000236559 RP11-243J16.7 path:04510_350 Focal adhesion 3 4.01876470038606 8.75322957348956e-05 0.0324744817176463
CESC ENSG00000258598 RP11-260M19.1 path:04062_169 Chemokine signaling pathway 27 -3.74561305149265 0.000495875610085168 0.0453726183227929
CESC ENSG00000258598 RP11-260M19.1 path:04660_129 T cell receptor signaling pathway 9 -4.90396950750985 9.12818145798239e-06 0.00167045720681078
CESC ENSG00000258598 RP11-260M19.1 path:04670_142 Leukocyte transendothelial migration 6 -4.05512953712353 0.000153688356290849 0.0187499794674836
CESC ENSG00000258598 RP11-260M19.1 path:04915_139 Estrogen signaling pathway 4 -8.44510106866434 7.09316234329053e-12 2.59609741764434e-09
CESC ENSG00000258913 RP11-260M19.2 path:04062_169 Chemokine signaling pathway 27 -3.74561305149265 0.000495875610085168 0.0453726183227929
CESC ENSG00000258913 RP11-260M19.2 path:04660_129 T cell receptor signaling pathway 9 -4.90396950750985 9.12818145798239e-06 0.00167045720681078
CESC ENSG00000258913 RP11-260M19.2 path:04670_142 Leukocyte transendothelial migration 6 -4.05512953712353 0.000153688356290849 0.0187499794674836
CESC ENSG00000258913 RP11-260M19.2 path:04915_139 Estrogen signaling pathway 4 -8.44510106866434 7.09316234329053e-12 2.59609741764434e-09
CESC ENSG00000261837 RP11-264L1.3 path:03320_1 PPAR signaling pathway 48 -3.64132473131084 0.000407257245432763 0.0233300222026483
CESC ENSG00000261837 RP11-264L1.3 path:04022_82 cGMP-PKG signaling pathway 17 -4.85424437938445 5.87273856696813e-06 0.00235496816535422
CESC ENSG00000261837 RP11-264L1.3 path:04062_265 Chemokine signaling pathway 8 -4.27853617812896 6.62813686817843e-05 0.0088596096137985
CESC ENSG00000261837 RP11-264L1.3 path:04310_42 Wnt signaling pathway 63 -3.9520857677986 0.000173486237536976 0.0173919953130819
CESC ENSG00000261837 RP11-264L1.3 path:04360_145 Axon guidance 8 -4.39296011705004 4.002990990193e-05 0.00802599693533697
CESC ENSG00000261837 RP11-264L1.3 path:04660_107 T cell receptor signaling pathway 12 -3.71408126263384 0.000401740841716858 0.0233300222026483
CESC ENSG00000261837 RP11-264L1.3 path:04915_139 Estrogen signaling pathway 4 -3.50040839066833 0.000815412556299431 0.040872554384509
CESC ENSG00000261837 RP11-264L1.3 path:05146_1 Amoebiasis 11 -3.71615841349395 0.000356322472195057 0.0233300222026483
CESC ENSG00000260733 RP11-264L1.4 path:00534_1 Glycosaminoglycan biosynthesis - heparan sulfate / heparin 4 -4.12339750437384 8.78789721926058e-05 0.0184545841604472
CESC ENSG00000260733 RP11-264L1.4 path:03320_1 PPAR signaling pathway 48 -3.57711953560603 0.00051909484334737 0.0467121108980697
CESC ENSG00000260733 RP11-264L1.4 path:04062_153 Chemokine signaling pathway 32 -4.01872238955216 0.000160614664177106 0.0224860529847949
CESC ENSG00000260733 RP11-264L1.4 path:04360_145 Axon guidance 8 -4.27206006836497 6.45701851148341e-05 0.0184545841604472
CESC ENSG00000260733 RP11-264L1.4 path:04610_87 Complement and coagulation cascades 4 -3.62625093798541 0.000556096558310354 0.0467121108980697
CESC ENSG00000261684 RP11-265N6.1 path:00230_18 Purine metabolism 117 -3.91217653277665 0.000189476725011798 0.0347846624038195
CESC ENSG00000261684 RP11-265N6.1 path:04024_100 cAMP signaling pathway 37 -3.95086249589602 0.00013721027096423 0.0347846624038195
CESC ENSG00000261684 RP11-265N6.1 path:04070_29 Phosphatidylinositol signaling system 25 -3.34041572101225 0.00117744424287895 0.0472155141394458
CESC ENSG00000261684 RP11-265N6.1 path:04370_2 VEGF signaling pathway 53 -3.64774827251458 0.00047713674541307 0.0347846624038195
CESC ENSG00000261684 RP11-265N6.1 path:04662_78 B cell receptor signaling pathway 6 -3.55907535413072 0.000693958352195899 0.0347846624038195
CESC ENSG00000261684 RP11-265N6.1 path:04713_90 Circadian entrainment 21 -3.54654308125873 0.000539102744287524 0.0347846624038195
CESC ENSG00000261684 RP11-265N6.1 path:04720_56 Long-term potentiation 17 -3.50828702096056 0.000636133724720179 0.0347846624038195
CESC ENSG00000261684 RP11-265N6.1 path:04740_2 Olfactory transduction 22 -3.59168013276418 0.000458967539760309 0.0347846624038195
CESC ENSG00000261684 RP11-265N6.1 path:04744_5 Phototransduction 5 -3.35449738226488 0.00103232007436437 0.045995594424457
CESC ENSG00000261684 RP11-265N6.1 path:05169_35 Epstein-Barr virus infection 7 -3.56360355246189 0.000666892290434796 0.0347846624038195
CESC ENSG00000261822 RP11-265N6.2 path:00230_18 Purine metabolism 117 -3.91217653277665 0.000189476725011798 0.0347846624038195
CESC ENSG00000261822 RP11-265N6.2 path:04024_100 cAMP signaling pathway 37 -3.95086249589602 0.00013721027096423 0.0347846624038195
CESC ENSG00000261822 RP11-265N6.2 path:04070_29 Phosphatidylinositol signaling system 25 -3.34041572101225 0.00117744424287895 0.0472155141394458
CESC ENSG00000261822 RP11-265N6.2 path:04370_2 VEGF signaling pathway 53 -3.64774827251458 0.00047713674541307 0.0347846624038195
CESC ENSG00000261822 RP11-265N6.2 path:04662_78 B cell receptor signaling pathway 6 -3.55907535413072 0.000693958352195899 0.0347846624038195
CESC ENSG00000261822 RP11-265N6.2 path:04713_90 Circadian entrainment 21 -3.54654308125873 0.000539102744287524 0.0347846624038195
CESC ENSG00000261822 RP11-265N6.2 path:04720_56 Long-term potentiation 17 -3.50828702096056 0.000636133724720179 0.0347846624038195
CESC ENSG00000261822 RP11-265N6.2 path:04740_2 Olfactory transduction 22 -3.59168013276418 0.000458967539760309 0.0347846624038195
CESC ENSG00000261822 RP11-265N6.2 path:04744_5 Phototransduction 5 -3.35449738226488 0.00103232007436437 0.045995594424457
CESC ENSG00000261822 RP11-265N6.2 path:05169_35 Epstein-Barr virus infection 7 -3.56360355246189 0.000666892290434796 0.0347846624038195
CESC ENSG00000228573 RP11-279N8.1 path:00640_31 Propanoate metabolism 3 -5.55189744255061 9.57912557969566e-08 3.82207110629857e-05
CESC ENSG00000243903 RP11-285B24.1 path:00051_33 Fructose and mannose metabolism 5 -3.4602925970913 0.000669360297186074 0.0116410486467143
CESC ENSG00000243903 RP11-285B24.1 path:00071_14 Fatty acid degradation 15 -4.16255952390921 4.78856288481799e-05 0.00179347888617035
CESC ENSG00000243903 RP11-285B24.1 path:00140_36 Steroid hormone biosynthesis 6 2.74357627599978 0.00690738510540293 0.0493384650385924
CESC ENSG00000243903 RP11-285B24.1 path:00270_57 Cysteine and methionine metabolism 7 -3.29998968685271 0.00115990733421158 0.0171838123586901
CESC ENSG00000243903 RP11-285B24.1 path:00330_29 Arginine and proline metabolism 26 -3.57795238586914 0.000450562353729396 0.00858214007103611
CESC ENSG00000243903 RP11-285B24.1 path:00340_11 Histidine metabolism 10 -4.28165785306819 2.95350867112365e-05 0.00147675433556182
CESC ENSG00000243903 RP11-285B24.1 path:00524_1 Butirosin and neomycin biosynthesis 4 2.96360628406625 0.00358216747075846 0.0358216747075846
CESC ENSG00000243903 RP11-285B24.1 path:00531_2 Glycosaminoglycan degradation 4 -3.33590514814314 0.00104310785464516 0.0160478131483871
CESC ENSG00000243903 RP11-285B24.1 path:00561_56 Glycerolipid metabolism 6 -2.71582991009166 0.00722408515164519 0.0494715799633842
CESC ENSG00000243903 RP11-285B24.1 path:00604_1 Glycosphingolipid biosynthesis - ganglio series 9 -3.6757363391747 0.000308894911506596 0.00754271215018023
CESC ENSG00000243903 RP11-285B24.1 path:00620_33 Pyruvate metabolism 16 -2.74196571207832 0.00669470752651882 0.048688782011046
CESC ENSG00000243903 RP11-285B24.1 path:00640_31 Propanoate metabolism 3 -3.37035969232366 0.000911156268699381 0.0145785002991901
CESC ENSG00000243903 RP11-285B24.1 path:04010_72 MAPK signaling pathway 34 3.10820084909273 0.00234800131921699 0.0276235449319646
CESC ENSG00000243903 RP11-285B24.1 path:04015_221 Rap1 signaling pathway 4 -3.66075044476277 0.00033942204675811 0.00754271215018023
CESC ENSG00000243903 RP11-285B24.1 path:04022_67 cGMP-PKG signaling pathway 27 -2.78414202243604 0.00602693559099054 0.0477530561695038
CESC ENSG00000243903 RP11-285B24.1 path:04062_146 Chemokine signaling pathway 34 -4.9285917064379 2.04529417702494e-06 0.000204529417702494
CESC ENSG00000243903 RP11-285B24.1 path:04066_1 HIF-1 signaling pathway 96 -2.78354223077143 0.00593598116124543 0.0477530561695038
CESC ENSG00000243903 RP11-285B24.1 path:04068_70 FoxO signaling pathway 3 2.85916012838525 0.00540718123255444 0.0470189672396039
CESC ENSG00000243903 RP11-285B24.1 path:04071_34 Sphingolipid signaling pathway 48 -3.66330159464154 0.000332967994104952 0.00754271215018023
CESC ENSG00000243903 RP11-285B24.1 path:04110_43 Cell cycle 77 2.88982629865903 0.00436760293411391 0.0426107603328187
CESC ENSG00000243903 RP11-285B24.1 path:04150_25 mTOR signaling pathway 35 -2.78908798419898 0.00582926676177531 0.0477530561695038
CESC ENSG00000243903 RP11-285B24.1 path:04152_66 AMPK signaling pathway 9 -2.7728668755804 0.0061636390685945 0.0477530561695038
CESC ENSG00000243903 RP11-285B24.1 path:04310_2 Wnt signaling pathway 115 -2.96702721360547 0.00341878552522323 0.0358216747075846
CESC ENSG00000243903 RP11-285B24.1 path:04330_22 Notch signaling pathway 24 4.38848550683947 2.2726961338488e-05 0.00130061949560794
CESC ENSG00000243903 RP11-285B24.1 path:04350_30 TGF-beta signaling pathway 24 -3.14190557644935 0.00197423004549607 0.0246778755687009
CESC ENSG00000243903 RP11-285B24.1 path:04360_168 Axon guidance 3 -4.18023458971711 4.88766678277284e-05 0.00179347888617035
CESC ENSG00000243903 RP11-285B24.1 path:04520_33 Adherens junction 38 -3.72466163058428 0.000261686037891977 0.00733665038276598
CESC ENSG00000243903 RP11-285B24.1 path:04520_61 Adherens junction 15 3.0575335027244 0.00270950684990346 0.030105631665594
CESC ENSG00000243903 RP11-285B24.1 path:04520_77 Adherens junction 5 4.44348058657213 1.75446024160183e-05 0.00130061949560794
CESC ENSG00000243903 RP11-285B24.1 path:04610_16 Complement and coagulation cascades 58 -3.0557359470428 0.00257162800819435 0.029390034379364
CESC ENSG00000243903 RP11-285B24.1 path:04611_105 Platelet activation 27 -3.55408986603925 0.000496770470186989 0.00903219036703617
CESC ENSG00000243903 RP11-285B24.1 path:04620_88 Toll-like receptor signaling pathway 12 -2.80623251354755 0.00559322468216496 0.0476019121886379
CESC ENSG00000243903 RP11-285B24.1 path:04660_50 T cell receptor signaling pathway 35 -3.19623406319623 0.00167193035751636 0.0222924047668848
CESC ENSG00000243903 RP11-285B24.1 path:04662_67 B cell receptor signaling pathway 10 -2.84461481211269 0.00498598718380218 0.0461592988966304
CESC ENSG00000243903 RP11-285B24.1 path:04722_146 Neurotrophin signaling pathway 6 2.7573762569468 0.00660110305854639 0.048688782011046
CESC ENSG00000243903 RP11-285B24.1 path:04723_13 Retrograde endocannabinoid signaling 31 3.72906493183134 0.000269045847498087 0.00733665038276598
CESC ENSG00000243903 RP11-285B24.1 path:04723_35 Retrograde endocannabinoid signaling 16 -3.12973556408891 0.00205672071610135 0.0249299480739557
CESC ENSG00000243903 RP11-285B24.1 path:04725_106 Cholinergic synapse 12 -3.59083929833944 0.000420417012171994 0.00840834024343987
CESC ENSG00000243903 RP11-285B24.1 path:04725_51 Cholinergic synapse 41 -3.29251392710253 0.00120741550315519 0.017248792902217
CESC ENSG00000243903 RP11-285B24.1 path:04810_179 Regulation of actin cytoskeleton 23 -2.84206703755991 0.00507752287862934 0.0461592988966304
CESC ENSG00000243903 RP11-285B24.1 path:04921_137 Oxytocin signaling pathway 16 -3.22955613316475 0.00149744023808247 0.0206543481114823
CESC ENSG00000243903 RP11-285B24.1 path:04921_44 Oxytocin signaling pathway 82 -2.95710935329771 0.00350885159230205 0.0358216747075846
CESC ENSG00000243903 RP11-285B24.1 path:04960_1 Aldosterone-regulated sodium reabsorption 29 2.74695093046334 0.00667198766981431 0.048688782011046
CESC ENSG00000243903 RP11-285B24.1 path:05030_43 Cocaine addiction 8 -5.80397549861488 2.69357625220166e-08 3.59143500293554e-06
CESC ENSG00000243903 RP11-285B24.1 path:05100_8 Bacterial invasion of epithelial cells 48 -2.87554225182397 0.00457441030825505 0.0435658124595719
CESC ENSG00000243903 RP11-285B24.1 path:05110_3 Vibrio cholerae infection 7 -3.6071288512545 0.000409876458612839 0.00840834024343987
CESC ENSG00000243903 RP11-285B24.1 path:05132_1 Salmonella infection 42 -3.37988325214859 0.000898266894725888 0.0145785002991901
CESC ENSG00000243903 RP11-285B24.1 path:05133_4 Pertussis 24 -2.71496182823893 0.00729705804459918 0.0494715799633842
CESC ENSG00000243903 RP11-285B24.1 path:05160_47 Hepatitis C 3 2.85916012838525 0.00540718123255444 0.0470189672396039
CESC ENSG00000243903 RP11-285B24.1 path:05161_51 Hepatitis B 31 -2.72533556772707 0.00703470638711182 0.049366360611311
CESC ENSG00000243903 RP11-285B24.1 path:05210_4 Colorectal cancer 34 -4.35182327992658 2.27608411731389e-05 0.00130061949560794
CESC ENSG00000243903 RP11-285B24.1 path:05210_46 Colorectal cancer 4 -4.1672849191542 4.93206693696845e-05 0.00179347888617035
CESC ENSG00000243903 RP11-285B24.1 path:05216_11 Thyroid cancer 5 -2.96863425521112 0.00338551865709216 0.0358216747075846
CESC ENSG00000243903 RP11-285B24.1 path:05221_1 Acute myeloid leukemia 54 3.88398930861748 0.000149357883443967 0.00497859611479889
CESC ENSG00000243903 RP11-285B24.1 path:05410_10 Hypertrophic cardiomyopathy (HCM) 3 -6.13952125333161 5.50838793168987e-09 1.10167758633797e-06
CESC ENSG00000243903 RP11-285B24.1 path:05410_9 Hypertrophic cardiomyopathy (HCM) 8 -3.176988907218 0.00178033309302991 0.0229720399100633
CESC ENSG00000243903 RP11-285B24.1 path:05414_12 Dilated cardiomyopathy 21 -2.77258698921082 0.00620789730203549 0.0477530561695038
CESC ENSG00000243903 RP11-285B24.1 path:05414_27 Dilated cardiomyopathy 3 -6.13952125333161 5.50838793168987e-09 1.10167758633797e-06
CESC ENSG00000243903 RP11-285B24.1 path:05416_1 Viral myocarditis 5 -3.71758989641219 0.000275124389353724 0.00733665038276598
CESC ENSG00000228886 RP11-290D2.3 path:00640_31 Propanoate metabolism 3 -5.42254258714793 1.78380054193679e-07 7.11736416232781e-05
CESC ENSG00000273149 RP11-290D2.6 path:00640_31 Propanoate metabolism 3 -5.42254258714793 1.78380054193679e-07 7.11736416232781e-05
CESC ENSG00000249747 RP11-308K2.1 path:00071_3 Fatty acid degradation 24 -4.32672679811154 2.5725434779485e-05 0.0106246045639273
CESC ENSG00000249747 RP11-308K2.1 path:00120_4 Primary bile acid biosynthesis 5 -3.82947547071375 0.000177629576425087 0.02299697695009
CESC ENSG00000249747 RP11-308K2.1 path:00280_27 Valine, leucine and isoleucine degradation 23 -3.74268563216373 0.000241525060289199 0.02299697695009
CESC ENSG00000249747 RP11-308K2.1 path:04151_181 PI3K-Akt signaling pathway 44 -3.70539802905459 0.000278413764528934 0.02299697695009
CESC ENSG00000249747 RP11-308K2.1 path:04932_97 Non-alcoholic fatty liver disease (NAFLD) 6 -3.9026495706904 0.000136444674549282 0.02299697695009
CESC ENSG00000260816 RP11-319G9.3 path:04022_82 cGMP-PKG signaling pathway 17 -4.68518158941937 1.14777905300677e-05 0.0042926936582453
CESC ENSG00000260816 RP11-319G9.3 path:04062_177 Chemokine signaling pathway 24 -3.69049312161951 0.000436552518484307 0.0354262313434959
CESC ENSG00000260816 RP11-319G9.3 path:04062_265 Chemokine signaling pathway 8 -4.45050231655451 3.90951329978568e-05 0.00731078987059923
CESC ENSG00000260816 RP11-319G9.3 path:04360_145 Axon guidance 8 -3.57042851461963 0.00067823987463618 0.0422769521856552
CESC ENSG00000260816 RP11-319G9.3 path:04660_107 T cell receptor signaling pathway 12 -3.66765759734977 0.000473612718495935 0.0354262313434959
CESC ENSG00000260816 RP11-319G9.3 path:05146_1 Amoebiasis 11 -3.75265210200515 0.000330558913965631 0.0354262313434959
CESC ENSG00000261537 RP11-319G9.5 path:04022_82 cGMP-PKG signaling pathway 17 -4.28500179472934 5.11745612837231e-05 0.0102604995373865
CESC ENSG00000261537 RP11-319G9.5 path:04062_265 Chemokine signaling pathway 8 -4.37868316346933 4.78701302854529e-05 0.0102604995373865
CESC ENSG00000261537 RP11-319G9.5 path:04915_139 Estrogen signaling pathway 4 -3.74502474778445 0.000363138568099337 0.0485395219359448
CESC ENSG00000223732 RP11-321C24.1 path:00640_31 Propanoate metabolism 3 -5.48914366022956 1.29521174104563e-07 5.16789484677207e-05
CESC ENSG00000256357 RP11-349I1.2 path:04144_32 Endocytosis 8 -3.8120411613074 0.00027465296025793 0.0140416325931867
CESC ENSG00000256357 RP11-349I1.2 path:04666_232 Fc gamma R-mediated phagocytosis 8 -5.93206723888842 3.90772055029302e-07 5.32752568356615e-05
CESC ENSG00000256357 RP11-349I1.2 path:04750_88 Inflammatory mediator regulation of TRP channels 5 -4.37576741008785 3.98693083245436e-05 0.00326130942094767
CESC ENSG00000256357 RP11-349I1.2 path:04810_134 Regulation of actin cytoskeleton 31 -3.92225757003324 0.000226955894199594 0.0132607086753763
CESC ENSG00000256357 RP11-349I1.2 path:04932_103 Non-alcoholic fatty liver disease (NAFLD) 4 -7.63219113822838 2.61083960396887e-10 5.33916699011635e-08
CESC ENSG00000256357 RP11-349I1.2 path:05206_136 MicroRNAs in cancer 2 -7.6192948454595 7.64545406442571e-11 3.12699071235011e-08
CESC ENSG00000256357 RP11-349I1.2 path:05206_97 MicroRNAs in cancer 26 -4.17580752031433 8.56420162379312e-05 0.00583793077355231
CESC ENSG00000256357 RP11-349I1.2 path:05222_63 Small cell lung cancer 6 -5.02599323818842 6.28076073558987e-06 0.000642207785214064
CESC ENSG00000259110 RP11-359N5.1 path:04144_32 Endocytosis 8 -3.9416060644509 0.00016747324200157 0.0158680896796488
CESC ENSG00000259110 RP11-359N5.1 path:04151_285 PI3K-Akt signaling pathway 16 -3.68988847823218 0.000384569068678518 0.0291503354058317
CESC ENSG00000259110 RP11-359N5.1 path:04810_134 Regulation of actin cytoskeleton 31 -4.10940181072005 0.000114497782985166 0.0144648865837927
CESC ENSG00000259110 RP11-359N5.1 path:04915_139 Estrogen signaling pathway 4 -7.78794033048715 9.63396136733793e-11 3.65127135822107e-08
CESC ENSG00000259110 RP11-359N5.1 path:05222_63 Small cell lung cancer 6 -5.17171115844146 3.3015761474502e-06 0.000625648679941813
CESC ENSG00000269984 RP11-362K14.5 path:00071_14 Fatty acid degradation 15 -3.41009789218762 0.0012885420823183 0.0370916042267339
CESC ENSG00000269984 RP11-362K14.5 path:00100_15 Steroid biosynthesis 9 4.20429704732536 5.44590945700872e-05 0.00365783585195752
CESC ENSG00000269984 RP11-362K14.5 path:00140_23 Steroid hormone biosynthesis 10 3.38508815748897 0.000888999108157138 0.0298555533822772
CESC ENSG00000269984 RP11-362K14.5 path:00980_121 Metabolism of xenobiotics by cytochrome P450 4 3.95651764919754 0.00011606920459113 0.00656032797741703
CESC ENSG00000269984 RP11-362K14.5 path:00980_73 Metabolism of xenobiotics by cytochrome P450 11 3.43051127716778 0.000751341473750407 0.0275264194474013
CESC ENSG00000269984 RP11-362K14.5 path:03460_52 Fanconi anemia pathway 3 3.96362813982066 0.000130229835779991 0.00656032797741703
CESC ENSG00000269984 RP11-362K14.5 path:04060_14 Cytokine-cytokine receptor interaction 8 4.5967318773826 7.90424909975221e-06 0.000796353096800035
CESC ENSG00000269984 RP11-362K14.5 path:04210_83 Apoptosis 5 4.76675513331163 3.77264349512409e-06 0.000506791776178336
CESC ENSG00000269984 RP11-362K14.5 path:04370_11 VEGF signaling pathway 46 4.29098436403437 5.26428372151558e-05 0.00365783585195752
CESC ENSG00000269984 RP11-362K14.5 path:04650_17 Natural killer cell mediated cytotoxicity 89 3.36567960300742 0.00100492095387095 0.0311525495699994
CESC ENSG00000269984 RP11-362K14.5 path:05162_43 Measles 5 4.76675513331163 3.77264349512409e-06 0.000506791776178336
CESC ENSG00000269984 RP11-362K14.5 path:05164_48 Influenza A 5 4.76675513331163 3.77264349512409e-06 0.000506791776178336
CESC ENSG00000269984 RP11-362K14.5 path:05220_62 Chronic myeloid leukemia 2 3.6395916917994 0.000510541787859457 0.0205915478068162
CESC ENSG00000269984 RP11-362K14.5 path:05221_7 Acute myeloid leukemia 49 3.63842077176597 0.000510956521260947 0.0205915478068162
CESC ENSG00000270096 RP11-362K14.6 path:00071_14 Fatty acid degradation 15 -3.41009789218762 0.0012885420823183 0.0370916042267339
CESC ENSG00000270096 RP11-362K14.6 path:00100_15 Steroid biosynthesis 9 4.20429704732536 5.44590945700872e-05 0.00365783585195752
CESC ENSG00000270096 RP11-362K14.6 path:00140_23 Steroid hormone biosynthesis 10 3.38508815748897 0.000888999108157138 0.0298555533822772
CESC ENSG00000270096 RP11-362K14.6 path:00980_121 Metabolism of xenobiotics by cytochrome P450 4 3.95651764919754 0.00011606920459113 0.00656032797741703
CESC ENSG00000270096 RP11-362K14.6 path:00980_73 Metabolism of xenobiotics by cytochrome P450 11 3.43051127716778 0.000751341473750407 0.0275264194474013
CESC ENSG00000270096 RP11-362K14.6 path:03460_52 Fanconi anemia pathway 3 3.96362813982066 0.000130229835779991 0.00656032797741703
CESC ENSG00000270096 RP11-362K14.6 path:04060_14 Cytokine-cytokine receptor interaction 8 4.5967318773826 7.90424909975221e-06 0.000796353096800035
CESC ENSG00000270096 RP11-362K14.6 path:04210_83 Apoptosis 5 4.76675513331163 3.77264349512409e-06 0.000506791776178336
CESC ENSG00000270096 RP11-362K14.6 path:04370_11 VEGF signaling pathway 46 4.29098436403437 5.26428372151558e-05 0.00365783585195752
CESC ENSG00000270096 RP11-362K14.6 path:04650_17 Natural killer cell mediated cytotoxicity 89 3.36567960300742 0.00100492095387095 0.0311525495699994
CESC ENSG00000270096 RP11-362K14.6 path:05162_43 Measles 5 4.76675513331163 3.77264349512409e-06 0.000506791776178336
CESC ENSG00000270096 RP11-362K14.6 path:05164_48 Influenza A 5 4.76675513331163 3.77264349512409e-06 0.000506791776178336
CESC ENSG00000270096 RP11-362K14.6 path:05220_62 Chronic myeloid leukemia 2 3.6395916917994 0.000510541787859457 0.0205915478068162
CESC ENSG00000270096 RP11-362K14.6 path:05221_7 Acute myeloid leukemia 49 3.63842077176597 0.000510956521260947 0.0205915478068162
CESC ENSG00000270135 RP11-362K14.7 path:00071_14 Fatty acid degradation 15 -3.41009789218762 0.0012885420823183 0.0370916042267339
CESC ENSG00000270135 RP11-362K14.7 path:00100_15 Steroid biosynthesis 9 4.20429704732536 5.44590945700872e-05 0.00365783585195752
CESC ENSG00000270135 RP11-362K14.7 path:00140_23 Steroid hormone biosynthesis 10 3.38508815748897 0.000888999108157138 0.0298555533822772
CESC ENSG00000270135 RP11-362K14.7 path:00980_121 Metabolism of xenobiotics by cytochrome P450 4 3.95651764919754 0.00011606920459113 0.00656032797741703
CESC ENSG00000270135 RP11-362K14.7 path:00980_73 Metabolism of xenobiotics by cytochrome P450 11 3.43051127716778 0.000751341473750407 0.0275264194474013
CESC ENSG00000270135 RP11-362K14.7 path:03460_52 Fanconi anemia pathway 3 3.96362813982066 0.000130229835779991 0.00656032797741703
CESC ENSG00000270135 RP11-362K14.7 path:04060_14 Cytokine-cytokine receptor interaction 8 4.5967318773826 7.90424909975221e-06 0.000796353096800035
CESC ENSG00000270135 RP11-362K14.7 path:04210_83 Apoptosis 5 4.76675513331163 3.77264349512409e-06 0.000506791776178336
CESC ENSG00000270135 RP11-362K14.7 path:04370_11 VEGF signaling pathway 46 4.29098436403437 5.26428372151558e-05 0.00365783585195752
CESC ENSG00000270135 RP11-362K14.7 path:04650_17 Natural killer cell mediated cytotoxicity 89 3.36567960300742 0.00100492095387095 0.0311525495699994
CESC ENSG00000270135 RP11-362K14.7 path:05162_43 Measles 5 4.76675513331163 3.77264349512409e-06 0.000506791776178336
CESC ENSG00000270135 RP11-362K14.7 path:05164_48 Influenza A 5 4.76675513331163 3.77264349512409e-06 0.000506791776178336
CESC ENSG00000270135 RP11-362K14.7 path:05220_62 Chronic myeloid leukemia 2 3.6395916917994 0.000510541787859457 0.0205915478068162
CESC ENSG00000270135 RP11-362K14.7 path:05221_7 Acute myeloid leukemia 49 3.63842077176597 0.000510956521260947 0.0205915478068162
CESC ENSG00000258620 RP11-362L22.1 path:04014_136 Ras signaling pathway 15 -3.35932987525971 0.00156098361951259 0.0493010659829392
CESC ENSG00000258620 RP11-362L22.1 path:04144_32 Endocytosis 8 -3.79250588125354 0.000283332788560431 0.0199835684716393
CESC ENSG00000258620 RP11-362L22.1 path:04151_285 PI3K-Akt signaling pathway 16 -3.51867875809173 0.000687822118579373 0.0325855728676978
CESC ENSG00000258620 RP11-362L22.1 path:04360_117 Axon guidance 15 -3.77222385734019 0.000440916737315015 0.0238724919203415
CESC ENSG00000258620 RP11-362L22.1 path:04512_73 ECM-receptor interaction 11 -3.33143827611793 0.00132539754573172 0.0456659699847565
CESC ENSG00000258620 RP11-362L22.1 path:04662_72 B cell receptor signaling pathway 8 -4.02041495091434 0.000187310299886989 0.0177476509142922
CESC ENSG00000258620 RP11-362L22.1 path:04810_134 Regulation of actin cytoskeleton 31 -4.00229285571665 0.000165924471229925 0.0177476509142922
CESC ENSG00000258620 RP11-362L22.1 path:04915_139 Estrogen signaling pathway 4 -8.41406486530196 5.72672287895484e-12 2.17042797112388e-09
CESC ENSG00000258620 RP11-362L22.1 path:05214_1 Glioma 51 -3.8161134249716 0.000316362561556295 0.0199835684716393
CESC ENSG00000258620 RP11-362L22.1 path:05218_1 Melanoma 63 -3.4792121008745 0.00105921735600022 0.0401443377924084
CESC ENSG00000258620 RP11-362L22.1 path:05222_63 Small cell lung cancer 6 -6.32875822818816 3.11627491995206e-08 5.90534097330916e-06
CESC ENSG00000258620 RP11-362L22.1 path:05231_46 Choline metabolism in cancer 24 -3.44725834743534 0.00104044835502111 0.0401443377924084
CESC ENSG00000259515 RP11-365N19.2 path:04728_178 Dopaminergic synapse 17 -4.64938903184529 2.57570024293522e-05 0.00503549397493835
CESC ENSG00000259515 RP11-365N19.2 path:05222_73 Small cell lung cancer 3 -8.4632253905838 2.10744885761159e-12 8.24012503326131e-10
CESC ENSG00000242268 RP11-368I23.2 path:00100_4 Steroid biosynthesis 11 4.13167758763128 7.24596097327209e-05 0.00481856404722594
CESC ENSG00000242268 RP11-368I23.2 path:00140_23 Steroid hormone biosynthesis 10 3.43080276961191 0.000762175465487852 0.0253423342274711
CESC ENSG00000242268 RP11-368I23.2 path:00563_10 Glycosylphosphatidylinositol(GPI)-anchor biosynthesis 5 4.85315055368681 6.50236040940809e-06 0.000648610450838457
CESC ENSG00000242268 RP11-368I23.2 path:00565_4 Ether lipid metabolism 24 3.51918550456677 0.0006343213280068 0.0230085645340648
CESC ENSG00000242268 RP11-368I23.2 path:00980_121 Metabolism of xenobiotics by cytochrome P450 4 3.89759327581809 0.000145402211156127 0.00725193528141183
CESC ENSG00000242268 RP11-368I23.2 path:00980_73 Metabolism of xenobiotics by cytochrome P450 11 3.66681702693277 0.000325248895592202 0.0144193677045876
CESC ENSG00000242268 RP11-368I23.2 path:03460_52 Fanconi anemia pathway 3 3.99235340243392 0.00011275232248205 0.00642688238147687
CESC ENSG00000242268 RP11-368I23.2 path:04210_83 Apoptosis 5 4.93574313631746 1.79495765812924e-06 0.000238729368531189
CESC ENSG00000242268 RP11-368I23.2 path:04370_11 VEGF signaling pathway 46 4.27967836266837 5.22053026365332e-05 0.00416598315039535
CESC ENSG00000242268 RP11-368I23.2 path:04650_17 Natural killer cell mediated cytotoxicity 89 3.38059514036687 0.000943672194722329 0.028963477361093
CESC ENSG00000242268 RP11-368I23.2 path:05162_43 Measles 5 4.93574313631746 1.79495765812924e-06 0.000238729368531189
CESC ENSG00000242268 RP11-368I23.2 path:05164_48 Influenza A 5 4.93574313631746 1.79495765812924e-06 0.000238729368531189
CESC ENSG00000242268 RP11-368I23.2 path:05220_62 Chronic myeloid leukemia 2 3.58533952410822 0.000583681111297343 0.0230085645340648
CESC ENSG00000242268 RP11-368I23.2 path:05221_7 Acute myeloid leukemia 49 3.35314358567171 0.00126720599589101 0.0361153708828937
CESC ENSG00000272797 RP11-368I23.3 path:00100_4 Steroid biosynthesis 11 4.13167758763128 7.24596097327209e-05 0.00481856404722594
CESC ENSG00000272797 RP11-368I23.3 path:00140_23 Steroid hormone biosynthesis 10 3.43080276961191 0.000762175465487852 0.0253423342274711
CESC ENSG00000272797 RP11-368I23.3 path:00563_10 Glycosylphosphatidylinositol(GPI)-anchor biosynthesis 5 4.85315055368681 6.50236040940809e-06 0.000648610450838457
CESC ENSG00000272797 RP11-368I23.3 path:00565_4 Ether lipid metabolism 24 3.51918550456677 0.0006343213280068 0.0230085645340648
CESC ENSG00000272797 RP11-368I23.3 path:00980_121 Metabolism of xenobiotics by cytochrome P450 4 3.89759327581809 0.000145402211156127 0.00725193528141183
CESC ENSG00000272797 RP11-368I23.3 path:00980_73 Metabolism of xenobiotics by cytochrome P450 11 3.66681702693277 0.000325248895592202 0.0144193677045876
CESC ENSG00000272797 RP11-368I23.3 path:03460_52 Fanconi anemia pathway 3 3.99235340243392 0.00011275232248205 0.00642688238147687
CESC ENSG00000272797 RP11-368I23.3 path:04210_83 Apoptosis 5 4.93574313631746 1.79495765812924e-06 0.000238729368531189
CESC ENSG00000272797 RP11-368I23.3 path:04370_11 VEGF signaling pathway 46 4.27967836266837 5.22053026365332e-05 0.00416598315039535
CESC ENSG00000272797 RP11-368I23.3 path:04650_17 Natural killer cell mediated cytotoxicity 89 3.38059514036687 0.000943672194722329 0.028963477361093
CESC ENSG00000272797 RP11-368I23.3 path:05162_43 Measles 5 4.93574313631746 1.79495765812924e-06 0.000238729368531189
CESC ENSG00000272797 RP11-368I23.3 path:05164_48 Influenza A 5 4.93574313631746 1.79495765812924e-06 0.000238729368531189
CESC ENSG00000272797 RP11-368I23.3 path:05220_62 Chronic myeloid leukemia 2 3.58533952410822 0.000583681111297343 0.0230085645340648
CESC ENSG00000272797 RP11-368I23.3 path:05221_7 Acute myeloid leukemia 49 3.35314358567171 0.00126720599589101 0.0361153708828937
CESC ENSG00000273177 RP11-368I23.4 path:00100_4 Steroid biosynthesis 11 4.13167758763128 7.24596097327209e-05 0.00481856404722594
CESC ENSG00000273177 RP11-368I23.4 path:00140_23 Steroid hormone biosynthesis 10 3.43080276961191 0.000762175465487852 0.0253423342274711
CESC ENSG00000273177 RP11-368I23.4 path:00563_10 Glycosylphosphatidylinositol(GPI)-anchor biosynthesis 5 4.85315055368681 6.50236040940809e-06 0.000648610450838457
CESC ENSG00000273177 RP11-368I23.4 path:00565_4 Ether lipid metabolism 24 3.51918550456677 0.0006343213280068 0.0230085645340648
CESC ENSG00000273177 RP11-368I23.4 path:00980_121 Metabolism of xenobiotics by cytochrome P450 4 3.89759327581809 0.000145402211156127 0.00725193528141183
CESC ENSG00000273177 RP11-368I23.4 path:00980_73 Metabolism of xenobiotics by cytochrome P450 11 3.66681702693277 0.000325248895592202 0.0144193677045876
CESC ENSG00000273177 RP11-368I23.4 path:03460_52 Fanconi anemia pathway 3 3.99235340243392 0.00011275232248205 0.00642688238147687
CESC ENSG00000273177 RP11-368I23.4 path:04210_83 Apoptosis 5 4.93574313631746 1.79495765812924e-06 0.000238729368531189
CESC ENSG00000273177 RP11-368I23.4 path:04370_11 VEGF signaling pathway 46 4.27967836266837 5.22053026365332e-05 0.00416598315039535
CESC ENSG00000273177 RP11-368I23.4 path:04650_17 Natural killer cell mediated cytotoxicity 89 3.38059514036687 0.000943672194722329 0.028963477361093
CESC ENSG00000273177 RP11-368I23.4 path:05162_43 Measles 5 4.93574313631746 1.79495765812924e-06 0.000238729368531189
CESC ENSG00000273177 RP11-368I23.4 path:05164_48 Influenza A 5 4.93574313631746 1.79495765812924e-06 0.000238729368531189
CESC ENSG00000273177 RP11-368I23.4 path:05220_62 Chronic myeloid leukemia 2 3.58533952410822 0.000583681111297343 0.0230085645340648
CESC ENSG00000273177 RP11-368I23.4 path:05221_7 Acute myeloid leukemia 49 3.35314358567171 0.00126720599589101 0.0361153708828937
CESC ENSG00000244738 RP11-373E16.3 path:00071_14 Fatty acid degradation 15 -3.41009789218762 0.0012885420823183 0.0370916042267339
CESC ENSG00000244738 RP11-373E16.3 path:00100_15 Steroid biosynthesis 9 4.20429704732536 5.44590945700872e-05 0.00365783585195752
CESC ENSG00000244738 RP11-373E16.3 path:00140_23 Steroid hormone biosynthesis 10 3.38508815748897 0.000888999108157138 0.0298555533822772
CESC ENSG00000244738 RP11-373E16.3 path:00980_121 Metabolism of xenobiotics by cytochrome P450 4 3.95651764919754 0.00011606920459113 0.00656032797741703
CESC ENSG00000244738 RP11-373E16.3 path:00980_73 Metabolism of xenobiotics by cytochrome P450 11 3.43051127716778 0.000751341473750407 0.0275264194474013
CESC ENSG00000244738 RP11-373E16.3 path:03460_52 Fanconi anemia pathway 3 3.96362813982066 0.000130229835779991 0.00656032797741703
CESC ENSG00000244738 RP11-373E16.3 path:04060_14 Cytokine-cytokine receptor interaction 8 4.5967318773826 7.90424909975221e-06 0.000796353096800035
CESC ENSG00000244738 RP11-373E16.3 path:04210_83 Apoptosis 5 4.76675513331163 3.77264349512409e-06 0.000506791776178336
CESC ENSG00000244738 RP11-373E16.3 path:04370_11 VEGF signaling pathway 46 4.29098436403437 5.26428372151558e-05 0.00365783585195752
CESC ENSG00000244738 RP11-373E16.3 path:04650_17 Natural killer cell mediated cytotoxicity 89 3.36567960300742 0.00100492095387095 0.0311525495699994
CESC ENSG00000244738 RP11-373E16.3 path:05162_43 Measles 5 4.76675513331163 3.77264349512409e-06 0.000506791776178336
CESC ENSG00000244738 RP11-373E16.3 path:05164_48 Influenza A 5 4.76675513331163 3.77264349512409e-06 0.000506791776178336
CESC ENSG00000244738 RP11-373E16.3 path:05220_62 Chronic myeloid leukemia 2 3.6395916917994 0.000510541787859457 0.0205915478068162
CESC ENSG00000244738 RP11-373E16.3 path:05221_7 Acute myeloid leukemia 49 3.63842077176597 0.000510956521260947 0.0205915478068162
CESC ENSG00000239739 RP11-373E16.4 path:00071_14 Fatty acid degradation 15 -3.41009789218762 0.0012885420823183 0.0370916042267339
CESC ENSG00000239739 RP11-373E16.4 path:00100_15 Steroid biosynthesis 9 4.20429704732536 5.44590945700872e-05 0.00365783585195752
CESC ENSG00000239739 RP11-373E16.4 path:00140_23 Steroid hormone biosynthesis 10 3.38508815748897 0.000888999108157138 0.0298555533822772
CESC ENSG00000239739 RP11-373E16.4 path:00980_121 Metabolism of xenobiotics by cytochrome P450 4 3.95651764919754 0.00011606920459113 0.00656032797741703
CESC ENSG00000239739 RP11-373E16.4 path:00980_73 Metabolism of xenobiotics by cytochrome P450 11 3.43051127716778 0.000751341473750407 0.0275264194474013
CESC ENSG00000239739 RP11-373E16.4 path:03460_52 Fanconi anemia pathway 3 3.96362813982066 0.000130229835779991 0.00656032797741703
CESC ENSG00000239739 RP11-373E16.4 path:04060_14 Cytokine-cytokine receptor interaction 8 4.5967318773826 7.90424909975221e-06 0.000796353096800035
CESC ENSG00000239739 RP11-373E16.4 path:04210_83 Apoptosis 5 4.76675513331163 3.77264349512409e-06 0.000506791776178336
CESC ENSG00000239739 RP11-373E16.4 path:04370_11 VEGF signaling pathway 46 4.29098436403437 5.26428372151558e-05 0.00365783585195752
CESC ENSG00000239739 RP11-373E16.4 path:04650_17 Natural killer cell mediated cytotoxicity 89 3.36567960300742 0.00100492095387095 0.0311525495699994
CESC ENSG00000239739 RP11-373E16.4 path:05162_43 Measles 5 4.76675513331163 3.77264349512409e-06 0.000506791776178336
CESC ENSG00000239739 RP11-373E16.4 path:05164_48 Influenza A 5 4.76675513331163 3.77264349512409e-06 0.000506791776178336
CESC ENSG00000239739 RP11-373E16.4 path:05220_62 Chronic myeloid leukemia 2 3.6395916917994 0.000510541787859457 0.0205915478068162
CESC ENSG00000239739 RP11-373E16.4 path:05221_7 Acute myeloid leukemia 49 3.63842077176597 0.000510956521260947 0.0205915478068162
CESC ENSG00000268220 RP11-379K17.12 path:00071_14 Fatty acid degradation 15 -3.41009789218762 0.0012885420823183 0.0370916042267339
CESC ENSG00000268220 RP11-379K17.12 path:00100_15 Steroid biosynthesis 9 4.20429704732536 5.44590945700872e-05 0.00365783585195752
CESC ENSG00000268220 RP11-379K17.12 path:00140_23 Steroid hormone biosynthesis 10 3.38508815748897 0.000888999108157138 0.0298555533822772
CESC ENSG00000268220 RP11-379K17.12 path:00980_121 Metabolism of xenobiotics by cytochrome P450 4 3.95651764919754 0.00011606920459113 0.00656032797741703
CESC ENSG00000268220 RP11-379K17.12 path:00980_73 Metabolism of xenobiotics by cytochrome P450 11 3.43051127716778 0.000751341473750407 0.0275264194474013
CESC ENSG00000268220 RP11-379K17.12 path:03460_52 Fanconi anemia pathway 3 3.96362813982066 0.000130229835779991 0.00656032797741703
CESC ENSG00000268220 RP11-379K17.12 path:04060_14 Cytokine-cytokine receptor interaction 8 4.5967318773826 7.90424909975221e-06 0.000796353096800035
CESC ENSG00000268220 RP11-379K17.12 path:04210_83 Apoptosis 5 4.76675513331163 3.77264349512409e-06 0.000506791776178336
CESC ENSG00000268220 RP11-379K17.12 path:04370_11 VEGF signaling pathway 46 4.29098436403437 5.26428372151558e-05 0.00365783585195752
CESC ENSG00000268220 RP11-379K17.12 path:04650_17 Natural killer cell mediated cytotoxicity 89 3.36567960300742 0.00100492095387095 0.0311525495699994
CESC ENSG00000268220 RP11-379K17.12 path:05162_43 Measles 5 4.76675513331163 3.77264349512409e-06 0.000506791776178336
CESC ENSG00000268220 RP11-379K17.12 path:05164_48 Influenza A 5 4.76675513331163 3.77264349512409e-06 0.000506791776178336
CESC ENSG00000268220 RP11-379K17.12 path:05220_62 Chronic myeloid leukemia 2 3.6395916917994 0.000510541787859457 0.0205915478068162
CESC ENSG00000268220 RP11-379K17.12 path:05221_7 Acute myeloid leukemia 49 3.63842077176597 0.000510956521260947 0.0205915478068162
CESC ENSG00000239219 RP11-379K17.4 path:00071_14 Fatty acid degradation 15 -3.41009789218762 0.0012885420823183 0.0370916042267339
CESC ENSG00000239219 RP11-379K17.4 path:00100_15 Steroid biosynthesis 9 4.20429704732536 5.44590945700872e-05 0.00365783585195752
CESC ENSG00000239219 RP11-379K17.4 path:00140_23 Steroid hormone biosynthesis 10 3.38508815748897 0.000888999108157138 0.0298555533822772
CESC ENSG00000239219 RP11-379K17.4 path:00980_121 Metabolism of xenobiotics by cytochrome P450 4 3.95651764919754 0.00011606920459113 0.00656032797741703
CESC ENSG00000239219 RP11-379K17.4 path:00980_73 Metabolism of xenobiotics by cytochrome P450 11 3.43051127716778 0.000751341473750407 0.0275264194474013
CESC ENSG00000239219 RP11-379K17.4 path:03460_52 Fanconi anemia pathway 3 3.96362813982066 0.000130229835779991 0.00656032797741703
CESC ENSG00000239219 RP11-379K17.4 path:04060_14 Cytokine-cytokine receptor interaction 8 4.5967318773826 7.90424909975221e-06 0.000796353096800035
CESC ENSG00000239219 RP11-379K17.4 path:04210_83 Apoptosis 5 4.76675513331163 3.77264349512409e-06 0.000506791776178336
CESC ENSG00000239219 RP11-379K17.4 path:04370_11 VEGF signaling pathway 46 4.29098436403437 5.26428372151558e-05 0.00365783585195752
CESC ENSG00000239219 RP11-379K17.4 path:04650_17 Natural killer cell mediated cytotoxicity 89 3.36567960300742 0.00100492095387095 0.0311525495699994
CESC ENSG00000239219 RP11-379K17.4 path:05162_43 Measles 5 4.76675513331163 3.77264349512409e-06 0.000506791776178336
CESC ENSG00000239219 RP11-379K17.4 path:05164_48 Influenza A 5 4.76675513331163 3.77264349512409e-06 0.000506791776178336
CESC ENSG00000239219 RP11-379K17.4 path:05220_62 Chronic myeloid leukemia 2 3.6395916917994 0.000510541787859457 0.0205915478068162
CESC ENSG00000239219 RP11-379K17.4 path:05221_7 Acute myeloid leukemia 49 3.63842077176597 0.000510956521260947 0.0205915478068162
CESC ENSG00000242795 RP11-3K16.2 path:00071_14 Fatty acid degradation 15 -3.23531219786892 0.00211986115493115 0.0479324161142766
CESC ENSG00000242795 RP11-3K16.2 path:00100_15 Steroid biosynthesis 9 4.26863116291523 4.10210658134736e-05 0.00267130063211421
CESC ENSG00000242795 RP11-3K16.2 path:00140_23 Steroid hormone biosynthesis 10 3.41407624057571 0.000807174925062791 0.0252707841923505
CESC ENSG00000242795 RP11-3K16.2 path:00563_10 Glycosylphosphatidylinositol(GPI)-anchor biosynthesis 5 4.98355961955554 3.95055470470262e-06 0.000401968941203491
CESC ENSG00000242795 RP11-3K16.2 path:00601_58 Glycosphingolipid biosynthesis - lacto and neolacto series 3 3.43849961596231 0.000776439526892875 0.0252707841923505
CESC ENSG00000242795 RP11-3K16.2 path:00980_121 Metabolism of xenobiotics by cytochrome P450 4 3.92674715733004 0.000130266457761578 0.00589093870099581
CESC ENSG00000242795 RP11-3K16.2 path:00980_73 Metabolism of xenobiotics by cytochrome P450 11 3.62825271604218 0.000373857074533279 0.0144933393349435
CESC ENSG00000242795 RP11-3K16.2 path:03460_52 Fanconi anemia pathway 3 4.13122937410623 6.79438996458755e-05 0.00345664589448391
CESC ENSG00000242795 RP11-3K16.2 path:04060_14 Cytokine-cytokine receptor interaction 8 4.64675272531475 6.39863553453765e-06 0.000520848932511365
CESC ENSG00000242795 RP11-3K16.2 path:04210_83 Apoptosis 5 4.78972301576347 3.42882890730144e-06 0.000401968941203491
CESC ENSG00000242795 RP11-3K16.2 path:04370_11 VEGF signaling pathway 46 4.31520283479856 4.59437455154779e-05 0.00267130063211421
CESC ENSG00000242795 RP11-3K16.2 path:04650_17 Natural killer cell mediated cytotoxicity 89 3.39694827823132 0.00089316000209867 0.0259654372038685
CESC ENSG00000242795 RP11-3K16.2 path:05146_3 Amoebiasis 9 3.16860466470682 0.00206148881342401 0.0479324161142766
CESC ENSG00000242795 RP11-3K16.2 path:05162_43 Measles 5 4.78972301576347 3.42882890730144e-06 0.000401968941203491
CESC ENSG00000242795 RP11-3K16.2 path:05164_48 Influenza A 5 4.78972301576347 3.42882890730144e-06 0.000401968941203491
CESC ENSG00000242795 RP11-3K16.2 path:05204_17 Chemical carcinogenesis 14 3.14555540554563 0.0019539679342565 0.0479324161142766
CESC ENSG00000242795 RP11-3K16.2 path:05220_62 Chronic myeloid leukemia 2 3.71076372579281 0.000391711873917392 0.0144933393349435
CESC ENSG00000242795 RP11-3K16.2 path:05221_7 Acute myeloid leukemia 49 3.32782586349916 0.00136987182585667 0.0371691888749109
CESC ENSG00000259793 RP11-400N9.1 path:00010_108 Glycolysis / Gluconeogenesis 3 3.51329802104095 0.000562791938726669 0.0171867999749606
CESC ENSG00000259793 RP11-400N9.1 path:00510_40 N-Glycan biosynthesis 16 -3.21897217651883 0.00153142365006481 0.0357632464162194
CESC ENSG00000259793 RP11-400N9.1 path:00512_18 Mucin type O-Glycan biosynthesis 9 -4.0118004152032 9.13442846081003e-05 0.00725273619788317
CESC ENSG00000259793 RP11-400N9.1 path:00532_1 Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate 5 -4.49638211431987 1.39142722169379e-05 0.00138099151753109
CESC ENSG00000259793 RP11-400N9.1 path:04152_47 AMPK signaling pathway 30 -4.77319571316324 4.44729609116668e-06 0.00111543557269143
CESC ENSG00000259793 RP11-400N9.1 path:04710_1 Circadian rhythm 27 -3.67597318290248 0.000308794380609024 0.0122026978294373
CESC ENSG00000259793 RP11-400N9.1 path:04713_21 Circadian entrainment 64 -3.33364606698491 0.0010316754424713 0.0255984469163192
CESC ENSG00000259793 RP11-400N9.1 path:04724_15 Glutamatergic synapse 75 -3.91536691507604 0.000131710868218703 0.00746988781183213
CESC ENSG00000259793 RP11-400N9.1 path:04730_2 Long-term depression 52 -3.58182135156347 0.000447861135295769 0.014816739226035
CESC ENSG00000259793 RP11-400N9.1 path:04911_2 Insulin secretion 52 -4.69486549483665 5.61932278433969e-06 0.00111543557269143
CESC ENSG00000259793 RP11-400N9.1 path:04918_12 Thyroid hormone synthesis 39 -4.55812316372109 1.01651560232419e-05 0.00134518898040902
CESC ENSG00000259793 RP11-400N9.1 path:04961_1 Endocrine and other factor-regulated calcium reabsorption 33 -3.39142660245134 0.000847520780089249 0.0224310499796955
CESC ENSG00000259793 RP11-400N9.1 path:04962_1 Vasopressin-regulated water reabsorption 19 -3.6696225918165 0.000323778004137094 0.0122026978294373
CESC ENSG00000259793 RP11-400N9.1 path:04970_1 Salivary secretion 32 -3.93238680874304 0.000123972024284854 0.00746988781183213
CESC ENSG00000259793 RP11-400N9.1 path:05030_37 Cocaine addiction 11 -3.43163660920162 0.000756457731304323 0.0214509799519869
CESC ENSG00000259793 RP11-400N9.1 path:05032_1 Morphine addiction 63 -3.67700642294971 0.000314562143376863 0.0122026978294373
CESC ENSG00000259793 RP11-400N9.1 path:05034_52 Alcoholism 26 -3.65639047748657 0.000338110015425214 0.0122026978294373
CESC ENSG00000260406 RP11-402F9.3 path:00230_18 Purine metabolism 117 -3.91217653277665 0.000189476725011798 0.0377058682773478
CESC ENSG00000260406 RP11-402F9.3 path:04370_1 VEGF signaling pathway 54 -3.60033270369129 0.00056158883986294 0.04470247165309
CESC ENSG00000260406 RP11-402F9.3 path:04713_90 Circadian entrainment 21 -3.54654308125873 0.000539102744287524 0.04470247165309
CESC ENSG00000260406 RP11-402F9.3 path:04740_10 Olfactory transduction 16 -3.59616242667078 0.000453867566297385 0.04470247165309
CESC ENSG00000260406 RP11-402F9.3 path:05219_2 Bladder cancer 13 -4.06878643239895 9.68563523290008e-05 0.0377058682773478
CESC ENSG00000259036 RP11-404P21.1 path:04144_32 Endocytosis 8 -3.8120411613074 0.00027465296025793 0.0140416325931867
CESC ENSG00000259036 RP11-404P21.1 path:04666_232 Fc gamma R-mediated phagocytosis 8 -5.93206723888842 3.90772055029302e-07 5.32752568356615e-05
CESC ENSG00000259036 RP11-404P21.1 path:04750_88 Inflammatory mediator regulation of TRP channels 5 -4.37576741008785 3.98693083245436e-05 0.00326130942094767
CESC ENSG00000259036 RP11-404P21.1 path:04810_134 Regulation of actin cytoskeleton 31 -3.92225757003324 0.000226955894199594 0.0132607086753763
CESC ENSG00000259036 RP11-404P21.1 path:04932_103 Non-alcoholic fatty liver disease (NAFLD) 4 -7.63219113822838 2.61083960396887e-10 5.33916699011635e-08
CESC ENSG00000259036 RP11-404P21.1 path:05206_136 MicroRNAs in cancer 2 -7.6192948454595 7.64545406442571e-11 3.12699071235011e-08
CESC ENSG00000259036 RP11-404P21.1 path:05206_97 MicroRNAs in cancer 26 -4.17580752031433 8.56420162379312e-05 0.00583793077355231
CESC ENSG00000259036 RP11-404P21.1 path:05222_63 Small cell lung cancer 6 -5.02599323818842 6.28076073558987e-06 0.000642207785214064
CESC ENSG00000258793 RP11-404P21.3 path:04144_32 Endocytosis 8 -3.8120411613074 0.00027465296025793 0.0140416325931867
CESC ENSG00000258793 RP11-404P21.3 path:04666_232 Fc gamma R-mediated phagocytosis 8 -5.93206723888842 3.90772055029302e-07 5.32752568356615e-05
CESC ENSG00000258793 RP11-404P21.3 path:04750_88 Inflammatory mediator regulation of TRP channels 5 -4.37576741008785 3.98693083245436e-05 0.00326130942094767
CESC ENSG00000258793 RP11-404P21.3 path:04810_134 Regulation of actin cytoskeleton 31 -3.92225757003324 0.000226955894199594 0.0132607086753763
CESC ENSG00000258793 RP11-404P21.3 path:04932_103 Non-alcoholic fatty liver disease (NAFLD) 4 -7.63219113822838 2.61083960396887e-10 5.33916699011635e-08
CESC ENSG00000258793 RP11-404P21.3 path:05206_136 MicroRNAs in cancer 2 -7.6192948454595 7.64545406442571e-11 3.12699071235011e-08
CESC ENSG00000258793 RP11-404P21.3 path:05206_97 MicroRNAs in cancer 26 -4.17580752031433 8.56420162379312e-05 0.00583793077355231
CESC ENSG00000258793 RP11-404P21.3 path:05222_63 Small cell lung cancer 6 -5.02599323818842 6.28076073558987e-06 0.000642207785214064
CESC ENSG00000258412 RP11-404P21.5 path:04144_32 Endocytosis 8 -3.8120411613074 0.00027465296025793 0.0140416325931867
CESC ENSG00000258412 RP11-404P21.5 path:04666_232 Fc gamma R-mediated phagocytosis 8 -5.93206723888842 3.90772055029302e-07 5.32752568356615e-05
CESC ENSG00000258412 RP11-404P21.5 path:04750_88 Inflammatory mediator regulation of TRP channels 5 -4.37576741008785 3.98693083245436e-05 0.00326130942094767
CESC ENSG00000258412 RP11-404P21.5 path:04810_134 Regulation of actin cytoskeleton 31 -3.92225757003324 0.000226955894199594 0.0132607086753763
CESC ENSG00000258412 RP11-404P21.5 path:04932_103 Non-alcoholic fatty liver disease (NAFLD) 4 -7.63219113822838 2.61083960396887e-10 5.33916699011635e-08
CESC ENSG00000258412 RP11-404P21.5 path:05206_136 MicroRNAs in cancer 2 -7.6192948454595 7.64545406442571e-11 3.12699071235011e-08
CESC ENSG00000258412 RP11-404P21.5 path:05206_97 MicroRNAs in cancer 26 -4.17580752031433 8.56420162379312e-05 0.00583793077355231
CESC ENSG00000258412 RP11-404P21.5 path:05222_63 Small cell lung cancer 6 -5.02599323818842 6.28076073558987e-06 0.000642207785214064
CESC ENSG00000238290 RP11-431K24.1 path:04662_38 B cell receptor signaling pathway 22 -4.23299421421007 0.000177554189028488 0.0459524462814587
CESC ENSG00000238290 RP11-431K24.1 path:05210_45 Colorectal cancer 4 -4.10866913939428 0.000239335657715931 0.0459524462814587
CESC ENSG00000227634 RP11-431K24.3 path:04662_38 B cell receptor signaling pathway 22 -4.23299421421007 0.000177554189028488 0.0461917819391746
CESC ENSG00000227634 RP11-431K24.3 path:05210_45 Colorectal cancer 4 -4.10866913939428 0.000239335657715931 0.0461917819391746
CESC ENSG00000233645 RP11-431K24.4 path:04662_38 B cell receptor signaling pathway 22 -4.23299421421007 0.000177554189028488 0.0461917819391746
CESC ENSG00000233645 RP11-431K24.4 path:05210_45 Colorectal cancer 4 -4.10866913939428 0.000239335657715931 0.0461917819391746
CESC ENSG00000258702 RP11-433J8.1 path:04144_32 Endocytosis 8 -3.9416060644509 0.00016747324200157 0.0158680896796488
CESC ENSG00000258702 RP11-433J8.1 path:04151_285 PI3K-Akt signaling pathway 16 -3.68988847823218 0.000384569068678518 0.0291503354058317
CESC ENSG00000258702 RP11-433J8.1 path:04810_134 Regulation of actin cytoskeleton 31 -4.10940181072005 0.000114497782985166 0.0144648865837927
CESC ENSG00000258702 RP11-433J8.1 path:04915_139 Estrogen signaling pathway 4 -7.78794033048715 9.63396136733793e-11 3.65127135822107e-08
CESC ENSG00000258702 RP11-433J8.1 path:05222_63 Small cell lung cancer 6 -5.17171115844146 3.3015761474502e-06 0.000625648679941813
CESC ENSG00000258979 RP11-433J8.2 path:04144_32 Endocytosis 8 -3.9416060644509 0.00016747324200157 0.0158680896796488
CESC ENSG00000258979 RP11-433J8.2 path:04151_285 PI3K-Akt signaling pathway 16 -3.68988847823218 0.000384569068678518 0.0291503354058317
CESC ENSG00000258979 RP11-433J8.2 path:04810_134 Regulation of actin cytoskeleton 31 -4.10940181072005 0.000114497782985166 0.0144648865837927
CESC ENSG00000258979 RP11-433J8.2 path:04915_139 Estrogen signaling pathway 4 -7.78794033048715 9.63396136733793e-11 3.65127135822107e-08
CESC ENSG00000258979 RP11-433J8.2 path:05222_63 Small cell lung cancer 6 -5.17171115844146 3.3015761474502e-06 0.000625648679941813
CESC ENSG00000258693 RP11-436M15.3 path:04014_136 Ras signaling pathway 15 -3.35932987525971 0.00156098361951259 0.0493010659829392
CESC ENSG00000258693 RP11-436M15.3 path:04144_32 Endocytosis 8 -3.79250588125354 0.000283332788560431 0.0199835684716393
CESC ENSG00000258693 RP11-436M15.3 path:04151_285 PI3K-Akt signaling pathway 16 -3.51867875809173 0.000687822118579373 0.0325855728676978
CESC ENSG00000258693 RP11-436M15.3 path:04360_117 Axon guidance 15 -3.77222385734019 0.000440916737315015 0.0238724919203415
CESC ENSG00000258693 RP11-436M15.3 path:04512_73 ECM-receptor interaction 11 -3.33143827611793 0.00132539754573172 0.0456659699847565
CESC ENSG00000258693 RP11-436M15.3 path:04662_72 B cell receptor signaling pathway 8 -4.02041495091434 0.000187310299886989 0.0177476509142922
CESC ENSG00000258693 RP11-436M15.3 path:04810_134 Regulation of actin cytoskeleton 31 -4.00229285571665 0.000165924471229925 0.0177476509142922
CESC ENSG00000258693 RP11-436M15.3 path:04915_139 Estrogen signaling pathway 4 -8.41406486530196 5.72672287895484e-12 2.17042797112388e-09
CESC ENSG00000258693 RP11-436M15.3 path:05214_1 Glioma 51 -3.8161134249716 0.000316362561556295 0.0199835684716393
CESC ENSG00000258693 RP11-436M15.3 path:05218_1 Melanoma 63 -3.4792121008745 0.00105921735600022 0.0401443377924084
CESC ENSG00000258693 RP11-436M15.3 path:05222_63 Small cell lung cancer 6 -6.32875822818816 3.11627491995206e-08 5.90534097330916e-06
CESC ENSG00000258693 RP11-436M15.3 path:05231_46 Choline metabolism in cancer 24 -3.44725834743534 0.00104044835502111 0.0401443377924084
CESC ENSG00000273293 RP11-445N20.3 path:00250_31 Alanine, aspartate and glutamate metabolism 10 -4.00305602273776 8.98468021200511e-05 0.0345910188162197
CESC ENSG00000257556 RP11-44N21.1 path:04062_169 Chemokine signaling pathway 27 -3.74561305149265 0.000495875610085168 0.0453726183227929
CESC ENSG00000257556 RP11-44N21.1 path:04660_129 T cell receptor signaling pathway 9 -4.90396950750985 9.12818145798239e-06 0.00167045720681078
CESC ENSG00000257556 RP11-44N21.1 path:04670_142 Leukocyte transendothelial migration 6 -4.05512953712353 0.000153688356290849 0.0187499794674836
CESC ENSG00000257556 RP11-44N21.1 path:04915_139 Estrogen signaling pathway 4 -8.44510106866434 7.09316234329053e-12 2.59609741764434e-09
CESC ENSG00000257622 RP11-44N21.4 path:04062_169 Chemokine signaling pathway 27 -3.74561305149265 0.000495875610085168 0.0453726183227929
CESC ENSG00000257622 RP11-44N21.4 path:04660_129 T cell receptor signaling pathway 9 -4.90396950750985 9.12818145798239e-06 0.00167045720681078
CESC ENSG00000257622 RP11-44N21.4 path:04670_142 Leukocyte transendothelial migration 6 -4.05512953712353 0.000153688356290849 0.0187499794674836
CESC ENSG00000257622 RP11-44N21.4 path:04915_139 Estrogen signaling pathway 4 -8.44510106866434 7.09316234329053e-12 2.59609741764434e-09
CESC ENSG00000259775 RP11-45P15.4 path:00240_204 Pyrimidine metabolism 2 -3.85118877777033 0.000234909217550938 0.0183229189689731
CESC ENSG00000259775 RP11-45P15.4 path:04261_79 Adrenergic signaling in cardiomyocytes 38 -3.52529099625749 0.000785276267876378 0.0437511063531125
CESC ENSG00000259775 RP11-45P15.4 path:04662_72 B cell receptor signaling pathway 8 -4.41157726496846 4.87456458086943e-05 0.00633693395513026
CESC ENSG00000259775 RP11-45P15.4 path:04670_142 Leukocyte transendothelial migration 6 -4.13705349646663 0.000106226364862271 0.0103570705740714
CESC ENSG00000259775 RP11-45P15.4 path:05206_78 MicroRNAs in cancer 48 -4.47485823510021 3.13116287151947e-05 0.00610576759946296
CESC ENSG00000259775 RP11-45P15.4 path:05214_1 Glioma 51 -3.57831652883344 0.00064217781280233 0.0417415578321515
CESC ENSG00000259775 RP11-45P15.4 path:05222_73 Small cell lung cancer 3 -8.424666082184 1.3911714147316e-12 5.42556851745323e-10
CESC ENSG00000261472 RP11-467I17.1 path:04020_216 Calcium signaling pathway 11 -4.02063438374057 0.000134548955212802 0.0248907733464373
CESC ENSG00000261472 RP11-467I17.1 path:04062_177 Chemokine signaling pathway 24 -3.63386869204325 0.000520403338726328 0.0395506537432009
CESC ENSG00000261472 RP11-467I17.1 path:04062_265 Chemokine signaling pathway 8 -3.97404832101243 0.000196357415679358 0.0248907733464373
CESC ENSG00000261472 RP11-467I17.1 path:04360_145 Axon guidance 8 -3.81350041414377 0.000301499693128256 0.0286424708471843
CESC ENSG00000261472 RP11-467I17.1 path:04660_107 T cell receptor signaling pathway 12 -3.92397760647377 0.00019650610536661 0.0248907733464373
CESC ENSG00000261472 RP11-467I17.1 path:05010_6 Alzheimer's disease 5 -3.57490236418559 0.000693015188536565 0.0438909619406491
CESC ENSG00000242578 RP11-469J4.3 path:00071_14 Fatty acid degradation 15 -3.41009789218762 0.0012885420823183 0.0370916042267339
CESC ENSG00000242578 RP11-469J4.3 path:00100_15 Steroid biosynthesis 9 4.20429704732536 5.44590945700872e-05 0.00365783585195752
CESC ENSG00000242578 RP11-469J4.3 path:00140_23 Steroid hormone biosynthesis 10 3.38508815748897 0.000888999108157138 0.0298555533822772
CESC ENSG00000242578 RP11-469J4.3 path:00980_121 Metabolism of xenobiotics by cytochrome P450 4 3.95651764919754 0.00011606920459113 0.00656032797741703
CESC ENSG00000242578 RP11-469J4.3 path:00980_73 Metabolism of xenobiotics by cytochrome P450 11 3.43051127716778 0.000751341473750407 0.0275264194474013
CESC ENSG00000242578 RP11-469J4.3 path:03460_52 Fanconi anemia pathway 3 3.96362813982066 0.000130229835779991 0.00656032797741703
CESC ENSG00000242578 RP11-469J4.3 path:04060_14 Cytokine-cytokine receptor interaction 8 4.5967318773826 7.90424909975221e-06 0.000796353096800035
CESC ENSG00000242578 RP11-469J4.3 path:04210_83 Apoptosis 5 4.76675513331163 3.77264349512409e-06 0.000506791776178336
CESC ENSG00000242578 RP11-469J4.3 path:04370_11 VEGF signaling pathway 46 4.29098436403437 5.26428372151558e-05 0.00365783585195752
CESC ENSG00000242578 RP11-469J4.3 path:04650_17 Natural killer cell mediated cytotoxicity 89 3.36567960300742 0.00100492095387095 0.0311525495699994
CESC ENSG00000242578 RP11-469J4.3 path:05162_43 Measles 5 4.76675513331163 3.77264349512409e-06 0.000506791776178336
CESC ENSG00000242578 RP11-469J4.3 path:05164_48 Influenza A 5 4.76675513331163 3.77264349512409e-06 0.000506791776178336
CESC ENSG00000242578 RP11-469J4.3 path:05220_62 Chronic myeloid leukemia 2 3.6395916917994 0.000510541787859457 0.0205915478068162
CESC ENSG00000242578 RP11-469J4.3 path:05221_7 Acute myeloid leukemia 49 3.63842077176597 0.000510956521260947 0.0205915478068162
CESC ENSG00000258481 RP11-472N19.3 path:04810_134 Regulation of actin cytoskeleton 31 -3.92225757003324 0.000226955894199594 0.0415329286385257
CESC ENSG00000258481 RP11-472N19.3 path:05222_63 Small cell lung cancer 6 -5.02599323818842 6.28076073558987e-06 0.00229875842922589
CESC ENSG00000261687 RP11-473C18.3 path:00230_18 Purine metabolism 117 -3.91217653277665 0.000189476725011798 0.0347846624038195
CESC ENSG00000261687 RP11-473C18.3 path:04024_100 cAMP signaling pathway 37 -3.95086249589602 0.00013721027096423 0.0347846624038195
CESC ENSG00000261687 RP11-473C18.3 path:04070_29 Phosphatidylinositol signaling system 25 -3.34041572101225 0.00117744424287895 0.0472155141394458
CESC ENSG00000261687 RP11-473C18.3 path:04370_2 VEGF signaling pathway 53 -3.64774827251458 0.00047713674541307 0.0347846624038195
CESC ENSG00000261687 RP11-473C18.3 path:04662_78 B cell receptor signaling pathway 6 -3.55907535413072 0.000693958352195899 0.0347846624038195
CESC ENSG00000261687 RP11-473C18.3 path:04713_90 Circadian entrainment 21 -3.54654308125873 0.000539102744287524 0.0347846624038195
CESC ENSG00000261687 RP11-473C18.3 path:04720_56 Long-term potentiation 17 -3.50828702096056 0.000636133724720179 0.0347846624038195
CESC ENSG00000261687 RP11-473C18.3 path:04740_2 Olfactory transduction 22 -3.59168013276418 0.000458967539760309 0.0347846624038195
CESC ENSG00000261687 RP11-473C18.3 path:04744_5 Phototransduction 5 -3.35449738226488 0.00103232007436437 0.045995594424457
CESC ENSG00000261687 RP11-473C18.3 path:05169_35 Epstein-Barr virus infection 7 -3.56360355246189 0.000666892290434796 0.0347846624038195
CESC ENSG00000230731 RP11-478K15.6 path:00640_31 Propanoate metabolism 3 -5.20298328672517 5.09726642875375e-07 0.000203380930507274
CESC ENSG00000259595 RP11-516C1.1 path:00230_18 Purine metabolism 117 -3.91217653277665 0.000189476725011798 0.0347846624038195
CESC ENSG00000259595 RP11-516C1.1 path:04024_100 cAMP signaling pathway 37 -3.95086249589602 0.00013721027096423 0.0347846624038195
CESC ENSG00000259595 RP11-516C1.1 path:04070_29 Phosphatidylinositol signaling system 25 -3.34041572101225 0.00117744424287895 0.0472155141394458
CESC ENSG00000259595 RP11-516C1.1 path:04370_2 VEGF signaling pathway 53 -3.64774827251458 0.00047713674541307 0.0347846624038195
CESC ENSG00000259595 RP11-516C1.1 path:04662_78 B cell receptor signaling pathway 6 -3.55907535413072 0.000693958352195899 0.0347846624038195
CESC ENSG00000259595 RP11-516C1.1 path:04713_90 Circadian entrainment 21 -3.54654308125873 0.000539102744287524 0.0347846624038195
CESC ENSG00000259595 RP11-516C1.1 path:04720_56 Long-term potentiation 17 -3.50828702096056 0.000636133724720179 0.0347846624038195
CESC ENSG00000259595 RP11-516C1.1 path:04740_2 Olfactory transduction 22 -3.59168013276418 0.000458967539760309 0.0347846624038195
CESC ENSG00000259595 RP11-516C1.1 path:04744_5 Phototransduction 5 -3.35449738226488 0.00103232007436437 0.045995594424457
CESC ENSG00000259595 RP11-516C1.1 path:05169_35 Epstein-Barr virus infection 7 -3.56360355246189 0.000666892290434796 0.0347846624038195
CESC ENSG00000251602 RP11-521B24.3 path:04062_169 Chemokine signaling pathway 27 -3.74561305149265 0.000495875610085168 0.0453726183227929
CESC ENSG00000251602 RP11-521B24.3 path:04660_129 T cell receptor signaling pathway 9 -4.90396950750985 9.12818145798239e-06 0.00167045720681078
CESC ENSG00000251602 RP11-521B24.3 path:04670_142 Leukocyte transendothelial migration 6 -4.05512953712353 0.000153688356290849 0.0187499794674836
CESC ENSG00000251602 RP11-521B24.3 path:04915_139 Estrogen signaling pathway 4 -8.44510106866434 7.09316234329053e-12 2.59609741764434e-09
CESC ENSG00000257270 RP11-521B24.5 path:04062_169 Chemokine signaling pathway 27 -3.74561305149265 0.000495875610085168 0.0453726183227929
CESC ENSG00000257270 RP11-521B24.5 path:04660_129 T cell receptor signaling pathway 9 -4.90396950750985 9.12818145798239e-06 0.00167045720681078
CESC ENSG00000257270 RP11-521B24.5 path:04670_142 Leukocyte transendothelial migration 6 -4.05512953712353 0.000153688356290849 0.0187499794674836
CESC ENSG00000257270 RP11-521B24.5 path:04915_139 Estrogen signaling pathway 4 -8.44510106866434 7.09316234329053e-12 2.59609741764434e-09
CESC ENSG00000247970 RP11-543C4.1 path:04014_136 Ras signaling pathway 15 -3.35932987525971 0.00156098361951259 0.0493010659829392
CESC ENSG00000247970 RP11-543C4.1 path:04144_32 Endocytosis 8 -3.79250588125354 0.000283332788560431 0.0199835684716393
CESC ENSG00000247970 RP11-543C4.1 path:04151_285 PI3K-Akt signaling pathway 16 -3.51867875809173 0.000687822118579373 0.0325855728676978
CESC ENSG00000247970 RP11-543C4.1 path:04360_117 Axon guidance 15 -3.77222385734019 0.000440916737315015 0.0238724919203415
CESC ENSG00000247970 RP11-543C4.1 path:04512_73 ECM-receptor interaction 11 -3.33143827611793 0.00132539754573172 0.0456659699847565
CESC ENSG00000247970 RP11-543C4.1 path:04662_72 B cell receptor signaling pathway 8 -4.02041495091434 0.000187310299886989 0.0177476509142922
CESC ENSG00000247970 RP11-543C4.1 path:04810_134 Regulation of actin cytoskeleton 31 -4.00229285571665 0.000165924471229925 0.0177476509142922
CESC ENSG00000247970 RP11-543C4.1 path:04915_139 Estrogen signaling pathway 4 -8.41406486530196 5.72672287895484e-12 2.17042797112388e-09
CESC ENSG00000247970 RP11-543C4.1 path:05214_1 Glioma 51 -3.8161134249716 0.000316362561556295 0.0199835684716393
CESC ENSG00000247970 RP11-543C4.1 path:05218_1 Melanoma 63 -3.4792121008745 0.00105921735600022 0.0401443377924084
CESC ENSG00000247970 RP11-543C4.1 path:05222_63 Small cell lung cancer 6 -6.32875822818816 3.11627491995206e-08 5.90534097330916e-06
CESC ENSG00000247970 RP11-543C4.1 path:05231_46 Choline metabolism in cancer 24 -3.44725834743534 0.00104044835502111 0.0401443377924084
CESC ENSG00000258672 RP11-543C4.3 path:04115_1 p53 signaling pathway 65 -3.61903870763223 0.000700900629677838 0.0395430808621532
CESC ENSG00000258672 RP11-543C4.3 path:04512_92 ECM-receptor interaction 3 -3.37245992657115 0.000994179247447727 0.0409822778670118
CESC ENSG00000258672 RP11-543C4.3 path:04662_72 B cell receptor signaling pathway 8 -3.82956233354121 0.000341978521414197 0.0317185078611668
CESC ENSG00000258672 RP11-543C4.3 path:04725_71 Cholinergic synapse 24 -3.57792280719016 0.000746095865323645 0.0395430808621532
CESC ENSG00000258672 RP11-543C4.3 path:04915_139 Estrogen signaling pathway 4 -8.32456568911902 8.54821886310418e-12 3.17138919821165e-09
CESC ENSG00000258672 RP11-543C4.3 path:04930_14 Type II diabetes mellitus 29 -3.67437078173342 0.000475104641670282 0.0352527644119349
CESC ENSG00000258672 RP11-543C4.3 path:05146_10 Amoebiasis 8 -5.5345567776907 1.27442273638215e-07 2.36405417598889e-05
CESC ENSG00000258672 RP11-543C4.3 path:05206_72 MicroRNAs in cancer 50 -5.51678990981379 7.22343353057853e-07 8.93297946614878e-05
CESC ENSG00000258672 RP11-543C4.3 path:05214_20 Glioma 36 -3.3514588554866 0.00133761497985183 0.049625515752503
CESC ENSG00000258672 RP11-543C4.3 path:05231_46 Choline metabolism in cancer 24 -3.50905417386772 0.000862799012823095 0.0400123042196711
CESC ENSG00000239628 RP11-543D10.2 path:00071_14 Fatty acid degradation 15 -3.41009789218762 0.0012885420823183 0.0370916042267339
CESC ENSG00000239628 RP11-543D10.2 path:00100_15 Steroid biosynthesis 9 4.20429704732536 5.44590945700872e-05 0.00365783585195752
CESC ENSG00000239628 RP11-543D10.2 path:00140_23 Steroid hormone biosynthesis 10 3.38508815748897 0.000888999108157138 0.0298555533822772
CESC ENSG00000239628 RP11-543D10.2 path:00980_121 Metabolism of xenobiotics by cytochrome P450 4 3.95651764919754 0.00011606920459113 0.00656032797741703
CESC ENSG00000239628 RP11-543D10.2 path:00980_73 Metabolism of xenobiotics by cytochrome P450 11 3.43051127716778 0.000751341473750407 0.0275264194474013
CESC ENSG00000239628 RP11-543D10.2 path:03460_52 Fanconi anemia pathway 3 3.96362813982066 0.000130229835779991 0.00656032797741703
CESC ENSG00000239628 RP11-543D10.2 path:04060_14 Cytokine-cytokine receptor interaction 8 4.5967318773826 7.90424909975221e-06 0.000796353096800035
CESC ENSG00000239628 RP11-543D10.2 path:04210_83 Apoptosis 5 4.76675513331163 3.77264349512409e-06 0.000506791776178336
CESC ENSG00000239628 RP11-543D10.2 path:04370_11 VEGF signaling pathway 46 4.29098436403437 5.26428372151558e-05 0.00365783585195752
CESC ENSG00000239628 RP11-543D10.2 path:04650_17 Natural killer cell mediated cytotoxicity 89 3.36567960300742 0.00100492095387095 0.0311525495699994
CESC ENSG00000239628 RP11-543D10.2 path:05162_43 Measles 5 4.76675513331163 3.77264349512409e-06 0.000506791776178336
CESC ENSG00000239628 RP11-543D10.2 path:05164_48 Influenza A 5 4.76675513331163 3.77264349512409e-06 0.000506791776178336
CESC ENSG00000239628 RP11-543D10.2 path:05220_62 Chronic myeloid leukemia 2 3.6395916917994 0.000510541787859457 0.0205915478068162
CESC ENSG00000239628 RP11-543D10.2 path:05221_7 Acute myeloid leukemia 49 3.63842077176597 0.000510956521260947 0.0205915478068162
CESC ENSG00000241449 RP11-545G3.1 path:00250_31 Alanine, aspartate and glutamate metabolism 10 -4.00305602273776 8.98468021200511e-05 0.0345910188162197
CESC ENSG00000260511 RP11-556H2.2 path:04022_82 cGMP-PKG signaling pathway 17 -4.68518158941937 1.14777905300677e-05 0.0042926936582453
CESC ENSG00000260511 RP11-556H2.2 path:04062_177 Chemokine signaling pathway 24 -3.69049312161951 0.000436552518484307 0.0354262313434959
CESC ENSG00000260511 RP11-556H2.2 path:04062_265 Chemokine signaling pathway 8 -4.45050231655451 3.90951329978568e-05 0.00731078987059923
CESC ENSG00000260511 RP11-556H2.2 path:04360_145 Axon guidance 8 -3.57042851461963 0.00067823987463618 0.0422769521856552
CESC ENSG00000260511 RP11-556H2.2 path:04660_107 T cell receptor signaling pathway 12 -3.66765759734977 0.000473612718495935 0.0354262313434959
CESC ENSG00000260511 RP11-556H2.2 path:05146_1 Amoebiasis 11 -3.75265210200515 0.000330558913965631 0.0354262313434959
CESC ENSG00000260479 RP11-556H2.3 path:04022_82 cGMP-PKG signaling pathway 17 -4.68518158941937 1.14777905300677e-05 0.0042926936582453
CESC ENSG00000260479 RP11-556H2.3 path:04062_177 Chemokine signaling pathway 24 -3.69049312161951 0.000436552518484307 0.0354262313434959
CESC ENSG00000260479 RP11-556H2.3 path:04062_265 Chemokine signaling pathway 8 -4.45050231655451 3.90951329978568e-05 0.00731078987059923
CESC ENSG00000260479 RP11-556H2.3 path:04360_145 Axon guidance 8 -3.57042851461963 0.00067823987463618 0.0422769521856552
CESC ENSG00000260479 RP11-556H2.3 path:04660_107 T cell receptor signaling pathway 12 -3.66765759734977 0.000473612718495935 0.0354262313434959
CESC ENSG00000260479 RP11-556H2.3 path:05146_1 Amoebiasis 11 -3.75265210200515 0.000330558913965631 0.0354262313434959
CESC ENSG00000260694 RP11-556H2.4 path:04022_82 cGMP-PKG signaling pathway 17 -4.68518158941937 1.14777905300677e-05 0.0042926936582453
CESC ENSG00000260694 RP11-556H2.4 path:04062_177 Chemokine signaling pathway 24 -3.69049312161951 0.000436552518484307 0.0354262313434959
CESC ENSG00000260694 RP11-556H2.4 path:04062_265 Chemokine signaling pathway 8 -4.45050231655451 3.90951329978568e-05 0.00731078987059923
CESC ENSG00000260694 RP11-556H2.4 path:04360_145 Axon guidance 8 -3.57042851461963 0.00067823987463618 0.0422769521856552
CESC ENSG00000260694 RP11-556H2.4 path:04660_107 T cell receptor signaling pathway 12 -3.66765759734977 0.000473612718495935 0.0354262313434959
CESC ENSG00000260694 RP11-556H2.4 path:05146_1 Amoebiasis 11 -3.75265210200515 0.000330558913965631 0.0354262313434959
CESC ENSG00000258717 RP11-566J3.2 path:04014_136 Ras signaling pathway 15 -3.35932987525971 0.00156098361951259 0.0493010659829392
CESC ENSG00000258717 RP11-566J3.2 path:04144_32 Endocytosis 8 -3.79250588125354 0.000283332788560431 0.0199835684716393
CESC ENSG00000258717 RP11-566J3.2 path:04151_285 PI3K-Akt signaling pathway 16 -3.51867875809173 0.000687822118579373 0.0325855728676978
CESC ENSG00000258717 RP11-566J3.2 path:04360_117 Axon guidance 15 -3.77222385734019 0.000440916737315015 0.0238724919203415
CESC ENSG00000258717 RP11-566J3.2 path:04512_73 ECM-receptor interaction 11 -3.33143827611793 0.00132539754573172 0.0456659699847565
CESC ENSG00000258717 RP11-566J3.2 path:04662_72 B cell receptor signaling pathway 8 -4.02041495091434 0.000187310299886989 0.0177476509142922
CESC ENSG00000258717 RP11-566J3.2 path:04810_134 Regulation of actin cytoskeleton 31 -4.00229285571665 0.000165924471229925 0.0177476509142922
CESC ENSG00000258717 RP11-566J3.2 path:04915_139 Estrogen signaling pathway 4 -8.41406486530196 5.72672287895484e-12 2.17042797112388e-09
CESC ENSG00000258717 RP11-566J3.2 path:05214_1 Glioma 51 -3.8161134249716 0.000316362561556295 0.0199835684716393
CESC ENSG00000258717 RP11-566J3.2 path:05218_1 Melanoma 63 -3.4792121008745 0.00105921735600022 0.0401443377924084
CESC ENSG00000258717 RP11-566J3.2 path:05222_63 Small cell lung cancer 6 -6.32875822818816 3.11627491995206e-08 5.90534097330916e-06
CESC ENSG00000258717 RP11-566J3.2 path:05231_46 Choline metabolism in cancer 24 -3.44725834743534 0.00104044835502111 0.0401443377924084
CESC ENSG00000260285 RP11-600F24.7 path:04062_169 Chemokine signaling pathway 27 -3.74561305149265 0.000495875610085168 0.0453726183227929
CESC ENSG00000260285 RP11-600F24.7 path:04660_129 T cell receptor signaling pathway 9 -4.90396950750985 9.12818145798239e-06 0.00167045720681078
CESC ENSG00000260285 RP11-600F24.7 path:04670_142 Leukocyte transendothelial migration 6 -4.05512953712353 0.000153688356290849 0.0187499794674836
CESC ENSG00000260285 RP11-600F24.7 path:04915_139 Estrogen signaling pathway 4 -8.44510106866434 7.09316234329053e-12 2.59609741764434e-09
CESC ENSG00000259037 RP11-614O9.1 path:04062_169 Chemokine signaling pathway 27 -3.74561305149265 0.000495875610085168 0.0453726183227929
CESC ENSG00000259037 RP11-614O9.1 path:04660_129 T cell receptor signaling pathway 9 -4.90396950750985 9.12818145798239e-06 0.00167045720681078
CESC ENSG00000259037 RP11-614O9.1 path:04670_142 Leukocyte transendothelial migration 6 -4.05512953712353 0.000153688356290849 0.0187499794674836
CESC ENSG00000259037 RP11-614O9.1 path:04915_139 Estrogen signaling pathway 4 -8.44510106866434 7.09316234329053e-12 2.59609741764434e-09
CESC ENSG00000259499 RP11-616K22.2 path:00230_18 Purine metabolism 117 -3.91217653277665 0.000189476725011798 0.0347846624038195
CESC ENSG00000259499 RP11-616K22.2 path:04024_100 cAMP signaling pathway 37 -3.95086249589602 0.00013721027096423 0.0347846624038195
CESC ENSG00000259499 RP11-616K22.2 path:04070_29 Phosphatidylinositol signaling system 25 -3.34041572101225 0.00117744424287895 0.0472155141394458
CESC ENSG00000259499 RP11-616K22.2 path:04370_2 VEGF signaling pathway 53 -3.64774827251458 0.00047713674541307 0.0347846624038195
CESC ENSG00000259499 RP11-616K22.2 path:04662_78 B cell receptor signaling pathway 6 -3.55907535413072 0.000693958352195899 0.0347846624038195
CESC ENSG00000259499 RP11-616K22.2 path:04713_90 Circadian entrainment 21 -3.54654308125873 0.000539102744287524 0.0347846624038195
CESC ENSG00000259499 RP11-616K22.2 path:04720_56 Long-term potentiation 17 -3.50828702096056 0.000636133724720179 0.0347846624038195
CESC ENSG00000259499 RP11-616K22.2 path:04740_2 Olfactory transduction 22 -3.59168013276418 0.000458967539760309 0.0347846624038195
CESC ENSG00000259499 RP11-616K22.2 path:04744_5 Phototransduction 5 -3.35449738226488 0.00103232007436437 0.045995594424457
CESC ENSG00000259499 RP11-616K22.2 path:05169_35 Epstein-Barr virus infection 7 -3.56360355246189 0.000666892290434796 0.0347846624038195
CESC ENSG00000259097 RP11-61O1.1 path:04144_32 Endocytosis 8 -3.85942891682161 0.000215403908962631 0.0204095203742093
CESC ENSG00000259097 RP11-61O1.1 path:04151_285 PI3K-Akt signaling pathway 16 -3.60005884541621 0.00050785811220903 0.0320797040878704
CESC ENSG00000259097 RP11-61O1.1 path:04360_117 Axon guidance 15 -3.48274180541256 0.00104262033041477 0.0475724426059716
CESC ENSG00000259097 RP11-61O1.1 path:04512_73 ECM-receptor interaction 11 -3.33092378646045 0.00129260215481327 0.0489896216674228
CESC ENSG00000259097 RP11-61O1.1 path:04662_72 B cell receptor signaling pathway 8 -3.5207020936867 0.00090247764965174 0.0475724426059716
CESC ENSG00000259097 RP11-61O1.1 path:04810_134 Regulation of actin cytoskeleton 31 -4.05721041677141 0.000130019966566195 0.016425855776196
CESC ENSG00000259097 RP11-61O1.1 path:04915_139 Estrogen signaling pathway 4 -8.03351644188768 2.42399911503361e-11 9.18695664597738e-09
CESC ENSG00000259097 RP11-61O1.1 path:05214_1 Glioma 51 -3.73439137078991 0.000397417724151354 0.0301242634906726
CESC ENSG00000259097 RP11-61O1.1 path:05222_63 Small cell lung cancer 6 -5.43972942772094 1.12072767134325e-06 0.000212377893719545
CESC ENSG00000259097 RP11-61O1.1 path:05231_46 Choline metabolism in cancer 24 -3.4104330246693 0.00112968861069589 0.0475724426059716
CESC ENSG00000258511 RP11-61O1.2 path:04144_32 Endocytosis 8 -3.85942891682161 0.000215403908962631 0.0204095203742093
CESC ENSG00000258511 RP11-61O1.2 path:04151_285 PI3K-Akt signaling pathway 16 -3.60005884541621 0.00050785811220903 0.0320797040878704
CESC ENSG00000258511 RP11-61O1.2 path:04360_117 Axon guidance 15 -3.48274180541256 0.00104262033041477 0.0475724426059716
CESC ENSG00000258511 RP11-61O1.2 path:04512_73 ECM-receptor interaction 11 -3.33092378646045 0.00129260215481327 0.0489896216674228
CESC ENSG00000258511 RP11-61O1.2 path:04662_72 B cell receptor signaling pathway 8 -3.5207020936867 0.00090247764965174 0.0475724426059716
CESC ENSG00000258511 RP11-61O1.2 path:04810_134 Regulation of actin cytoskeleton 31 -4.05721041677141 0.000130019966566195 0.016425855776196
CESC ENSG00000258511 RP11-61O1.2 path:04915_139 Estrogen signaling pathway 4 -8.03351644188768 2.42399911503361e-11 9.18695664597738e-09
CESC ENSG00000258511 RP11-61O1.2 path:05214_1 Glioma 51 -3.73439137078991 0.000397417724151354 0.0301242634906726
CESC ENSG00000258511 RP11-61O1.2 path:05222_63 Small cell lung cancer 6 -5.43972942772094 1.12072767134325e-06 0.000212377893719545
CESC ENSG00000258511 RP11-61O1.2 path:05231_46 Choline metabolism in cancer 24 -3.4104330246693 0.00112968861069589 0.0475724426059716
CESC ENSG00000255191 RP11-626H12.1 path:00250_1 Alanine, aspartate and glutamate metabolism 27 -5.24332559656715 2.12327254848793e-06 0.000434209236165781
CESC ENSG00000255191 RP11-626H12.1 path:00330_2 Arginine and proline metabolism 49 -4.86460130322601 9.98024781664144e-06 0.00136064045233545
CESC ENSG00000255191 RP11-626H12.1 path:00910_1 Nitrogen metabolism 4 -5.81283470693019 5.90529514003344e-08 2.41526571227368e-05
CESC ENSG00000254605 RP11-626H12.2 path:00250_1 Alanine, aspartate and glutamate metabolism 27 -5.24332559656715 2.12327254848793e-06 0.000434209236165781
CESC ENSG00000254605 RP11-626H12.2 path:00330_2 Arginine and proline metabolism 49 -4.86460130322601 9.98024781664144e-06 0.00136064045233545
CESC ENSG00000254605 RP11-626H12.2 path:00910_1 Nitrogen metabolism 4 -5.81283470693019 5.90529514003344e-08 2.41526571227368e-05
CESC ENSG00000248844 RP11-626H12.3 path:00250_1 Alanine, aspartate and glutamate metabolism 27 -5.24332559656715 2.12327254848793e-06 0.000434209236165781
CESC ENSG00000248844 RP11-626H12.3 path:00330_2 Arginine and proline metabolism 49 -4.86460130322601 9.98024781664144e-06 0.00136064045233545
CESC ENSG00000248844 RP11-626H12.3 path:00910_1 Nitrogen metabolism 4 -5.81283470693019 5.90529514003344e-08 2.41526571227368e-05
CESC ENSG00000258904 RP11-638I2.2 path:04014_136 Ras signaling pathway 15 -3.35932987525971 0.00156098361951259 0.0493010659829392
CESC ENSG00000258904 RP11-638I2.2 path:04144_32 Endocytosis 8 -3.79250588125354 0.000283332788560431 0.0199835684716393
CESC ENSG00000258904 RP11-638I2.2 path:04151_285 PI3K-Akt signaling pathway 16 -3.51867875809173 0.000687822118579373 0.0325855728676978
CESC ENSG00000258904 RP11-638I2.2 path:04360_117 Axon guidance 15 -3.77222385734019 0.000440916737315015 0.0238724919203415
CESC ENSG00000258904 RP11-638I2.2 path:04512_73 ECM-receptor interaction 11 -3.33143827611793 0.00132539754573172 0.0456659699847565
CESC ENSG00000258904 RP11-638I2.2 path:04662_72 B cell receptor signaling pathway 8 -4.02041495091434 0.000187310299886989 0.0177476509142922
CESC ENSG00000258904 RP11-638I2.2 path:04810_134 Regulation of actin cytoskeleton 31 -4.00229285571665 0.000165924471229925 0.0177476509142922
CESC ENSG00000258904 RP11-638I2.2 path:04915_139 Estrogen signaling pathway 4 -8.41406486530196 5.72672287895484e-12 2.17042797112388e-09
CESC ENSG00000258904 RP11-638I2.2 path:05214_1 Glioma 51 -3.8161134249716 0.000316362561556295 0.0199835684716393
CESC ENSG00000258904 RP11-638I2.2 path:05218_1 Melanoma 63 -3.4792121008745 0.00105921735600022 0.0401443377924084
CESC ENSG00000258904 RP11-638I2.2 path:05222_63 Small cell lung cancer 6 -6.32875822818816 3.11627491995206e-08 5.90534097330916e-06
CESC ENSG00000258904 RP11-638I2.2 path:05231_46 Choline metabolism in cancer 24 -3.44725834743534 0.00104044835502111 0.0401443377924084
CESC ENSG00000258982 RP11-638I2.4 path:04014_136 Ras signaling pathway 15 -3.35932987525971 0.00156098361951259 0.0493010659829392
CESC ENSG00000258982 RP11-638I2.4 path:04144_32 Endocytosis 8 -3.79250588125354 0.000283332788560431 0.0199835684716393
CESC ENSG00000258982 RP11-638I2.4 path:04151_285 PI3K-Akt signaling pathway 16 -3.51867875809173 0.000687822118579373 0.0325855728676978
CESC ENSG00000258982 RP11-638I2.4 path:04360_117 Axon guidance 15 -3.77222385734019 0.000440916737315015 0.0238724919203415
CESC ENSG00000258982 RP11-638I2.4 path:04512_73 ECM-receptor interaction 11 -3.33143827611793 0.00132539754573172 0.0456659699847565
CESC ENSG00000258982 RP11-638I2.4 path:04662_72 B cell receptor signaling pathway 8 -4.02041495091434 0.000187310299886989 0.0177476509142922
CESC ENSG00000258982 RP11-638I2.4 path:04810_134 Regulation of actin cytoskeleton 31 -4.00229285571665 0.000165924471229925 0.0177476509142922
CESC ENSG00000258982 RP11-638I2.4 path:04915_139 Estrogen signaling pathway 4 -8.41406486530196 5.72672287895484e-12 2.17042797112388e-09
CESC ENSG00000258982 RP11-638I2.4 path:05214_1 Glioma 51 -3.8161134249716 0.000316362561556295 0.0199835684716393
CESC ENSG00000258982 RP11-638I2.4 path:05218_1 Melanoma 63 -3.4792121008745 0.00105921735600022 0.0401443377924084
CESC ENSG00000258982 RP11-638I2.4 path:05222_63 Small cell lung cancer 6 -6.32875822818816 3.11627491995206e-08 5.90534097330916e-06
CESC ENSG00000258982 RP11-638I2.4 path:05231_46 Choline metabolism in cancer 24 -3.44725834743534 0.00104044835502111 0.0401443377924084
CESC ENSG00000258504 RP11-638I2.6 path:04014_136 Ras signaling pathway 15 -3.35932987525971 0.00156098361951259 0.0493010659829392
CESC ENSG00000258504 RP11-638I2.6 path:04144_32 Endocytosis 8 -3.79250588125354 0.000283332788560431 0.0199835684716393
CESC ENSG00000258504 RP11-638I2.6 path:04151_285 PI3K-Akt signaling pathway 16 -3.51867875809173 0.000687822118579373 0.0325855728676978
CESC ENSG00000258504 RP11-638I2.6 path:04360_117 Axon guidance 15 -3.77222385734019 0.000440916737315015 0.0238724919203415
CESC ENSG00000258504 RP11-638I2.6 path:04512_73 ECM-receptor interaction 11 -3.33143827611793 0.00132539754573172 0.0456659699847565
CESC ENSG00000258504 RP11-638I2.6 path:04662_72 B cell receptor signaling pathway 8 -4.02041495091434 0.000187310299886989 0.0177476509142922
CESC ENSG00000258504 RP11-638I2.6 path:04810_134 Regulation of actin cytoskeleton 31 -4.00229285571665 0.000165924471229925 0.0177476509142922
CESC ENSG00000258504 RP11-638I2.6 path:04915_139 Estrogen signaling pathway 4 -8.41406486530196 5.72672287895484e-12 2.17042797112388e-09
CESC ENSG00000258504 RP11-638I2.6 path:05214_1 Glioma 51 -3.8161134249716 0.000316362561556295 0.0199835684716393
CESC ENSG00000258504 RP11-638I2.6 path:05218_1 Melanoma 63 -3.4792121008745 0.00105921735600022 0.0401443377924084
CESC ENSG00000258504 RP11-638I2.6 path:05222_63 Small cell lung cancer 6 -6.32875822818816 3.11627491995206e-08 5.90534097330916e-06
CESC ENSG00000258504 RP11-638I2.6 path:05231_46 Choline metabolism in cancer 24 -3.44725834743534 0.00104044835502111 0.0401443377924084
CESC ENSG00000258666 RP11-638I2.8 path:04014_136 Ras signaling pathway 15 -3.35932987525971 0.00156098361951259 0.0493010659829392
CESC ENSG00000258666 RP11-638I2.8 path:04144_32 Endocytosis 8 -3.79250588125354 0.000283332788560431 0.0199835684716393
CESC ENSG00000258666 RP11-638I2.8 path:04151_285 PI3K-Akt signaling pathway 16 -3.51867875809173 0.000687822118579373 0.0325855728676978
CESC ENSG00000258666 RP11-638I2.8 path:04360_117 Axon guidance 15 -3.77222385734019 0.000440916737315015 0.0238724919203415
CESC ENSG00000258666 RP11-638I2.8 path:04512_73 ECM-receptor interaction 11 -3.33143827611793 0.00132539754573172 0.0456659699847565
CESC ENSG00000258666 RP11-638I2.8 path:04662_72 B cell receptor signaling pathway 8 -4.02041495091434 0.000187310299886989 0.0177476509142922
CESC ENSG00000258666 RP11-638I2.8 path:04810_134 Regulation of actin cytoskeleton 31 -4.00229285571665 0.000165924471229925 0.0177476509142922
CESC ENSG00000258666 RP11-638I2.8 path:04915_139 Estrogen signaling pathway 4 -8.41406486530196 5.72672287895484e-12 2.17042797112388e-09
CESC ENSG00000258666 RP11-638I2.8 path:05214_1 Glioma 51 -3.8161134249716 0.000316362561556295 0.0199835684716393
CESC ENSG00000258666 RP11-638I2.8 path:05218_1 Melanoma 63 -3.4792121008745 0.00105921735600022 0.0401443377924084
CESC ENSG00000258666 RP11-638I2.8 path:05222_63 Small cell lung cancer 6 -6.32875822818816 3.11627491995206e-08 5.90534097330916e-06
CESC ENSG00000258666 RP11-638I2.8 path:05231_46 Choline metabolism in cancer 24 -3.44725834743534 0.00104044835502111 0.0401443377924084
CESC ENSG00000258521 RP11-638I2.9 path:04014_136 Ras signaling pathway 15 -3.35932987525971 0.00156098361951259 0.0493010659829392
CESC ENSG00000258521 RP11-638I2.9 path:04144_32 Endocytosis 8 -3.79250588125354 0.000283332788560431 0.0199835684716393
CESC ENSG00000258521 RP11-638I2.9 path:04151_285 PI3K-Akt signaling pathway 16 -3.51867875809173 0.000687822118579373 0.0325855728676978
CESC ENSG00000258521 RP11-638I2.9 path:04360_117 Axon guidance 15 -3.77222385734019 0.000440916737315015 0.0238724919203415
CESC ENSG00000258521 RP11-638I2.9 path:04512_73 ECM-receptor interaction 11 -3.33143827611793 0.00132539754573172 0.0456659699847565
CESC ENSG00000258521 RP11-638I2.9 path:04662_72 B cell receptor signaling pathway 8 -4.02041495091434 0.000187310299886989 0.0177476509142922
CESC ENSG00000258521 RP11-638I2.9 path:04810_134 Regulation of actin cytoskeleton 31 -4.00229285571665 0.000165924471229925 0.0177476509142922
CESC ENSG00000258521 RP11-638I2.9 path:04915_139 Estrogen signaling pathway 4 -8.41406486530196 5.72672287895484e-12 2.17042797112388e-09
CESC ENSG00000258521 RP11-638I2.9 path:05214_1 Glioma 51 -3.8161134249716 0.000316362561556295 0.0199835684716393
CESC ENSG00000258521 RP11-638I2.9 path:05218_1 Melanoma 63 -3.4792121008745 0.00105921735600022 0.0401443377924084
CESC ENSG00000258521 RP11-638I2.9 path:05222_63 Small cell lung cancer 6 -6.32875822818816 3.11627491995206e-08 5.90534097330916e-06
CESC ENSG00000258521 RP11-638I2.9 path:05231_46 Choline metabolism in cancer 24 -3.44725834743534 0.00104044835502111 0.0401443377924084
CESC ENSG00000241479 RP11-641D5.2 path:00071_14 Fatty acid degradation 15 -3.23531219786892 0.00211986115493115 0.0479324161142766
CESC ENSG00000241479 RP11-641D5.2 path:00100_15 Steroid biosynthesis 9 4.26863116291523 4.10210658134736e-05 0.00267130063211421
CESC ENSG00000241479 RP11-641D5.2 path:00140_23 Steroid hormone biosynthesis 10 3.41407624057571 0.000807174925062791 0.0252707841923505
CESC ENSG00000241479 RP11-641D5.2 path:00563_10 Glycosylphosphatidylinositol(GPI)-anchor biosynthesis 5 4.98355961955554 3.95055470470262e-06 0.000401968941203491
CESC ENSG00000241479 RP11-641D5.2 path:00601_58 Glycosphingolipid biosynthesis - lacto and neolacto series 3 3.43849961596231 0.000776439526892875 0.0252707841923505
CESC ENSG00000241479 RP11-641D5.2 path:00980_121 Metabolism of xenobiotics by cytochrome P450 4 3.92674715733004 0.000130266457761578 0.00589093870099581
CESC ENSG00000241479 RP11-641D5.2 path:00980_73 Metabolism of xenobiotics by cytochrome P450 11 3.62825271604218 0.000373857074533279 0.0144933393349435
CESC ENSG00000241479 RP11-641D5.2 path:03460_52 Fanconi anemia pathway 3 4.13122937410623 6.79438996458755e-05 0.00345664589448391
CESC ENSG00000241479 RP11-641D5.2 path:04060_14 Cytokine-cytokine receptor interaction 8 4.64675272531475 6.39863553453765e-06 0.000520848932511365
CESC ENSG00000241479 RP11-641D5.2 path:04210_83 Apoptosis 5 4.78972301576347 3.42882890730144e-06 0.000401968941203491
CESC ENSG00000241479 RP11-641D5.2 path:04370_11 VEGF signaling pathway 46 4.31520283479856 4.59437455154779e-05 0.00267130063211421
CESC ENSG00000241479 RP11-641D5.2 path:04650_17 Natural killer cell mediated cytotoxicity 89 3.39694827823132 0.00089316000209867 0.0259654372038685
CESC ENSG00000241479 RP11-641D5.2 path:05146_3 Amoebiasis 9 3.16860466470682 0.00206148881342401 0.0479324161142766
CESC ENSG00000241479 RP11-641D5.2 path:05162_43 Measles 5 4.78972301576347 3.42882890730144e-06 0.000401968941203491
CESC ENSG00000241479 RP11-641D5.2 path:05164_48 Influenza A 5 4.78972301576347 3.42882890730144e-06 0.000401968941203491
CESC ENSG00000241479 RP11-641D5.2 path:05204_17 Chemical carcinogenesis 14 3.14555540554563 0.0019539679342565 0.0479324161142766
CESC ENSG00000241479 RP11-641D5.2 path:05220_62 Chronic myeloid leukemia 2 3.71076372579281 0.000391711873917392 0.0144933393349435
CESC ENSG00000241479 RP11-641D5.2 path:05221_7 Acute myeloid leukemia 49 3.32782586349916 0.00136987182585667 0.0371691888749109
CESC ENSG00000259508 RP11-661D19.3 path:04728_178 Dopaminergic synapse 17 -4.64938903184529 2.57570024293522e-05 0.00503549397493835
CESC ENSG00000259508 RP11-661D19.3 path:05222_73 Small cell lung cancer 3 -8.4632253905838 2.10744885761159e-12 8.24012503326131e-10
CESC ENSG00000262020 RP11-66H6.3 path:03460_17 Fanconi anemia pathway 35 4.20642104804768 6.72431642934148e-05 0.0241402959813359
CESC ENSG00000262020 RP11-66H6.3 path:03460_52 Fanconi anemia pathway 3 4.06287770987049 0.000209477473391044 0.0376012064736924
CESC ENSG00000261722 RP11-679B19.2 path:04020_216 Calcium signaling pathway 11 -4.02063438374057 0.000134548955212802 0.0248907733464373
CESC ENSG00000261722 RP11-679B19.2 path:04062_177 Chemokine signaling pathway 24 -3.63386869204325 0.000520403338726328 0.0395506537432009
CESC ENSG00000261722 RP11-679B19.2 path:04062_265 Chemokine signaling pathway 8 -3.97404832101243 0.000196357415679358 0.0248907733464373
CESC ENSG00000261722 RP11-679B19.2 path:04360_145 Axon guidance 8 -3.81350041414377 0.000301499693128256 0.0286424708471843
CESC ENSG00000261722 RP11-679B19.2 path:04660_107 T cell receptor signaling pathway 12 -3.92397760647377 0.00019650610536661 0.0248907733464373
CESC ENSG00000261722 RP11-679B19.2 path:05010_6 Alzheimer's disease 5 -3.57490236418559 0.000693015188536565 0.0438909619406491
CESC ENSG00000258749 RP11-688G15.3 path:04014_136 Ras signaling pathway 15 -3.35932987525971 0.00156098361951259 0.0493010659829392
CESC ENSG00000258749 RP11-688G15.3 path:04144_32 Endocytosis 8 -3.79250588125354 0.000283332788560431 0.0199835684716393
CESC ENSG00000258749 RP11-688G15.3 path:04151_285 PI3K-Akt signaling pathway 16 -3.51867875809173 0.000687822118579373 0.0325855728676978
CESC ENSG00000258749 RP11-688G15.3 path:04360_117 Axon guidance 15 -3.77222385734019 0.000440916737315015 0.0238724919203415
CESC ENSG00000258749 RP11-688G15.3 path:04512_73 ECM-receptor interaction 11 -3.33143827611793 0.00132539754573172 0.0456659699847565
CESC ENSG00000258749 RP11-688G15.3 path:04662_72 B cell receptor signaling pathway 8 -4.02041495091434 0.000187310299886989 0.0177476509142922
CESC ENSG00000258749 RP11-688G15.3 path:04810_134 Regulation of actin cytoskeleton 31 -4.00229285571665 0.000165924471229925 0.0177476509142922
CESC ENSG00000258749 RP11-688G15.3 path:04915_139 Estrogen signaling pathway 4 -8.41406486530196 5.72672287895484e-12 2.17042797112388e-09
CESC ENSG00000258749 RP11-688G15.3 path:05214_1 Glioma 51 -3.8161134249716 0.000316362561556295 0.0199835684716393
CESC ENSG00000258749 RP11-688G15.3 path:05218_1 Melanoma 63 -3.4792121008745 0.00105921735600022 0.0401443377924084
CESC ENSG00000258749 RP11-688G15.3 path:05222_63 Small cell lung cancer 6 -6.32875822818816 3.11627491995206e-08 5.90534097330916e-06
CESC ENSG00000258749 RP11-688G15.3 path:05231_46 Choline metabolism in cancer 24 -3.44725834743534 0.00104044835502111 0.0401443377924084
CESC ENSG00000250971 RP11-696F12.1 path:00071_3 Fatty acid degradation 24 -4.0050406095701 9.2622497228382e-05 0.0188982288964326
CESC ENSG00000250971 RP11-696F12.1 path:00120_4 Primary bile acid biosynthesis 5 -3.89646758596671 0.000137275270434135 0.0188982288964326
CESC ENSG00000250971 RP11-696F12.1 path:00280_36 Valine, leucine and isoleucine degradation 21 -3.36478289363856 0.000928455727685789 0.0479315269417788
CESC ENSG00000250971 RP11-696F12.1 path:00650_11 Butanoate metabolism 6 -3.67959626244465 0.000307028730675982 0.026313678832767
CESC ENSG00000250971 RP11-696F12.1 path:00830_44 Retinol metabolism 8 -4.91576886564569 1.91330089528597e-06 0.000790193269753104
CESC ENSG00000250971 RP11-696F12.1 path:00980_127 Metabolism of xenobiotics by cytochrome P450 3 -3.51218359727048 0.00056943526287993 0.0390474692816042
CESC ENSG00000250971 RP11-696F12.1 path:04151_194 PI3K-Akt signaling pathway 41 -3.46260249177689 0.000661821513247528 0.0390474692816042
CESC ENSG00000250971 RP11-696F12.1 path:04932_97 Non-alcoholic fatty liver disease (NAFLD) 6 -3.67380504377377 0.000318567540348269 0.026313678832767
CESC ENSG00000242545 RP11-719N22.2 path:00051_30 Fructose and mannose metabolism 6 -3.34541158790257 0.000992732327146321 0.0157691711965935
CESC ENSG00000242545 RP11-719N22.2 path:00071_14 Fatty acid degradation 15 -4.16255952390921 4.78856288481799e-05 0.00203694364496797
CESC ENSG00000242545 RP11-719N22.2 path:00100_21 Steroid biosynthesis 2 3.03946238834622 0.00288716480585963 0.0305743349953853
CESC ENSG00000242545 RP11-719N22.2 path:00140_36 Steroid hormone biosynthesis 6 2.74357627599978 0.00690738510540293 0.0491853456643347
CESC ENSG00000242545 RP11-719N22.2 path:00270_57 Cysteine and methionine metabolism 7 -3.29998968685271 0.00115990733421158 0.0171086331796209
CESC ENSG00000242545 RP11-719N22.2 path:00330_29 Arginine and proline metabolism 26 -3.57795238586914 0.000450562353729396 0.00930411260451202
CESC ENSG00000242545 RP11-719N22.2 path:00340_11 Histidine metabolism 10 -4.28165785306819 2.95350867112365e-05 0.00203299846862344
CESC ENSG00000242545 RP11-719N22.2 path:00520_36 Amino sugar and nucleotide sugar metabolism 6 -3.34541158790257 0.000992732327146321 0.0157691711965935
CESC ENSG00000242545 RP11-719N22.2 path:00524_1 Butirosin and neomycin biosynthesis 4 2.96360628406625 0.00358216747075846 0.0352246467957916
CESC ENSG00000242545 RP11-719N22.2 path:00531_2 Glycosaminoglycan degradation 4 -3.33590514814314 0.00104310785464516 0.0159556868136463
CESC ENSG00000242545 RP11-719N22.2 path:00604_1 Glycosphingolipid biosynthesis - ganglio series 9 -3.6757363391747 0.000308894911506596 0.00824595913594703
CESC ENSG00000242545 RP11-719N22.2 path:00620_33 Pyruvate metabolism 16 -2.74196571207832 0.00669470752651882 0.0491853456643347
CESC ENSG00000242545 RP11-719N22.2 path:00640_31 Propanoate metabolism 3 -3.37035969232366 0.000911156268699381 0.0157691711965935
CESC ENSG00000242545 RP11-719N22.2 path:04010_72 MAPK signaling pathway 34 3.10820084909273 0.00234800131921699 0.0269367929121283
CESC ENSG00000242545 RP11-719N22.2 path:04015_221 Rap1 signaling pathway 4 -3.66075044476277 0.00033942204675811 0.00824595913594703
CESC ENSG00000242545 RP11-719N22.2 path:04022_67 cGMP-PKG signaling pathway 27 -2.78414202243604 0.00602693559099054 0.0483747469007671
CESC ENSG00000242545 RP11-719N22.2 path:04066_1 HIF-1 signaling pathway 96 -2.78354223077143 0.00593598116124543 0.0483747469007671
CESC ENSG00000242545 RP11-719N22.2 path:04068_70 FoxO signaling pathway 3 2.85916012838525 0.00540718123255444 0.0475141670009571
CESC ENSG00000242545 RP11-719N22.2 path:04071_34 Sphingolipid signaling pathway 48 -3.66330159464154 0.000332967994104952 0.00824595913594703
CESC ENSG00000242545 RP11-719N22.2 path:04150_25 mTOR signaling pathway 35 -2.78908798419898 0.00582926676177531 0.0483747469007671
CESC ENSG00000242545 RP11-719N22.2 path:04152_66 AMPK signaling pathway 9 -2.7728668755804 0.0061636390685945 0.0483747469007671
CESC ENSG00000242545 RP11-719N22.2 path:04260_2 Cardiac muscle contraction 11 -3.24510199651366 0.00138961721950323 0.0191303970551611
CESC ENSG00000242545 RP11-719N22.2 path:04310_51 Wnt signaling pathway 52 -4.18800744723909 4.42110748216045e-05 0.00203694364496797
CESC ENSG00000242545 RP11-719N22.2 path:04330_18 Notch signaling pathway 33 2.74697141107655 0.00683719241211069 0.0491853456643347
CESC ENSG00000242545 RP11-719N22.2 path:04350_30 TGF-beta signaling pathway 24 -3.14190557644935 0.00197423004549607 0.0239810884938199
CESC ENSG00000242545 RP11-719N22.2 path:04360_168 Axon guidance 3 -4.18023458971711 4.88766678277284e-05 0.00203694364496797
CESC ENSG00000242545 RP11-719N22.2 path:04520_33 Adherens junction 38 -3.72466163058428 0.000261686037891977 0.00811616948593486
CESC ENSG00000242545 RP11-719N22.2 path:04520_61 Adherens junction 15 3.0575335027244 0.00270950684990346 0.0294480612897403
CESC ENSG00000242545 RP11-719N22.2 path:04520_77 Adherens junction 5 4.44348058657213 1.75446024160183e-05 0.00181148019945388
CESC ENSG00000242545 RP11-719N22.2 path:04610_16 Complement and coagulation cascades 58 -3.0557359470428 0.00257162800819435 0.0287049288482234
CESC ENSG00000242545 RP11-719N22.2 path:04611_105 Platelet activation 27 -3.55408986603925 0.000496770470186989 0.00976981924701079
CESC ENSG00000242545 RP11-719N22.2 path:04620_88 Toll-like receptor signaling pathway 12 -2.80623251354755 0.00559322468216496 0.048125037369461
CESC ENSG00000242545 RP11-719N22.2 path:04660_50 T cell receptor signaling pathway 35 -3.19623406319623 0.00167193035751636 0.0215783511766955
CESC ENSG00000242545 RP11-719N22.2 path:04662_67 B cell receptor signaling pathway 10 -2.84461481211269 0.00498598718380218 0.0466003766416426
CESC ENSG00000242545 RP11-719N22.2 path:04722_146 Neurotrophin signaling pathway 6 2.7573762569468 0.00660110305854639 0.0491853456643347
CESC ENSG00000242545 RP11-719N22.2 path:04723_13 Retrograde endocannabinoid signaling 31 3.72906493183134 0.000269045847498087 0.00811616948593486
CESC ENSG00000242545 RP11-719N22.2 path:04723_35 Retrograde endocannabinoid signaling 16 -3.12973556408891 0.00205672071610135 0.0242693044499959
CESC ENSG00000242545 RP11-719N22.2 path:04725_106 Cholinergic synapse 12 -3.59083929833944 0.000420417012171994 0.00913853821194912
CESC ENSG00000242545 RP11-719N22.2 path:04725_51 Cholinergic synapse 41 -3.29251392710253 0.00120741550315519 0.0171952621656239
CESC ENSG00000242545 RP11-719N22.2 path:04810_179 Regulation of actin cytoskeleton 23 -2.84206703755991 0.00507752287862934 0.0466003766416426
CESC ENSG00000242545 RP11-719N22.2 path:04921_137 Oxytocin signaling pathway 16 -3.22955613316475 0.00149744023808247 0.0199497683331632
CESC ENSG00000242545 RP11-719N22.2 path:04921_44 Oxytocin signaling pathway 82 -2.95710935329771 0.00350885159230205 0.0352246467957916
CESC ENSG00000242545 RP11-719N22.2 path:04960_1 Aldosterone-regulated sodium reabsorption 29 2.74695093046334 0.00667198766981431 0.0491853456643347
CESC ENSG00000242545 RP11-719N22.2 path:05030_43 Cocaine addiction 8 -5.80397549861488 2.69357625220166e-08 3.70815664053095e-06
CESC ENSG00000242545 RP11-719N22.2 path:05100_8 Bacterial invasion of epithelial cells 48 -2.87554225182397 0.00457441030825505 0.0439356152862636
CESC ENSG00000242545 RP11-719N22.2 path:05110_3 Vibrio cholerae infection 7 -3.6071288512545 0.000409876458612839 0.00913853821194912
CESC ENSG00000242545 RP11-719N22.2 path:05132_1 Salmonella infection 42 -3.37988325214859 0.000898266894725888 0.0157691711965935
CESC ENSG00000242545 RP11-719N22.2 path:05160_47 Hepatitis C 3 2.85916012838525 0.00540718123255444 0.0475141670009571
CESC ENSG00000242545 RP11-719N22.2 path:05205_111 Proteoglycans in cancer 42 -3.35938721688621 0.000945795482013888 0.0157691711965935
CESC ENSG00000242545 RP11-719N22.2 path:05210_4 Colorectal cancer 34 -4.35182327992658 2.27608411731389e-05 0.00188004548090127
CESC ENSG00000242545 RP11-719N22.2 path:05210_46 Colorectal cancer 4 -4.1672849191542 4.93206693696845e-05 0.00203694364496797
CESC ENSG00000242545 RP11-719N22.2 path:05216_11 Thyroid cancer 5 -2.96863425521112 0.00338551865709216 0.0349554801344765
CESC ENSG00000242545 RP11-719N22.2 path:05221_1 Acute myeloid leukemia 54 3.88398930861748 0.000149357883443967 0.00560770962385075
CESC ENSG00000242545 RP11-719N22.2 path:05410_10 Hypertrophic cardiomyopathy (HCM) 3 -6.13952125333161 5.50838793168987e-09 1.13748210789396e-06
CESC ENSG00000242545 RP11-719N22.2 path:05410_9 Hypertrophic cardiomyopathy (HCM) 8 -3.176988907218 0.00178033309302991 0.0222811384067076
CESC ENSG00000242545 RP11-719N22.2 path:05414_12 Dilated cardiomyopathy 21 -2.77258698921082 0.00620789730203549 0.0483747469007671
CESC ENSG00000242545 RP11-719N22.2 path:05414_27 Dilated cardiomyopathy 3 -6.13952125333161 5.50838793168987e-09 1.13748210789396e-06
CESC ENSG00000242545 RP11-719N22.2 path:05416_1 Viral myocarditis 5 -3.71758989641219 0.000275124389353724 0.00811616948593486
CESC ENSG00000258630 RP11-725G5.2 path:04144_32 Endocytosis 8 -3.8120411613074 0.00027465296025793 0.0140416325931867
CESC ENSG00000258630 RP11-725G5.2 path:04666_232 Fc gamma R-mediated phagocytosis 8 -5.93206723888842 3.90772055029302e-07 5.32752568356615e-05
CESC ENSG00000258630 RP11-725G5.2 path:04750_88 Inflammatory mediator regulation of TRP channels 5 -4.37576741008785 3.98693083245436e-05 0.00326130942094767
CESC ENSG00000258630 RP11-725G5.2 path:04810_134 Regulation of actin cytoskeleton 31 -3.92225757003324 0.000226955894199594 0.0132607086753763
CESC ENSG00000258630 RP11-725G5.2 path:04932_103 Non-alcoholic fatty liver disease (NAFLD) 4 -7.63219113822838 2.61083960396887e-10 5.33916699011635e-08
CESC ENSG00000258630 RP11-725G5.2 path:05206_136 MicroRNAs in cancer 2 -7.6192948454595 7.64545406442571e-11 3.12699071235011e-08
CESC ENSG00000258630 RP11-725G5.2 path:05206_97 MicroRNAs in cancer 26 -4.17580752031433 8.56420162379312e-05 0.00583793077355231
CESC ENSG00000258630 RP11-725G5.2 path:05222_63 Small cell lung cancer 6 -5.02599323818842 6.28076073558987e-06 0.000642207785214064
CESC ENSG00000260555 RP11-728K20.2 path:00250_31 Alanine, aspartate and glutamate metabolism 10 -4.00305602273776 8.98468021200511e-05 0.0345910188162197
CESC ENSG00000273011 RP11-728K20.3 path:00250_31 Alanine, aspartate and glutamate metabolism 10 -4.00305602273776 8.98468021200511e-05 0.0345910188162197
CESC ENSG00000260008 RP11-732A21.2 path:00010_104 Glycolysis / Gluconeogenesis 4 2.99918727938516 0.00399775518163518 0.0352529320562375
CESC ENSG00000260008 RP11-732A21.2 path:00010_75 Glycolysis / Gluconeogenesis 12 -3.34870410226996 0.0013475989150937 0.0209147351622542
CESC ENSG00000260008 RP11-732A21.2 path:00010_92 Glycolysis / Gluconeogenesis 7 -3.62491984085262 0.000455439979721518 0.0135931317024576
CESC ENSG00000260008 RP11-732A21.2 path:00020_1 Citrate cycle (TCA cycle) 26 -3.21722257129339 0.00198822709549298 0.0249902876618145
CESC ENSG00000260008 RP11-732A21.2 path:00071_3 Fatty acid degradation 24 -4.6158717784903 1.40131896925447e-05 0.00181237253356912
CESC ENSG00000260008 RP11-732A21.2 path:00120_1 Primary bile acid biosynthesis 9 -2.74558131321597 0.00813281179229976 0.0464962450108103
CESC ENSG00000260008 RP11-732A21.2 path:00250_1 Alanine, aspartate and glutamate metabolism 27 -3.03524141317439 0.00343629288315464 0.0319971602485026
CESC ENSG00000260008 RP11-732A21.2 path:00280_39 Valine, leucine and isoleucine degradation 20 -4.0644663878075 0.000111599241535733 0.00618578653083777
CESC ENSG00000260008 RP11-732A21.2 path:00330_64 Arginine and proline metabolism 16 -2.70232147343423 0.00873432281842908 0.0491147428050795
CESC ENSG00000260008 RP11-732A21.2 path:00340_3 Histidine metabolism 14 -3.14543731131038 0.00237683509670098 0.0263489147862852
CESC ENSG00000260008 RP11-732A21.2 path:00410_21 beta-Alanine metabolism 5 -3.52463006015934 0.000740693242536035 0.016577616914621
CESC ENSG00000260008 RP11-732A21.2 path:00512_24 Mucin type O-Glycan biosynthesis 4 -2.74526623310117 0.00683543809886892 0.0447897432283553
CESC ENSG00000260008 RP11-732A21.2 path:00534_1 Glycosaminoglycan biosynthesis - heparan sulfate / heparin 4 3.12600934221785 0.00330791696811558 0.0319971602485026
CESC ENSG00000260008 RP11-732A21.2 path:00592_2 alpha-Linolenic acid metabolism 11 -3.32425812270368 0.00118711443317746 0.0191916833363689
CESC ENSG00000260008 RP11-732A21.2 path:00640_13 Propanoate metabolism 14 -4.05613195515034 0.00014057642943914 0.00681795682779829
CESC ENSG00000260008 RP11-732A21.2 path:00670_15 One carbon pool by folate 2 -3.91600604420862 0.000240058854869448 0.00931428356893456
CESC ENSG00000260008 RP11-732A21.2 path:00760_1 Nicotinate and nicotinamide metabolism 20 3.49448883151211 0.000964783129454523 0.0170152661012889
CESC ENSG00000260008 RP11-732A21.2 path:00830_3 Retinol metabolism 28 -3.60094302960021 0.00045422574047734 0.0135931317024576
CESC ENSG00000260008 RP11-732A21.2 path:00920_1 Sulfur metabolism 5 -2.80324079090701 0.00612233439196292 0.0439901063718817
CESC ENSG00000260008 RP11-732A21.2 path:00983_7 Drug metabolism - other enzymes 9 3.51565104508434 0.000893226670511402 0.016577616914621
CESC ENSG00000260008 RP11-732A21.2 path:04014_194 Ras signaling pathway 5 4.05496480737756 0.000208754040972636 0.00899961865526475
CESC ENSG00000260008 RP11-732A21.2 path:04015_130 Rap1 signaling pathway 19 -3.36891843063108 0.0011573160885101 0.0191916833363689
CESC ENSG00000260008 RP11-732A21.2 path:04020_127 Calcium signaling pathway 32 -3.0626280029813 0.00259454233652205 0.0264916428044883
CESC ENSG00000260008 RP11-732A21.2 path:04022_2 cGMP-PKG signaling pathway 143 -3.53425487262058 0.000897242152595467 0.016577616914621
CESC ENSG00000260008 RP11-732A21.2 path:04024_11 cAMP signaling pathway 155 -4.48429204410702 3.19633044945998e-05 0.00310044053597618
CESC ENSG00000260008 RP11-732A21.2 path:04024_141 cAMP signaling pathway 16 -2.8190114626859 0.00668698682387751 0.0447897432283553
CESC ENSG00000260008 RP11-732A21.2 path:04060_21 Cytokine-cytokine receptor interaction 5 3.01173036030424 0.00433052455960513 0.0361158416104885
CESC ENSG00000260008 RP11-732A21.2 path:04062_153 Chemokine signaling pathway 32 4.26353639671475 9.67151815059519e-05 0.00618578653083777
CESC ENSG00000260008 RP11-732A21.2 path:04064_20 NF-kappa B signaling pathway 35 2.82864089394543 0.00775084636254357 0.0462665905948755
CESC ENSG00000260008 RP11-732A21.2 path:04064_51 NF-kappa B signaling pathway 15 3.6233912721054 0.000851196032661579 0.016577616914621
CESC ENSG00000260008 RP11-732A21.2 path:04064_52 NF-kappa B signaling pathway 15 3.25048468223735 0.00226472001708705 0.0258444519596993
CESC ENSG00000260008 RP11-732A21.2 path:04071_118 Sphingolipid signaling pathway 6 2.85313708315863 0.00576596180855126 0.0422111921078847
CESC ENSG00000260008 RP11-732A21.2 path:04150_50 mTOR signaling pathway 7 -3.00676758061191 0.00346361012999255 0.0319971602485026
CESC ENSG00000260008 RP11-732A21.2 path:04151_176 PI3K-Akt signaling pathway 45 -3.15706823441739 0.00251410470698391 0.0264916428044883
CESC ENSG00000260008 RP11-732A21.2 path:04152_12 AMPK signaling pathway 73 -3.48464543554009 0.000817640534353912 0.016577616914621
CESC ENSG00000260008 RP11-732A21.2 path:04152_66 AMPK signaling pathway 9 -5.71250230891073 1.22827944897034e-07 4.76572426200493e-05
CESC ENSG00000260008 RP11-732A21.2 path:04261_1 Adrenergic signaling in cardiomyocytes 130 -3.55266733119794 0.000774500043620032 0.016577616914621
CESC ENSG00000260008 RP11-732A21.2 path:04270_1 Vascular smooth muscle contraction 96 -3.43179980384903 0.000828375461285425 0.016577616914621
CESC ENSG00000260008 RP11-732A21.2 path:04514_32 Cell adhesion molecules (CAMs) 2 2.80718529044202 0.00738799888302768 0.0447897432283553
CESC ENSG00000260008 RP11-732A21.2 path:04520_73 Adherens junction 7 -2.7901274047883 0.00659121219593539 0.0447897432283553
CESC ENSG00000260008 RP11-732A21.2 path:04611_212 Platelet activation 9 -2.73797817079094 0.00814882644519356 0.0464962450108103
CESC ENSG00000260008 RP11-732A21.2 path:04621_42 NOD-like receptor signaling pathway 12 3.39170533672102 0.00181041560818901 0.0249902876618145
CESC ENSG00000260008 RP11-732A21.2 path:04672_6 Intestinal immune network for IgA production 2 2.80718529044202 0.00738799888302768 0.0447897432283553
CESC ENSG00000260008 RP11-732A21.2 path:04713_7 Circadian entrainment 81 -2.91598604862996 0.00491200153853153 0.0381171319390047
CESC ENSG00000260008 RP11-732A21.2 path:04725_106 Cholinergic synapse 12 -3.23835876042451 0.00193399470547641 0.0249902876618145
CESC ENSG00000260008 RP11-732A21.2 path:04728_2 Dopaminergic synapse 119 -3.21041133191234 0.00207770963940772 0.0251922293778186
CESC ENSG00000260008 RP11-732A21.2 path:04750_17 Inflammatory mediator regulation of TRP channels 58 -3.01607158337748 0.00374261259007247 0.0337705508127469
CESC ENSG00000260008 RP11-732A21.2 path:04911_1 Insulin secretion 54 -2.94311219680937 0.00420440531960966 0.0361158416104885
CESC ENSG00000260008 RP11-732A21.2 path:04913_24 Ovarian steroidogenesis 2 -4.14267238143926 5.87536444499288e-05 0.00455928280931447
CESC ENSG00000260008 RP11-732A21.2 path:04916_7 Melanogenesis 64 -3.70481633929219 0.000367688642112954 0.0129693811945296
CESC ENSG00000260008 RP11-732A21.2 path:04918_1 Thyroid hormone synthesis 44 -3.10262284541724 0.00256545550423336 0.0264916428044883
CESC ENSG00000260008 RP11-732A21.2 path:04921_99 Oxytocin signaling pathway 40 -3.17560136799188 0.00221377563376718 0.0258444519596993
CESC ENSG00000260008 RP11-732A21.2 path:04932_104 Non-alcoholic fatty liver disease (NAFLD) 4 -2.85105386783704 0.00513216155750601 0.0382938208521602
CESC ENSG00000260008 RP11-732A21.2 path:04932_7 Non-alcoholic fatty liver disease (NAFLD) 58 -2.96115087169556 0.00467178933394023 0.0373182055610748
CESC ENSG00000260008 RP11-732A21.2 path:04961_1 Endocrine and other factor-regulated calcium reabsorption 33 -5.12769873615529 2.50944847413662e-06 0.000486833003982505
CESC ENSG00000260008 RP11-732A21.2 path:04973_1 Carbohydrate digestion and absorption 12 -3.53743505934081 0.00074696871406727 0.016577616914621
CESC ENSG00000260008 RP11-732A21.2 path:05016_6 Huntington's disease 5 -3.26174172034747 0.00170227010839663 0.0244622519280701
CESC ENSG00000260008 RP11-732A21.2 path:05030_44 Cocaine addiction 8 -2.9299091494566 0.00437485710230144 0.0361158416104885
CESC ENSG00000260008 RP11-732A21.2 path:05031_2 Amphetamine addiction 38 -2.9440655460174 0.00471286616621821 0.0373182055610748
CESC ENSG00000260008 RP11-732A21.2 path:05133_14 Pertussis 7 3.37538110743259 0.00167611566413576 0.0244622519280701
CESC ENSG00000260008 RP11-732A21.2 path:05134_11 Legionellosis 7 3.13702939927786 0.00326111741735622 0.0319971602485026
CESC ENSG00000260008 RP11-732A21.2 path:05160_1 Hepatitis C 47 2.77126132862379 0.00810123472863041 0.0464962450108103
CESC ENSG00000260008 RP11-732A21.2 path:05164_41 Influenza A 6 3.32323647462873 0.00199664669462951 0.0249902876618145
CESC ENSG00000260008 RP11-732A21.2 path:05222_12 Small cell lung cancer 56 2.98536443480688 0.00509413202872575 0.0382938208521602
CESC ENSG00000260008 RP11-732A21.2 path:05310_1 Asthma 2 2.80718529044202 0.00738799888302768 0.0447897432283553
CESC ENSG00000260008 RP11-732A21.2 path:05320_3 Autoimmune thyroid disease 2 2.80718529044202 0.00738799888302768 0.0447897432283553
CESC ENSG00000260008 RP11-732A21.2 path:05322_4 Systemic lupus erythematosus 2 2.80718529044202 0.00738799888302768 0.0447897432283553
CESC ENSG00000260008 RP11-732A21.2 path:05330_3 Allograft rejection 2 2.80718529044202 0.00738799888302768 0.0447897432283553
CESC ENSG00000260008 RP11-732A21.2 path:05416_6 Viral myocarditis 2 2.80718529044202 0.00738799888302768 0.0447897432283553
CESC ENSG00000259444 RP11-736N17.8 path:04014_136 Ras signaling pathway 15 -3.56275251658194 0.000827209242788163 0.0348347003351904
CESC ENSG00000259444 RP11-736N17.8 path:04151_285 PI3K-Akt signaling pathway 16 -3.67558898141013 0.000394184204421611 0.0248993022459651
CESC ENSG00000259444 RP11-736N17.8 path:04360_117 Axon guidance 15 -4.00931509832394 0.000200283268993397 0.0151814717896995
CESC ENSG00000259444 RP11-736N17.8 path:04512_73 ECM-receptor interaction 11 -3.51548076622067 0.000716598834260619 0.0339488697730968
CESC ENSG00000259444 RP11-736N17.8 path:04662_72 B cell receptor signaling pathway 8 -4.32651156209582 6.96500888680659e-05 0.00745004463869429
CESC ENSG00000259444 RP11-736N17.8 path:04810_134 Regulation of actin cytoskeleton 31 -4.2043558540194 7.86284394585149e-05 0.00745004463869429
CESC ENSG00000259444 RP11-736N17.8 path:04915_139 Estrogen signaling pathway 4 -8.7302243647037 1.43439292186618e-12 5.43634917387284e-10
CESC ENSG00000259444 RP11-736N17.8 path:05214_1 Glioma 51 -3.61327842189849 0.000594190697243503 0.0321711820364697
CESC ENSG00000259444 RP11-736N17.8 path:05222_63 Small cell lung cancer 6 -6.47987205940697 1.35326603474504e-08 2.56443913584185e-06
CESC ENSG00000259444 RP11-736N17.8 path:05231_46 Choline metabolism in cancer 24 -3.43054481651577 0.00106049036922131 0.0401925849934876
CESC ENSG00000269910 RP11-73M18.10 path:04062_169 Chemokine signaling pathway 27 -3.74561305149265 0.000495875610085168 0.0453726183227929
CESC ENSG00000269910 RP11-73M18.10 path:04660_129 T cell receptor signaling pathway 9 -4.90396950750985 9.12818145798239e-06 0.00167045720681078
CESC ENSG00000269910 RP11-73M18.10 path:04670_142 Leukocyte transendothelial migration 6 -4.05512953712353 0.000153688356290849 0.0187499794674836
CESC ENSG00000269910 RP11-73M18.10 path:04915_139 Estrogen signaling pathway 4 -8.44510106866434 7.09316234329053e-12 2.59609741764434e-09
CESC ENSG00000270108 RP11-73M18.6 path:04062_169 Chemokine signaling pathway 27 -3.74561305149265 0.000495875610085168 0.0453726183227929
CESC ENSG00000270108 RP11-73M18.6 path:04660_129 T cell receptor signaling pathway 9 -4.90396950750985 9.12818145798239e-06 0.00167045720681078
CESC ENSG00000270108 RP11-73M18.6 path:04670_142 Leukocyte transendothelial migration 6 -4.05512953712353 0.000153688356290849 0.0187499794674836
CESC ENSG00000270108 RP11-73M18.6 path:04915_139 Estrogen signaling pathway 4 -8.44510106866434 7.09316234329053e-12 2.59609741764434e-09
CESC ENSG00000269940 RP11-73M18.7 path:04062_169 Chemokine signaling pathway 27 -3.74561305149265 0.000495875610085168 0.0453726183227929
CESC ENSG00000269940 RP11-73M18.7 path:04660_129 T cell receptor signaling pathway 9 -4.90396950750985 9.12818145798239e-06 0.00167045720681078
CESC ENSG00000269940 RP11-73M18.7 path:04670_142 Leukocyte transendothelial migration 6 -4.05512953712353 0.000153688356290849 0.0187499794674836
CESC ENSG00000269940 RP11-73M18.7 path:04915_139 Estrogen signaling pathway 4 -8.44510106866434 7.09316234329053e-12 2.59609741764434e-09
CESC ENSG00000269958 RP11-73M18.8 path:04062_169 Chemokine signaling pathway 27 -3.74561305149265 0.000495875610085168 0.0453726183227929
CESC ENSG00000269958 RP11-73M18.8 path:04660_129 T cell receptor signaling pathway 9 -4.90396950750985 9.12818145798239e-06 0.00167045720681078
CESC ENSG00000269958 RP11-73M18.8 path:04670_142 Leukocyte transendothelial migration 6 -4.05512953712353 0.000153688356290849 0.0187499794674836
CESC ENSG00000269958 RP11-73M18.8 path:04915_139 Estrogen signaling pathway 4 -8.44510106866434 7.09316234329053e-12 2.59609741764434e-09
CESC ENSG00000260711 RP11-747H7.3 path:04810_134 Regulation of actin cytoskeleton 31 -3.92225757003324 0.000226955894199594 0.0415329286385257
CESC ENSG00000260711 RP11-747H7.3 path:05222_63 Small cell lung cancer 6 -5.02599323818842 6.28076073558987e-06 0.00229875842922589
CESC ENSG00000197176 RP11-76E12.1 path:04144_32 Endocytosis 8 -3.9416060644509 0.00016747324200157 0.0158680896796488
CESC ENSG00000197176 RP11-76E12.1 path:04151_285 PI3K-Akt signaling pathway 16 -3.68988847823218 0.000384569068678518 0.0291503354058317
CESC ENSG00000197176 RP11-76E12.1 path:04810_134 Regulation of actin cytoskeleton 31 -4.10940181072005 0.000114497782985166 0.0144648865837927
CESC ENSG00000197176 RP11-76E12.1 path:04915_139 Estrogen signaling pathway 4 -7.78794033048715 9.63396136733793e-11 3.65127135822107e-08
CESC ENSG00000197176 RP11-76E12.1 path:05222_63 Small cell lung cancer 6 -5.17171115844146 3.3015761474502e-06 0.000625648679941813
CESC ENSG00000255143 RP11-805J14.3 path:00250_1 Alanine, aspartate and glutamate metabolism 27 -5.24332559656715 2.12327254848793e-06 0.000429962691068805
CESC ENSG00000255143 RP11-805J14.3 path:00330_2 Arginine and proline metabolism 49 -4.86460130322601 9.98024781664144e-06 0.00134733345524659
CESC ENSG00000255143 RP11-805J14.3 path:00910_1 Nitrogen metabolism 4 -5.81283470693019 5.90529514003344e-08 2.39164453171354e-05
CESC ENSG00000255143 RP11-805J14.3 path:04015_204 Rap1 signaling pathway 6 -3.77032186114971 0.000275505321869178 0.0185966092261695
CESC ENSG00000255143 RP11-805J14.3 path:04152_66 AMPK signaling pathway 9 -4.32385012170038 7.22670823416972e-05 0.00731704208709684
CESC ENSG00000255143 RP11-805J14.3 path:04530_89 Tight junction 39 -3.61133325804688 0.000767392474427052 0.0345326613492173
CESC ENSG00000255143 RP11-805J14.3 path:04662_68 B cell receptor signaling pathway 9 -3.75198858769731 0.000591851191230892 0.0299624665560639
CESC ENSG00000255143 RP11-805J14.3 path:04920_78 Adipocytokine signaling pathway 4 -3.78767242757758 0.000461015790334286 0.0266730564407694
CESC ENSG00000255143 RP11-805J14.3 path:04973_1 Carbohydrate digestion and absorption 12 -4.27956312704729 9.58718248016551e-05 0.00776561780893406
CESC ENSG00000254721 RP11-805J14.5 path:00250_1 Alanine, aspartate and glutamate metabolism 27 -5.24332559656715 2.12327254848793e-06 0.000429962691068805
CESC ENSG00000254721 RP11-805J14.5 path:00330_2 Arginine and proline metabolism 49 -4.86460130322601 9.98024781664144e-06 0.00134733345524659
CESC ENSG00000254721 RP11-805J14.5 path:00910_1 Nitrogen metabolism 4 -5.81283470693019 5.90529514003344e-08 2.39164453171354e-05
CESC ENSG00000254721 RP11-805J14.5 path:04015_204 Rap1 signaling pathway 6 -3.77032186114971 0.000275505321869178 0.0185966092261695
CESC ENSG00000254721 RP11-805J14.5 path:04152_66 AMPK signaling pathway 9 -4.32385012170038 7.22670823416972e-05 0.00731704208709684
CESC ENSG00000254721 RP11-805J14.5 path:04530_89 Tight junction 39 -3.61133325804688 0.000767392474427052 0.0345326613492173
CESC ENSG00000254721 RP11-805J14.5 path:04662_68 B cell receptor signaling pathway 9 -3.75198858769731 0.000591851191230892 0.0299624665560639
CESC ENSG00000254721 RP11-805J14.5 path:04920_78 Adipocytokine signaling pathway 4 -3.78767242757758 0.000461015790334286 0.0266730564407694
CESC ENSG00000254721 RP11-805J14.5 path:04973_1 Carbohydrate digestion and absorption 12 -4.27956312704729 9.58718248016551e-05 0.00776561780893406
CESC ENSG00000241326 RP11-807G9.2 path:00330_108 Arginine and proline metabolism 2 -4.06764012763149 0.000117339271518361 0.0336867836462151
CESC ENSG00000241326 RP11-807G9.2 path:04725_51 Cholinergic synapse 41 -3.97617981701704 0.000163528075952501 0.0336867836462151
CESC ENSG00000269889 RP11-816J6.3 path:00071_14 Fatty acid degradation 15 -3.41009789218762 0.0012885420823183 0.0370916042267339
CESC ENSG00000269889 RP11-816J6.3 path:00100_15 Steroid biosynthesis 9 4.20429704732536 5.44590945700872e-05 0.00365783585195752
CESC ENSG00000269889 RP11-816J6.3 path:00140_23 Steroid hormone biosynthesis 10 3.38508815748897 0.000888999108157138 0.0298555533822772
CESC ENSG00000269889 RP11-816J6.3 path:00980_121 Metabolism of xenobiotics by cytochrome P450 4 3.95651764919754 0.00011606920459113 0.00656032797741703
CESC ENSG00000269889 RP11-816J6.3 path:00980_73 Metabolism of xenobiotics by cytochrome P450 11 3.43051127716778 0.000751341473750407 0.0275264194474013
CESC ENSG00000269889 RP11-816J6.3 path:03460_52 Fanconi anemia pathway 3 3.96362813982066 0.000130229835779991 0.00656032797741703
CESC ENSG00000269889 RP11-816J6.3 path:04060_14 Cytokine-cytokine receptor interaction 8 4.5967318773826 7.90424909975221e-06 0.000796353096800035
CESC ENSG00000269889 RP11-816J6.3 path:04210_83 Apoptosis 5 4.76675513331163 3.77264349512409e-06 0.000506791776178336
CESC ENSG00000269889 RP11-816J6.3 path:04370_11 VEGF signaling pathway 46 4.29098436403437 5.26428372151558e-05 0.00365783585195752
CESC ENSG00000269889 RP11-816J6.3 path:04650_17 Natural killer cell mediated cytotoxicity 89 3.36567960300742 0.00100492095387095 0.0311525495699994
CESC ENSG00000269889 RP11-816J6.3 path:05162_43 Measles 5 4.76675513331163 3.77264349512409e-06 0.000506791776178336
CESC ENSG00000269889 RP11-816J6.3 path:05164_48 Influenza A 5 4.76675513331163 3.77264349512409e-06 0.000506791776178336
CESC ENSG00000269889 RP11-816J6.3 path:05220_62 Chronic myeloid leukemia 2 3.6395916917994 0.000510541787859457 0.0205915478068162
CESC ENSG00000269889 RP11-816J6.3 path:05221_7 Acute myeloid leukemia 49 3.63842077176597 0.000510956521260947 0.0205915478068162
CESC ENSG00000228150 RP11-84A14.4 path:00330_108 Arginine and proline metabolism 2 -4.06764012763149 0.000117339271518361 0.0336867836462151
CESC ENSG00000228150 RP11-84A14.4 path:04725_51 Cholinergic synapse 41 -3.97617981701704 0.000163528075952501 0.0336867836462151
CESC ENSG00000223989 RP11-84A14.5 path:00330_108 Arginine and proline metabolism 2 -4.29753215374342 4.80512856226761e-05 0.0197971296765426
CESC ENSG00000223989 RP11-84A14.5 path:04725_51 Cholinergic synapse 41 -4.04110313447155 0.000119517705236951 0.024620647278812
CESC ENSG00000258742 RP11-862G15.1 path:04144_32 Endocytosis 8 -3.8120411613074 0.00027465296025793 0.0140416325931867
CESC ENSG00000258742 RP11-862G15.1 path:04666_232 Fc gamma R-mediated phagocytosis 8 -5.93206723888842 3.90772055029302e-07 5.32752568356615e-05
CESC ENSG00000258742 RP11-862G15.1 path:04750_88 Inflammatory mediator regulation of TRP channels 5 -4.37576741008785 3.98693083245436e-05 0.00326130942094767
CESC ENSG00000258742 RP11-862G15.1 path:04810_134 Regulation of actin cytoskeleton 31 -3.92225757003324 0.000226955894199594 0.0132607086753763
CESC ENSG00000258742 RP11-862G15.1 path:04932_103 Non-alcoholic fatty liver disease (NAFLD) 4 -7.63219113822838 2.61083960396887e-10 5.33916699011635e-08
CESC ENSG00000258742 RP11-862G15.1 path:05206_136 MicroRNAs in cancer 2 -7.6192948454595 7.64545406442571e-11 3.12699071235011e-08
CESC ENSG00000258742 RP11-862G15.1 path:05206_97 MicroRNAs in cancer 26 -4.17580752031433 8.56420162379312e-05 0.00583793077355231
CESC ENSG00000258742 RP11-862G15.1 path:05222_63 Small cell lung cancer 6 -5.02599323818842 6.28076073558987e-06 0.000642207785214064
CESC ENSG00000258499 RP11-862G15.2 path:04144_32 Endocytosis 8 -3.8120411613074 0.00027465296025793 0.0140416325931867
CESC ENSG00000258499 RP11-862G15.2 path:04666_232 Fc gamma R-mediated phagocytosis 8 -5.93206723888842 3.90772055029302e-07 5.32752568356615e-05
CESC ENSG00000258499 RP11-862G15.2 path:04750_88 Inflammatory mediator regulation of TRP channels 5 -4.37576741008785 3.98693083245436e-05 0.00326130942094767
CESC ENSG00000258499 RP11-862G15.2 path:04810_134 Regulation of actin cytoskeleton 31 -3.92225757003324 0.000226955894199594 0.0132607086753763
CESC ENSG00000258499 RP11-862G15.2 path:04932_103 Non-alcoholic fatty liver disease (NAFLD) 4 -7.63219113822838 2.61083960396887e-10 5.33916699011635e-08
CESC ENSG00000258499 RP11-862G15.2 path:05206_136 MicroRNAs in cancer 2 -7.6192948454595 7.64545406442571e-11 3.12699071235011e-08
CESC ENSG00000258499 RP11-862G15.2 path:05206_97 MicroRNAs in cancer 26 -4.17580752031433 8.56420162379312e-05 0.00583793077355231
CESC ENSG00000258499 RP11-862G15.2 path:05222_63 Small cell lung cancer 6 -5.02599323818842 6.28076073558987e-06 0.000642207785214064
CESC ENSG00000254422 RP11-864G5.3 path:00010_104 Glycolysis / Gluconeogenesis 4 3.12448141658491 0.00289670856927445 0.0451403752045269
CESC ENSG00000254422 RP11-864G5.3 path:00010_75 Glycolysis / Gluconeogenesis 12 -3.21672436733098 0.00216953958517166 0.04057039024271
CESC ENSG00000254422 RP11-864G5.3 path:00010_92 Glycolysis / Gluconeogenesis 7 -3.71914963936942 0.000360371733144116 0.0164723584216732
CESC ENSG00000254422 RP11-864G5.3 path:00071_3 Fatty acid degradation 24 -4.15601950731374 9.09396749288794e-05 0.00850285960585023
CESC ENSG00000254422 RP11-864G5.3 path:00280_39 Valine, leucine and isoleucine degradation 20 -3.92261034156268 0.000209671259593916 0.0114761398416083
CESC ENSG00000254422 RP11-864G5.3 path:00340_3 Histidine metabolism 14 -3.29976995187327 0.00158063374633254 0.0369850195384407
CESC ENSG00000254422 RP11-864G5.3 path:00410_21 beta-Alanine metabolism 5 -3.21954819176145 0.00208550415437573 0.04057039024271
CESC ENSG00000254422 RP11-864G5.3 path:00512_24 Mucin type O-Glycan biosynthesis 4 -3.02366885225171 0.00302162776495839 0.0452035513637775
CESC ENSG00000254422 RP11-864G5.3 path:00592_2 alpha-Linolenic acid metabolism 11 -3.3007125983835 0.00135085586788514 0.0369850195384407
CESC ENSG00000254422 RP11-864G5.3 path:00640_9 Propanoate metabolism 16 -3.95382748079475 0.000214794061206572 0.0114761398416083
CESC ENSG00000254422 RP11-864G5.3 path:00670_15 One carbon pool by folate 2 -3.38177390572153 0.00140267821643041 0.0369850195384407
CESC ENSG00000254422 RP11-864G5.3 path:00830_3 Retinol metabolism 28 -3.64006665078574 0.000423953845330725 0.0164723584216732
CESC ENSG00000254422 RP11-864G5.3 path:00983_7 Drug metabolism - other enzymes 9 3.59116543284882 0.000796511914177574 0.0248246213252011
CESC ENSG00000254422 RP11-864G5.3 path:04024_11 cAMP signaling pathway 155 -4.019171654276 0.000186311857956546 0.0114761398416083
CESC ENSG00000254422 RP11-864G5.3 path:04064_51 NF-kappa B signaling pathway 15 3.43672731693398 0.00158224682517393 0.0369850195384407
CESC ENSG00000254422 RP11-864G5.3 path:04064_52 NF-kappa B signaling pathway 15 3.204250150851 0.00278535363821144 0.0451403752045269
CESC ENSG00000254422 RP11-864G5.3 path:04152_66 AMPK signaling pathway 9 -5.65934571725668 2.30717374000448e-07 8.62882978761675e-05
CESC ENSG00000254422 RP11-864G5.3 path:04261_1 Adrenergic signaling in cardiomyocytes 130 -3.17397719649249 0.00256700971379382 0.0444334419846954
CESC ENSG00000254422 RP11-864G5.3 path:04270_1 Vascular smooth muscle contraction 96 -3.2011595559432 0.00179625532516939 0.0395176171537265
CESC ENSG00000254422 RP11-864G5.3 path:04725_119 Cholinergic synapse 8 -3.14553907865464 0.00261373188145267 0.0444334419846954
CESC ENSG00000254422 RP11-864G5.3 path:04916_7 Melanogenesis 64 -3.21118206340576 0.00193917546790719 0.0402917569442938
CESC ENSG00000254422 RP11-864G5.3 path:04961_1 Endocrine and other factor-regulated calcium reabsorption 33 -4.8270848991008 1.00846347962973e-05 0.0018858267069076
CESC ENSG00000254422 RP11-864G5.3 path:04973_1 Carbohydrate digestion and absorption 12 -3.58522156053957 0.000695958575801908 0.0236625915772649
CESC ENSG00000254422 RP11-864G5.3 path:05152_138 Tuberculosis 7 3.84941430491874 0.00044043739095383 0.0164723584216732
CESC ENSG00000254422 RP11-864G5.3 path:05215_54 Prostate cancer 28 -4.47334939866383 2.22490819869291e-05 0.00277371888770382
CESC ENSG00000260806 RP11-872J21.3 path:04144_32 Endocytosis 8 -3.9416060644509 0.00016747324200157 0.0158680896796488
CESC ENSG00000260806 RP11-872J21.3 path:04151_285 PI3K-Akt signaling pathway 16 -3.68988847823218 0.000384569068678518 0.0291503354058317
CESC ENSG00000260806 RP11-872J21.3 path:04810_134 Regulation of actin cytoskeleton 31 -4.10940181072005 0.000114497782985166 0.0144648865837927
CESC ENSG00000260806 RP11-872J21.3 path:04915_139 Estrogen signaling pathway 4 -7.78794033048715 9.63396136733793e-11 3.65127135822107e-08
CESC ENSG00000260806 RP11-872J21.3 path:05222_63 Small cell lung cancer 6 -5.17171115844146 3.3015761474502e-06 0.000625648679941813
CESC ENSG00000262151 RP11-876N24.2 path:03460_17 Fanconi anemia pathway 35 4.20642104804768 6.72431642934148e-05 0.0241402959813359
CESC ENSG00000262151 RP11-876N24.2 path:03460_52 Fanconi anemia pathway 3 4.06287770987049 0.000209477473391044 0.0376012064736924
CESC ENSG00000262222 RP11-876N24.4 path:03460_17 Fanconi anemia pathway 35 4.20642104804768 6.72431642934148e-05 0.0241402959813359
CESC ENSG00000262222 RP11-876N24.4 path:03460_52 Fanconi anemia pathway 3 4.06287770987049 0.000209477473391044 0.0376012064736924
CESC ENSG00000263013 RP11-876N24.5 path:03460_17 Fanconi anemia pathway 35 4.20642104804768 6.72431642934148e-05 0.0241402959813359
CESC ENSG00000263013 RP11-876N24.5 path:03460_52 Fanconi anemia pathway 3 4.06287770987049 0.000209477473391044 0.0376012064736924
CESC ENSG00000246451 RP11-894P9.1 path:04062_169 Chemokine signaling pathway 27 -3.74561305149265 0.000495875610085168 0.0453726183227929
CESC ENSG00000246451 RP11-894P9.1 path:04660_129 T cell receptor signaling pathway 9 -4.90396950750985 9.12818145798239e-06 0.00167045720681078
CESC ENSG00000246451 RP11-894P9.1 path:04670_142 Leukocyte transendothelial migration 6 -4.05512953712353 0.000153688356290849 0.0187499794674836
CESC ENSG00000246451 RP11-894P9.1 path:04915_139 Estrogen signaling pathway 4 -8.44510106866434 7.09316234329053e-12 2.59609741764434e-09
CESC ENSG00000258851 RP11-894P9.2 path:04062_169 Chemokine signaling pathway 27 -3.74561305149265 0.000495875610085168 0.0453726183227929
CESC ENSG00000258851 RP11-894P9.2 path:04660_129 T cell receptor signaling pathway 9 -4.90396950750985 9.12818145798239e-06 0.00167045720681078
CESC ENSG00000258851 RP11-894P9.2 path:04670_142 Leukocyte transendothelial migration 6 -4.05512953712353 0.000153688356290849 0.0187499794674836
CESC ENSG00000258851 RP11-894P9.2 path:04915_139 Estrogen signaling pathway 4 -8.44510106866434 7.09316234329053e-12 2.59609741764434e-09
CESC ENSG00000258798 RP11-895M11.3 path:04810_134 Regulation of actin cytoskeleton 31 -3.92225757003324 0.000226955894199594 0.0415329286385257
CESC ENSG00000258798 RP11-895M11.3 path:05222_63 Small cell lung cancer 6 -5.02599323818842 6.28076073558987e-06 0.00229875842922589
CESC ENSG00000259004 RP11-8L8.2 path:04014_136 Ras signaling pathway 15 -3.35932987525971 0.00156098361951259 0.0493010659829392
CESC ENSG00000259004 RP11-8L8.2 path:04144_32 Endocytosis 8 -3.79250588125354 0.000283332788560431 0.0199835684716393
CESC ENSG00000259004 RP11-8L8.2 path:04151_285 PI3K-Akt signaling pathway 16 -3.51867875809173 0.000687822118579373 0.0325855728676978
CESC ENSG00000259004 RP11-8L8.2 path:04360_117 Axon guidance 15 -3.77222385734019 0.000440916737315015 0.0238724919203415
CESC ENSG00000259004 RP11-8L8.2 path:04512_73 ECM-receptor interaction 11 -3.33143827611793 0.00132539754573172 0.0456659699847565
CESC ENSG00000259004 RP11-8L8.2 path:04662_72 B cell receptor signaling pathway 8 -4.02041495091434 0.000187310299886989 0.0177476509142922
CESC ENSG00000259004 RP11-8L8.2 path:04810_134 Regulation of actin cytoskeleton 31 -4.00229285571665 0.000165924471229925 0.0177476509142922
CESC ENSG00000259004 RP11-8L8.2 path:04915_139 Estrogen signaling pathway 4 -8.41406486530196 5.72672287895484e-12 2.17042797112388e-09
CESC ENSG00000259004 RP11-8L8.2 path:05214_1 Glioma 51 -3.8161134249716 0.000316362561556295 0.0199835684716393
CESC ENSG00000259004 RP11-8L8.2 path:05218_1 Melanoma 63 -3.4792121008745 0.00105921735600022 0.0401443377924084
CESC ENSG00000259004 RP11-8L8.2 path:05222_63 Small cell lung cancer 6 -6.32875822818816 3.11627491995206e-08 5.90534097330916e-06
CESC ENSG00000259004 RP11-8L8.2 path:05231_46 Choline metabolism in cancer 24 -3.44725834743534 0.00104044835502111 0.0401443377924084
CESC ENSG00000259026 RP11-907D1.1 path:04144_32 Endocytosis 8 -3.9416060644509 0.00016747324200157 0.0158680896796488
CESC ENSG00000259026 RP11-907D1.1 path:04151_285 PI3K-Akt signaling pathway 16 -3.68988847823218 0.000384569068678518 0.0291503354058317
CESC ENSG00000259026 RP11-907D1.1 path:04810_134 Regulation of actin cytoskeleton 31 -4.10940181072005 0.000114497782985166 0.0144648865837927
CESC ENSG00000259026 RP11-907D1.1 path:04915_139 Estrogen signaling pathway 4 -7.78794033048715 9.63396136733793e-11 3.65127135822107e-08
CESC ENSG00000259026 RP11-907D1.1 path:05222_63 Small cell lung cancer 6 -5.17171115844146 3.3015761474502e-06 0.000625648679941813
CESC ENSG00000258393 RP11-907D1.2 path:04144_32 Endocytosis 8 -3.9416060644509 0.00016747324200157 0.0158680896796488
CESC ENSG00000258393 RP11-907D1.2 path:04151_285 PI3K-Akt signaling pathway 16 -3.68988847823218 0.000384569068678518 0.0291503354058317
CESC ENSG00000258393 RP11-907D1.2 path:04810_134 Regulation of actin cytoskeleton 31 -4.10940181072005 0.000114497782985166 0.0144648865837927
CESC ENSG00000258393 RP11-907D1.2 path:04915_139 Estrogen signaling pathway 4 -7.78794033048715 9.63396136733793e-11 3.65127135822107e-08
CESC ENSG00000258393 RP11-907D1.2 path:05222_63 Small cell lung cancer 6 -5.17171115844146 3.3015761474502e-06 0.000625648679941813
CESC ENSG00000258430 RP11-982M15.2 path:04062_169 Chemokine signaling pathway 27 -3.74561305149265 0.000495875610085168 0.0453726183227929
CESC ENSG00000258430 RP11-982M15.2 path:04660_129 T cell receptor signaling pathway 9 -4.90396950750985 9.12818145798239e-06 0.00167045720681078
CESC ENSG00000258430 RP11-982M15.2 path:04670_142 Leukocyte transendothelial migration 6 -4.05512953712353 0.000153688356290849 0.0187499794674836
CESC ENSG00000258430 RP11-982M15.2 path:04915_139 Estrogen signaling pathway 4 -8.44510106866434 7.09316234329053e-12 2.59609741764434e-09
CESC ENSG00000258858 RP11-982M15.5 path:04062_169 Chemokine signaling pathway 27 -3.74561305149265 0.000495875610085168 0.0453726183227929
CESC ENSG00000258858 RP11-982M15.5 path:04660_129 T cell receptor signaling pathway 9 -4.90396950750985 9.12818145798239e-06 0.00167045720681078
CESC ENSG00000258858 RP11-982M15.5 path:04670_142 Leukocyte transendothelial migration 6 -4.05512953712353 0.000153688356290849 0.0187499794674836
CESC ENSG00000258858 RP11-982M15.5 path:04915_139 Estrogen signaling pathway 4 -8.44510106866434 7.09316234329053e-12 2.59609741764434e-09
CESC ENSG00000256050 RP11-982M15.6 path:04062_169 Chemokine signaling pathway 27 -3.74561305149265 0.000495875610085168 0.0453726183227929
CESC ENSG00000256050 RP11-982M15.6 path:04660_129 T cell receptor signaling pathway 9 -4.90396950750985 9.12818145798239e-06 0.00167045720681078
CESC ENSG00000256050 RP11-982M15.6 path:04670_142 Leukocyte transendothelial migration 6 -4.05512953712353 0.000153688356290849 0.0187499794674836
CESC ENSG00000256050 RP11-982M15.6 path:04915_139 Estrogen signaling pathway 4 -8.44510106866434 7.09316234329053e-12 2.59609741764434e-09
CESC ENSG00000258736 RP11-982M15.7 path:04062_169 Chemokine signaling pathway 27 -3.74561305149265 0.000495875610085168 0.0453726183227929
CESC ENSG00000258736 RP11-982M15.7 path:04660_129 T cell receptor signaling pathway 9 -4.90396950750985 9.12818145798239e-06 0.00167045720681078
CESC ENSG00000258736 RP11-982M15.7 path:04670_142 Leukocyte transendothelial migration 6 -4.05512953712353 0.000153688356290849 0.0187499794674836
CESC ENSG00000258736 RP11-982M15.7 path:04915_139 Estrogen signaling pathway 4 -8.44510106866434 7.09316234329053e-12 2.59609741764434e-09
CESC ENSG00000260792 RP11-982M15.8 path:04062_169 Chemokine signaling pathway 27 -3.74561305149265 0.000495875610085168 0.0453726183227929
CESC ENSG00000260792 RP11-982M15.8 path:04660_129 T cell receptor signaling pathway 9 -4.90396950750985 9.12818145798239e-06 0.00167045720681078
CESC ENSG00000260792 RP11-982M15.8 path:04670_142 Leukocyte transendothelial migration 6 -4.05512953712353 0.000153688356290849 0.0187499794674836
CESC ENSG00000260792 RP11-982M15.8 path:04915_139 Estrogen signaling pathway 4 -8.44510106866434 7.09316234329053e-12 2.59609741764434e-09
CESC ENSG00000258933 RP11-991C1.1 path:04144_32 Endocytosis 8 -3.8120411613074 0.00027465296025793 0.0140416325931867
CESC ENSG00000258933 RP11-991C1.1 path:04666_232 Fc gamma R-mediated phagocytosis 8 -5.93206723888842 3.90772055029302e-07 5.32752568356615e-05
CESC ENSG00000258933 RP11-991C1.1 path:04750_88 Inflammatory mediator regulation of TRP channels 5 -4.37576741008785 3.98693083245436e-05 0.00326130942094767
CESC ENSG00000258933 RP11-991C1.1 path:04810_134 Regulation of actin cytoskeleton 31 -3.92225757003324 0.000226955894199594 0.0132607086753763
CESC ENSG00000258933 RP11-991C1.1 path:04932_103 Non-alcoholic fatty liver disease (NAFLD) 4 -7.63219113822838 2.61083960396887e-10 5.33916699011635e-08
CESC ENSG00000258933 RP11-991C1.1 path:05206_136 MicroRNAs in cancer 2 -7.6192948454595 7.64545406442571e-11 3.12699071235011e-08
CESC ENSG00000258933 RP11-991C1.1 path:05206_97 MicroRNAs in cancer 26 -4.17580752031433 8.56420162379312e-05 0.00583793077355231
CESC ENSG00000258933 RP11-991C1.1 path:05222_63 Small cell lung cancer 6 -5.02599323818842 6.28076073558987e-06 0.000642207785214064
CESC ENSG00000258866 RP11-991C1.2 path:04144_32 Endocytosis 8 -3.8120411613074 0.00027465296025793 0.0140416325931867
CESC ENSG00000258866 RP11-991C1.2 path:04666_232 Fc gamma R-mediated phagocytosis 8 -5.93206723888842 3.90772055029302e-07 5.32752568356615e-05
CESC ENSG00000258866 RP11-991C1.2 path:04750_88 Inflammatory mediator regulation of TRP channels 5 -4.37576741008785 3.98693083245436e-05 0.00326130942094767
CESC ENSG00000258866 RP11-991C1.2 path:04810_134 Regulation of actin cytoskeleton 31 -3.92225757003324 0.000226955894199594 0.0132607086753763
CESC ENSG00000258866 RP11-991C1.2 path:04932_103 Non-alcoholic fatty liver disease (NAFLD) 4 -7.63219113822838 2.61083960396887e-10 5.33916699011635e-08
CESC ENSG00000258866 RP11-991C1.2 path:05206_136 MicroRNAs in cancer 2 -7.6192948454595 7.64545406442571e-11 3.12699071235011e-08
CESC ENSG00000258866 RP11-991C1.2 path:05206_97 MicroRNAs in cancer 26 -4.17580752031433 8.56420162379312e-05 0.00583793077355231
CESC ENSG00000258866 RP11-991C1.2 path:05222_63 Small cell lung cancer 6 -5.02599323818842 6.28076073558987e-06 0.000642207785214064
CESC ENSG00000235263 RP13-392I16.1 path:00330_108 Arginine and proline metabolism 2 -4.39819184364159 2.98806795895875e-05 0.00966316373428374
CESC ENSG00000235263 RP13-392I16.1 path:04725_51 Cholinergic synapse 41 -4.29869663796693 4.69085618169114e-05 0.00966316373428374
CESC ENSG00000237728 RP3-453P22.2 path:04530_214 Tight junction 2 -5.25314438100398 5.46950218487821e-06 0.00213857535428738
CESC ENSG00000237728 RP3-453P22.2 path:04666_128 Fc gamma R-mediated phagocytosis 28 -4.13232942376634 0.000255084300241558 0.0498689806972247
CESC ENSG00000234546 RP3-510D11.2 path:00330_108 Arginine and proline metabolism 2 -4.39819184364159 2.98806795895875e-05 0.00966316373428374
CESC ENSG00000234546 RP3-510D11.2 path:04725_51 Cholinergic synapse 41 -4.29869663796693 4.69085618169114e-05 0.00966316373428374
CESC ENSG00000225126 RP4-549F15.1 path:04530_214 Tight junction 2 -5.25314438100398 5.46950218487821e-06 0.00213857535428738
CESC ENSG00000225126 RP4-549F15.1 path:04666_128 Fc gamma R-mediated phagocytosis 28 -4.13232942376634 0.000255084300241558 0.0498689806972247
CESC ENSG00000240449 RP4-584D14.5 path:00250_31 Alanine, aspartate and glutamate metabolism 10 -4.00305602273776 8.98468021200511e-05 0.0345910188162197
CESC ENSG00000261305 RP4-584D14.7 path:00250_31 Alanine, aspartate and glutamate metabolism 10 -4.00305602273776 8.98468021200511e-05 0.0345910188162197
CESC ENSG00000228423 RP4-633I8.4 path:04662_38 B cell receptor signaling pathway 22 -4.23299421421007 0.000177554189028488 0.0461917819391746
CESC ENSG00000228423 RP4-633I8.4 path:05210_45 Colorectal cancer 4 -4.10866913939428 0.000239335657715931 0.0461917819391746
CESC ENSG00000273419 RP4-751H13.7 path:00250_31 Alanine, aspartate and glutamate metabolism 10 -4.00305602273776 8.98468021200511e-05 0.0345910188162197
CESC ENSG00000270114 RP5-1048B16.1 path:00250_31 Alanine, aspartate and glutamate metabolism 10 -3.99686568024612 9.2461190772425e-05 0.0355975584473836
CESC ENSG00000232912 RP5-1115A15.1 path:04662_38 B cell receptor signaling pathway 22 -4.23299421421007 0.000177554189028488 0.0461917819391746
CESC ENSG00000232912 RP5-1115A15.1 path:05210_45 Colorectal cancer 4 -4.10866913939428 0.000239335657715931 0.0461917819391746
CESC ENSG00000240373 SEC62-AS1 path:00071_14 Fatty acid degradation 15 -3.41009789218762 0.0012885420823183 0.0370916042267339
CESC ENSG00000240373 SEC62-AS1 path:00100_15 Steroid biosynthesis 9 4.20429704732536 5.44590945700872e-05 0.00365783585195752
CESC ENSG00000240373 SEC62-AS1 path:00140_23 Steroid hormone biosynthesis 10 3.38508815748897 0.000888999108157138 0.0298555533822772
CESC ENSG00000240373 SEC62-AS1 path:00980_121 Metabolism of xenobiotics by cytochrome P450 4 3.95651764919754 0.00011606920459113 0.00656032797741703
CESC ENSG00000240373 SEC62-AS1 path:00980_73 Metabolism of xenobiotics by cytochrome P450 11 3.43051127716778 0.000751341473750407 0.0275264194474013
CESC ENSG00000240373 SEC62-AS1 path:03460_52 Fanconi anemia pathway 3 3.96362813982066 0.000130229835779991 0.00656032797741703
CESC ENSG00000240373 SEC62-AS1 path:04060_14 Cytokine-cytokine receptor interaction 8 4.5967318773826 7.90424909975221e-06 0.000796353096800035
CESC ENSG00000240373 SEC62-AS1 path:04210_83 Apoptosis 5 4.76675513331163 3.77264349512409e-06 0.000506791776178336
CESC ENSG00000240373 SEC62-AS1 path:04370_11 VEGF signaling pathway 46 4.29098436403437 5.26428372151558e-05 0.00365783585195752
CESC ENSG00000240373 SEC62-AS1 path:04650_17 Natural killer cell mediated cytotoxicity 89 3.36567960300742 0.00100492095387095 0.0311525495699994
CESC ENSG00000240373 SEC62-AS1 path:05162_43 Measles 5 4.76675513331163 3.77264349512409e-06 0.000506791776178336
CESC ENSG00000240373 SEC62-AS1 path:05164_48 Influenza A 5 4.76675513331163 3.77264349512409e-06 0.000506791776178336
CESC ENSG00000240373 SEC62-AS1 path:05220_62 Chronic myeloid leukemia 2 3.6395916917994 0.000510541787859457 0.0205915478068162
CESC ENSG00000240373 SEC62-AS1 path:05221_7 Acute myeloid leukemia 49 3.63842077176597 0.000510956521260947 0.0205915478068162
CESC ENSG00000251015 SLC25A30-AS1 path:00640_31 Propanoate metabolism 3 -5.42254258714793 1.78380054193679e-07 7.11736416232781e-05
CESC ENSG00000227258 SMIM2-AS1 path:00640_31 Propanoate metabolism 3 -5.20298328672517 5.09726642875375e-07 0.000203380930507274
CESC ENSG00000235285 SMIM2-IT1 path:00640_31 Propanoate metabolism 3 -5.20298328672517 5.09726642875375e-07 0.000203380930507274
CESC ENSG00000247092 SNHG10 path:04144_32 Endocytosis 8 -3.8120411613074 0.00027465296025793 0.0140416325931867
CESC ENSG00000247092 SNHG10 path:04666_232 Fc gamma R-mediated phagocytosis 8 -5.93206723888842 3.90772055029302e-07 5.32752568356615e-05
CESC ENSG00000247092 SNHG10 path:04750_88 Inflammatory mediator regulation of TRP channels 5 -4.37576741008785 3.98693083245436e-05 0.00326130942094767
CESC ENSG00000247092 SNHG10 path:04810_134 Regulation of actin cytoskeleton 31 -3.92225757003324 0.000226955894199594 0.0132607086753763
CESC ENSG00000247092 SNHG10 path:04932_103 Non-alcoholic fatty liver disease (NAFLD) 4 -7.63219113822838 2.61083960396887e-10 5.33916699011635e-08
CESC ENSG00000247092 SNHG10 path:05206_136 MicroRNAs in cancer 2 -7.6192948454595 7.64545406442571e-11 3.12699071235011e-08
CESC ENSG00000247092 SNHG10 path:05206_97 MicroRNAs in cancer 26 -4.17580752031433 8.56420162379312e-05 0.00583793077355231
CESC ENSG00000247092 SNHG10 path:05222_63 Small cell lung cancer 6 -5.02599323818842 6.28076073558987e-06 0.000642207785214064
CESC ENSG00000225746 SNHG23 path:04014_136 Ras signaling pathway 15 -3.35932987525971 0.00156098361951259 0.0493010659829392
CESC ENSG00000225746 SNHG23 path:04144_32 Endocytosis 8 -3.79250588125354 0.000283332788560431 0.0199835684716393
CESC ENSG00000225746 SNHG23 path:04151_285 PI3K-Akt signaling pathway 16 -3.51867875809173 0.000687822118579373 0.0325855728676978
CESC ENSG00000225746 SNHG23 path:04360_117 Axon guidance 15 -3.77222385734019 0.000440916737315015 0.0238724919203415
CESC ENSG00000225746 SNHG23 path:04512_73 ECM-receptor interaction 11 -3.33143827611793 0.00132539754573172 0.0456659699847565
CESC ENSG00000225746 SNHG23 path:04662_72 B cell receptor signaling pathway 8 -4.02041495091434 0.000187310299886989 0.0177476509142922
CESC ENSG00000225746 SNHG23 path:04810_134 Regulation of actin cytoskeleton 31 -4.00229285571665 0.000165924471229925 0.0177476509142922
CESC ENSG00000225746 SNHG23 path:04915_139 Estrogen signaling pathway 4 -8.41406486530196 5.72672287895484e-12 2.17042797112388e-09
CESC ENSG00000225746 SNHG23 path:05214_1 Glioma 51 -3.8161134249716 0.000316362561556295 0.0199835684716393
CESC ENSG00000225746 SNHG23 path:05218_1 Melanoma 63 -3.4792121008745 0.00105921735600022 0.0401443377924084
CESC ENSG00000225746 SNHG23 path:05222_63 Small cell lung cancer 6 -6.32875822818816 3.11627491995206e-08 5.90534097330916e-06
CESC ENSG00000225746 SNHG23 path:05231_46 Choline metabolism in cancer 24 -3.44725834743534 0.00104044835502111 0.0401443377924084
CESC ENSG00000271417 SNHG24 path:04014_136 Ras signaling pathway 15 -3.35932987525971 0.00156098361951259 0.0493010659829392
CESC ENSG00000271417 SNHG24 path:04144_32 Endocytosis 8 -3.79250588125354 0.000283332788560431 0.0199835684716393
CESC ENSG00000271417 SNHG24 path:04151_285 PI3K-Akt signaling pathway 16 -3.51867875809173 0.000687822118579373 0.0325855728676978
CESC ENSG00000271417 SNHG24 path:04360_117 Axon guidance 15 -3.77222385734019 0.000440916737315015 0.0238724919203415
CESC ENSG00000271417 SNHG24 path:04512_73 ECM-receptor interaction 11 -3.33143827611793 0.00132539754573172 0.0456659699847565
CESC ENSG00000271417 SNHG24 path:04662_72 B cell receptor signaling pathway 8 -4.02041495091434 0.000187310299886989 0.0177476509142922
CESC ENSG00000271417 SNHG24 path:04810_134 Regulation of actin cytoskeleton 31 -4.00229285571665 0.000165924471229925 0.0177476509142922
CESC ENSG00000271417 SNHG24 path:04915_139 Estrogen signaling pathway 4 -8.41406486530196 5.72672287895484e-12 2.17042797112388e-09
CESC ENSG00000271417 SNHG24 path:05214_1 Glioma 51 -3.8161134249716 0.000316362561556295 0.0199835684716393
CESC ENSG00000271417 SNHG24 path:05218_1 Melanoma 63 -3.4792121008745 0.00105921735600022 0.0401443377924084
CESC ENSG00000271417 SNHG24 path:05222_63 Small cell lung cancer 6 -6.32875822818816 3.11627491995206e-08 5.90534097330916e-06
CESC ENSG00000271417 SNHG24 path:05231_46 Choline metabolism in cancer 24 -3.44725834743534 0.00104044835502111 0.0401443377924084
CESC ENSG00000227848 SUCLA2-AS1 path:00640_31 Propanoate metabolism 3 -5.55189744255061 9.57912557969566e-08 3.82207110629857e-05
CESC ENSG00000187621 TCL6 path:04144_32 Endocytosis 8 -3.8120411613074 0.00027465296025793 0.0140416325931867
CESC ENSG00000187621 TCL6 path:04666_232 Fc gamma R-mediated phagocytosis 8 -5.93206723888842 3.90772055029302e-07 5.32752568356615e-05
CESC ENSG00000187621 TCL6 path:04750_88 Inflammatory mediator regulation of TRP channels 5 -4.37576741008785 3.98693083245436e-05 0.00326130942094767
CESC ENSG00000187621 TCL6 path:04810_134 Regulation of actin cytoskeleton 31 -3.92225757003324 0.000226955894199594 0.0132607086753763
CESC ENSG00000187621 TCL6 path:04932_103 Non-alcoholic fatty liver disease (NAFLD) 4 -7.63219113822838 2.61083960396887e-10 5.33916699011635e-08
CESC ENSG00000187621 TCL6 path:05206_136 MicroRNAs in cancer 2 -7.6192948454595 7.64545406442571e-11 3.12699071235011e-08
CESC ENSG00000187621 TCL6 path:05206_97 MicroRNAs in cancer 26 -4.17580752031433 8.56420162379312e-05 0.00583793077355231
CESC ENSG00000187621 TCL6 path:05222_63 Small cell lung cancer 6 -5.02599323818842 6.28076073558987e-06 0.000642207785214064
CESC ENSG00000270141 TERC path:00071_14 Fatty acid degradation 15 -3.41009789218762 0.0012885420823183 0.0370916042267339
CESC ENSG00000270141 TERC path:00100_15 Steroid biosynthesis 9 4.20429704732536 5.44590945700872e-05 0.00365783585195752
CESC ENSG00000270141 TERC path:00140_23 Steroid hormone biosynthesis 10 3.38508815748897 0.000888999108157138 0.0298555533822772
CESC ENSG00000270141 TERC path:00980_121 Metabolism of xenobiotics by cytochrome P450 4 3.95651764919754 0.00011606920459113 0.00656032797741703
CESC ENSG00000270141 TERC path:00980_73 Metabolism of xenobiotics by cytochrome P450 11 3.43051127716778 0.000751341473750407 0.0275264194474013
CESC ENSG00000270141 TERC path:03460_52 Fanconi anemia pathway 3 3.96362813982066 0.000130229835779991 0.00656032797741703
CESC ENSG00000270141 TERC path:04060_14 Cytokine-cytokine receptor interaction 8 4.5967318773826 7.90424909975221e-06 0.000796353096800035
CESC ENSG00000270141 TERC path:04210_83 Apoptosis 5 4.76675513331163 3.77264349512409e-06 0.000506791776178336
CESC ENSG00000270141 TERC path:04370_11 VEGF signaling pathway 46 4.29098436403437 5.26428372151558e-05 0.00365783585195752
CESC ENSG00000270141 TERC path:04650_17 Natural killer cell mediated cytotoxicity 89 3.36567960300742 0.00100492095387095 0.0311525495699994
CESC ENSG00000270141 TERC path:05162_43 Measles 5 4.76675513331163 3.77264349512409e-06 0.000506791776178336
CESC ENSG00000270141 TERC path:05164_48 Influenza A 5 4.76675513331163 3.77264349512409e-06 0.000506791776178336
CESC ENSG00000270141 TERC path:05220_62 Chronic myeloid leukemia 2 3.6395916917994 0.000510541787859457 0.0205915478068162
CESC ENSG00000270141 TERC path:05221_7 Acute myeloid leukemia 49 3.63842077176597 0.000510956521260947 0.0205915478068162
CESC ENSG00000234717 TMEM212-AS1 path:00100_15 Steroid biosynthesis 9 3.96171587106316 0.00013023892706176 0.00588969370157072
CESC ENSG00000234717 TMEM212-AS1 path:00140_23 Steroid hormone biosynthesis 10 3.4438608917796 0.000730511564248184 0.0247765172207509
CESC ENSG00000234717 TMEM212-AS1 path:00480_17 Glutathione metabolism 19 3.17476254002884 0.00180153413896391 0.0407346885865727
CESC ENSG00000234717 TMEM212-AS1 path:00563_10 Glycosylphosphatidylinositol(GPI)-anchor biosynthesis 5 4.88886088495968 5.37058952288706e-06 0.000789432860292211
CESC ENSG00000234717 TMEM212-AS1 path:00601_58 Glycosphingolipid biosynthesis - lacto and neolacto series 3 3.50624852235087 0.000607751689450578 0.0224868125096714
CESC ENSG00000234717 TMEM212-AS1 path:00980_121 Metabolism of xenobiotics by cytochrome P450 4 3.9353462776982 0.000126514154277756 0.00588969370157072
CESC ENSG00000234717 TMEM212-AS1 path:00980_73 Metabolism of xenobiotics by cytochrome P450 11 3.69628164386011 0.0002904177768182 0.0118200035165007
CESC ENSG00000234717 TMEM212-AS1 path:03460_52 Fanconi anemia pathway 3 4.08194075234927 7.9797088504473e-05 0.0046396307173315
CESC ENSG00000234717 TMEM212-AS1 path:04060_14 Cytokine-cytokine receptor interaction 8 4.44838478809383 1.49066564146269e-05 0.00121340183215063
CESC ENSG00000234717 TMEM212-AS1 path:04210_83 Apoptosis 5 4.60250005270254 7.75855390950576e-06 0.000789432860292211
CESC ENSG00000234717 TMEM212-AS1 path:04370_11 VEGF signaling pathway 46 4.47041332934277 2.46636642383474e-05 0.00167301855750123
CESC ENSG00000234717 TMEM212-AS1 path:04650_17 Natural killer cell mediated cytotoxicity 89 3.30064686874264 0.0012207876267621 0.0336313716500411
CESC ENSG00000234717 TMEM212-AS1 path:05146_3 Amoebiasis 9 3.32488848593629 0.00123948544164771 0.0336313716500411
CESC ENSG00000234717 TMEM212-AS1 path:05162_43 Measles 5 4.60250005270254 7.75855390950576e-06 0.000789432860292211
CESC ENSG00000234717 TMEM212-AS1 path:05164_48 Influenza A 5 4.60250005270254 7.75855390950576e-06 0.000789432860292211
CESC ENSG00000234717 TMEM212-AS1 path:05204_17 Chemical carcinogenesis 14 3.24702433932981 0.00139664810316104 0.0338003366506612
CESC ENSG00000234717 TMEM212-AS1 path:05220_62 Chronic myeloid leukemia 2 3.31425859201454 0.00141180767336914 0.0338003366506612
CESC ENSG00000234717 TMEM212-AS1 path:05221_7 Acute myeloid leukemia 49 3.3972285214544 0.00107829587647695 0.0336313716500411
CESC ENSG00000235943 TMEM212-IT1 path:00100_15 Steroid biosynthesis 9 3.96171587106316 0.00013023892706176 0.00588969370157072
CESC ENSG00000235943 TMEM212-IT1 path:00140_23 Steroid hormone biosynthesis 10 3.4438608917796 0.000730511564248184 0.0247765172207509
CESC ENSG00000235943 TMEM212-IT1 path:00480_17 Glutathione metabolism 19 3.17476254002884 0.00180153413896391 0.0407346885865727
CESC ENSG00000235943 TMEM212-IT1 path:00563_10 Glycosylphosphatidylinositol(GPI)-anchor biosynthesis 5 4.88886088495968 5.37058952288706e-06 0.000789432860292211
CESC ENSG00000235943 TMEM212-IT1 path:00601_58 Glycosphingolipid biosynthesis - lacto and neolacto series 3 3.50624852235087 0.000607751689450578 0.0224868125096714
CESC ENSG00000235943 TMEM212-IT1 path:00980_121 Metabolism of xenobiotics by cytochrome P450 4 3.9353462776982 0.000126514154277756 0.00588969370157072
CESC ENSG00000235943 TMEM212-IT1 path:00980_73 Metabolism of xenobiotics by cytochrome P450 11 3.69628164386011 0.0002904177768182 0.0118200035165007
CESC ENSG00000235943 TMEM212-IT1 path:03460_52 Fanconi anemia pathway 3 4.08194075234927 7.9797088504473e-05 0.0046396307173315
CESC ENSG00000235943 TMEM212-IT1 path:04060_14 Cytokine-cytokine receptor interaction 8 4.44838478809383 1.49066564146269e-05 0.00121340183215063
CESC ENSG00000235943 TMEM212-IT1 path:04210_83 Apoptosis 5 4.60250005270254 7.75855390950576e-06 0.000789432860292211
CESC ENSG00000235943 TMEM212-IT1 path:04370_11 VEGF signaling pathway 46 4.47041332934277 2.46636642383474e-05 0.00167301855750123
CESC ENSG00000235943 TMEM212-IT1 path:04650_17 Natural killer cell mediated cytotoxicity 89 3.30064686874264 0.0012207876267621 0.0336313716500411
CESC ENSG00000235943 TMEM212-IT1 path:05146_3 Amoebiasis 9 3.32488848593629 0.00123948544164771 0.0336313716500411
CESC ENSG00000235943 TMEM212-IT1 path:05162_43 Measles 5 4.60250005270254 7.75855390950576e-06 0.000789432860292211
CESC ENSG00000235943 TMEM212-IT1 path:05164_48 Influenza A 5 4.60250005270254 7.75855390950576e-06 0.000789432860292211
CESC ENSG00000235943 TMEM212-IT1 path:05204_17 Chemical carcinogenesis 14 3.24702433932981 0.00139664810316104 0.0338003366506612
CESC ENSG00000235943 TMEM212-IT1 path:05220_62 Chronic myeloid leukemia 2 3.31425859201454 0.00141180767336914 0.0338003366506612
CESC ENSG00000235943 TMEM212-IT1 path:05221_7 Acute myeloid leukemia 49 3.3972285214544 0.00107829587647695 0.0336313716500411
CESC ENSG00000170919 TPT1-AS1 path:00640_31 Propanoate metabolism 3 -5.42254258714793 1.78380054193679e-07 7.11736416232781e-05
CESC ENSG00000228677 TTC3-AS1 path:00603_9 Glycosphingolipid biosynthesis - globo series 3 -4.92228114270879 4.58932118398926e-06 0.00191374693372352
CESC ENSG00000228677 TTC3-AS1 path:03460_36 Fanconi anemia pathway 23 4.16835771508427 0.000136894876442126 0.0285425817381832
CESC ENSG00000250366 TUNAR path:04144_32 Endocytosis 8 -3.8120411613074 0.00027465296025793 0.0140416325931867
CESC ENSG00000250366 TUNAR path:04666_232 Fc gamma R-mediated phagocytosis 8 -5.93206723888842 3.90772055029302e-07 5.32752568356615e-05
CESC ENSG00000250366 TUNAR path:04750_88 Inflammatory mediator regulation of TRP channels 5 -4.37576741008785 3.98693083245436e-05 0.00326130942094767
CESC ENSG00000250366 TUNAR path:04810_134 Regulation of actin cytoskeleton 31 -3.92225757003324 0.000226955894199594 0.0132607086753763
CESC ENSG00000250366 TUNAR path:04932_103 Non-alcoholic fatty liver disease (NAFLD) 4 -7.63219113822838 2.61083960396887e-10 5.33916699011635e-08
CESC ENSG00000250366 TUNAR path:05206_136 MicroRNAs in cancer 2 -7.6192948454595 7.64545406442571e-11 3.12699071235011e-08
CESC ENSG00000250366 TUNAR path:05206_97 MicroRNAs in cancer 26 -4.17580752031433 8.56420162379312e-05 0.00583793077355231
CESC ENSG00000250366 TUNAR path:05222_63 Small cell lung cancer 6 -5.02599323818842 6.28076073558987e-06 0.000642207785214064
CESC ENSG00000237361 TUSC8 path:00640_31 Propanoate metabolism 3 -5.36565383399629 2.34788259612976e-07 9.36805155855774e-05